NDC properties for "lenalidomide 25 MG Oral Capsule" (RxCUI 643720)
About this data
The tables show NDC propoerties for lenalidomide 25 MG Oral Capsule with the RxCUI 643720
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for lenalidomide 25 MG Oral Capsule (RxCUI 643720)
| ANDA | ANDA201452 |
|---|---|
| ANDA | ANDA209348 |
| ANDA | ANDA210154 |
| ANDA | ANDA210435 |
| ANDA | ANDA210480 |
| ANDA | ANDA211022 |
| ANDA | ANDA211846 |
| ANDA | ANDA212414 |
| ANDA | ANDA213885 |
| ANDA | ANDA213912 |
| ANDA | ANDA215759 |
| ANDA | ANDA216213 |
| MMSL_CODE | BD16978 |
| MMSL_CODE | CD16978 |
| RxCUI | 643720 |
| SNOMEDCT | 840662000 |
| SPL_SET_ID | 1b2716cf-24b4-4157-a218-58ede63917bd |
| SPL_SET_ID | 51bfdd53-8fd9-4f86-bebe-75de29e6379d |
| SPL_SET_ID | 682e8a86-9f49-45db-a2ea-403ee1dc62d2 |
| SPL_SET_ID | 76f6c1e7-985b-43d9-892c-849df50ae80e |
| SPL_SET_ID | 84d9dec7-9250-4dbd-9a0d-23e75f111892 |
| SPL_SET_ID | 9943e098-20b0-dbb3-af12-7816eedd3f70 |
| SPL_SET_ID | adee5af1-c9ab-c0c7-e400-dea7d2a0d4be |
| SPL_SET_ID | ba2a07fd-ca60-40bc-b79b-9caf81900fa3 |
| SPL_SET_ID | c98fb504-76d0-4c25-9c0b-412885828a7a |
| SPL_SET_ID | ca8cc2cc-c856-e676-4f60-1e46d7b53d73 |
| SPL_SET_ID | da7b5dda-79ed-4c4a-88aa-52394fdc7c54 |
| SPL_SET_ID | ed7a3099-ce31-4865-b212-358d9ff6261b |
| SPL_SET_ID | f27092f3-3977-4f4a-b214-45309e136e46 |
| SPL_SET_ID | fd23328f-b019-4c14-80d9-4ebd997f26b2 |
| VUID | 4025613 |
| Prescribable Synonym | lenalidomide 25 MG Oral Capsule |
| RXNAV_STR | lenalidomide 25 MG Oral Capsule |
| RxNorm Name | lenalidomide 25 MG Oral Capsule |
| Related queries | Interactions (for RxCUI 643720) |
NDC Properties
NDC Item 00378194001
| NDC 9 | 0378-1940 |
|---|---|
| NDC 10 | 0378-1940-01 |
| NDC Item | 00378194001 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1940-01) |
| ANDA | ANDA213912 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| Imprint code | MYLAN;LL;25 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1940 |
NDC Item 00378194021
| NDC 9 | 0378-1940 |
|---|---|
| NDC 10 | 0378-1940-21 |
| NDC Item | 00378194021 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (0378-1940-21) |
| ANDA | ANDA213912 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| Imprint code | MYLAN;LL;25 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1940 |
NDC Item 00480124621
| NDC 9 | 0480-1246 |
|---|---|
| NDC 10 | 0480-1246-21 |
| NDC Item | 00480124621 |
| Packaging | 21 CAPSULE in 1 BOTTLE (0480-1246-21) |
| ANDA | ANDA201452 |
| COLORTEXT | white |
| Color | C48325 __ |
| Imprint code | NAT;25mg |
| Labeler | Teva Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0480-1246 |
NDC Item 31722026201
| NDC 9 | 31722-262 |
|---|---|
| NDC 10 | 31722-262-01 |
| NDC Item | 31722026201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (31722-262-01) |
| ANDA | ANDA212414 |
| COLORTEXT | white |
| Color | C48325 __ |
| Imprint code | H;L7 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-262 |
NDC Item 31722026221
| NDC 9 | 31722-262 |
|---|---|
| NDC 10 | 31722-262-21 |
| NDC Item | 31722026221 |
| Packaging | 21 CAPSULE in 1 BOTTLE (31722-262-21) |
| ANDA | ANDA212414 |
| COLORTEXT | white |
| Color | C48325 __ |
| Imprint code | H;L7 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-262 |
NDC Item 43598051501
| NDC 9 | 43598-515 |
|---|---|
| NDC 10 | 43598-515-01 |
| NDC Item | 43598051501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (43598-515-01) |
| ANDA | ANDA209348 |
| COLORTEXT | WHITE(opaque white colored cap and body) |
| Color | C48325 __ |
| Imprint code | RDY;25;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 43598-515 |
NDC Item 43598051521
| NDC 9 | 43598-515 |
|---|---|
| NDC 10 | 43598-515-21 |
| NDC Item | 43598051521 |
| Packaging | 21 CAPSULE in 1 BOTTLE (43598-515-21) |
| ANDA | ANDA209348 |
| COLORTEXT | WHITE(opaque white colored cap and body) |
| Color | C48325 __ |
| Imprint code | RDY;25;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 43598-515 |
NDC Item 47781048801
| NDC 9 | 47781-488 |
|---|---|
| NDC 10 | 47781-488-01 |
| NDC Item | 47781048801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-488-01) |
| ANDA | ANDA210480 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | LP;642 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-488 |
NDC Item 47781048877
| NDC 9 | 47781-488 |
|---|---|
| NDC 10 | 47781-488-77 |
| NDC Item | 47781048877 |
| Packaging | 21 CAPSULE in 1 BOTTLE (47781-488-77) |
| ANDA | ANDA210480 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | LP;642 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-488 |
NDC Item 59651034701
| NDC 9 | 59651-347 |
|---|---|
| NDC 10 | 59651-347-01 |
| NDC Item | 59651034701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (59651-347-01) |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| Imprint code | L;25 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-347 |
NDC Item 59651034707
| NDC 9 | 59651-347 |
|---|---|
| NDC 10 | 59651-347-07 |
| NDC Item | 59651034707 |
| Packaging | 1 BLISTER PACK in 1 CARTON (59651-347-07) / 7 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| Imprint code | L;25 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-347 |
NDC Item 59651034721
| NDC 9 | 59651-347 |
|---|---|
| NDC 10 | 59651-347-21 |
| NDC Item | 59651034721 |
| Packaging | 21 CAPSULE in 1 BOTTLE (59651-347-21) |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| Imprint code | L;25 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-347 |
NDC Item 60219171901
| NDC 9 | 60219-1719 |
|---|---|
| NDC 10 | 60219-1719-1 |
| NDC Item | 60219171901 |
| Packaging | 21 CAPSULE in 1 BOTTLE (60219-1719-1) |
| ANDA | ANDA216213 |
| COLORTEXT | white(white opaque cap),white(white opaque body) |
| Color | C48325;C48325 __ |
| Imprint code | AA22A |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60219-1719 |
NDC Item 60219171902
| NDC 9 | 60219-1719 |
|---|---|
| NDC 10 | 60219-1719-2 |
| NDC Item | 60219171902 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60219-1719-2) |
| ANDA | ANDA216213 |
| COLORTEXT | white(white opaque cap),white(white opaque body) |
| Color | C48325;C48325 __ |
| Imprint code | AA22A |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60219-1719 |
NDC Item 60505453701
| NDC 9 | 60505-4537 |
|---|---|
| NDC 10 | 60505-4537-1 |
| NDC Item | 60505453701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60505-4537-1) |
| ANDA | ANDA211022 |
| COLORTEXT | WHITE(White opaque),WHITE(White opaque) |
| Color | C48325;C48325 __ |
| Imprint code | APO;L25 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60505-4537 |
NDC Item 60505453702
| NDC 9 | 60505-4537 |
|---|---|
| NDC 10 | 60505-4537-2 |
| NDC Item | 60505453702 |
| Packaging | 21 CAPSULE in 1 BOTTLE (60505-4537-2) |
| ANDA | ANDA211022 |
| COLORTEXT | WHITE(White opaque),WHITE(White opaque) |
| Color | C48325;C48325 __ |
| Imprint code | APO;L25 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60505-4537 |
NDC Item 63304004601
| NDC 9 | 63304-046 |
|---|---|
| NDC 10 | 63304-046-01 |
| NDC Item | 63304004601 |
| Packaging | 100 CAPSULE in 1 BOTTLE (63304-046-01) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| Imprint code | RL;;83 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-046 |
NDC Item 63304004622
| NDC 9 | 63304-046 |
|---|---|
| NDC 10 | 63304-046-22 |
| NDC Item | 63304004622 |
| Packaging | 21 CAPSULE in 1 BOTTLE (63304-046-22) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| Imprint code | RL;;83 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-046 |
NDC Item 69097038581
| NDC 9 | 69097-385 |
|---|---|
| NDC 10 | 69097-385-81 |
| NDC Item | 69097038581 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (69097-385-81) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Cipla25mg;385 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 69097-385 |
NDC Item 70377005411
| NDC 9 | 70377-054 |
|---|---|
| NDC 10 | 70377-054-11 |
| NDC Item | 70377005411 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70377-054-11) |
| ANDA | ANDA215759 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Biocon;logo;25;mg |
| Labeler | BIOCON PHARMA INC., |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70377-054 |
NDC Item 70377005412
| NDC 9 | 70377-054 |
|---|---|
| NDC 10 | 70377-054-12 |
| NDC Item | 70377005412 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70377-054-12) |
| ANDA | ANDA215759 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Biocon;logo;25;mg |
| Labeler | BIOCON PHARMA INC., |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70377-054 |
NDC Item 70710103501
| NDC 9 | 70710-1035 |
|---|---|
| NDC 10 | 70710-1035-1 |
| NDC Item | 70710103501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70710-1035-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70710-1035 |
NDC Item 70710103508
| NDC 9 | 70710-1035 |
|---|---|
| NDC 10 | 70710-1035-8 |
| NDC Item | 70710103508 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70710-1035-8) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70710-1035 |
NDC Item 70771168101
| NDC 9 | 70771-1681 |
|---|---|
| NDC 10 | 70771-1681-1 |
| NDC Item | 70771168101 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70771-1681-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(White opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70771-1681 |
NDC Item 70771168108
| NDC 9 | 70771-1681 |
|---|---|
| NDC 10 | 70771-1681-8 |
| NDC Item | 70771168108 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70771-1681-8) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(White opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70771-1681 |
NDC Item 76282070147
| NDC 9 | 76282-701 |
|---|---|
| NDC 10 | 76282-701-47 |
| NDC Item | 76282070147 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (76282-701-47) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Cipla25mg;385 |
| Labeler | EXELAN PHARMACEUTICALS INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 76282-701 |
NDC Item 00378194001
| NDC 9 | 0378-1940 |
|---|---|
| NDC 10 | 0378-1940-01 |
| NDC Item | 00378194001 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1940-01) |
| ANDA | ANDA213912 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| Imprint code | MYLAN;LL;25 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1940 |
NDC Item 00378194021
| NDC 9 | 0378-1940 |
|---|---|
| NDC 10 | 0378-1940-21 |
| NDC Item | 00378194021 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (0378-1940-21) |
| ANDA | ANDA213912 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| Imprint code | MYLAN;LL;25 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1940 |
NDC Item 00480124621
| NDC 9 | 0480-1246 |
|---|---|
| NDC 10 | 0480-1246-21 |
| NDC Item | 00480124621 |
| Packaging | 21 CAPSULE in 1 BOTTLE (0480-1246-21) |
| ANDA | ANDA201452 |
| COLORTEXT | white |
| Color | C48325 __ |
| Imprint code | NAT;25mg |
| Labeler | Teva Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0480-1246 |
NDC Item 31722026201
| NDC 9 | 31722-262 |
|---|---|
| NDC 10 | 31722-262-01 |
| NDC Item | 31722026201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (31722-262-01) |
| ANDA | ANDA212414 |
| COLORTEXT | white |
| Color | C48325 __ |
| Imprint code | H;L7 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-262 |
NDC Item 31722026221
| NDC 9 | 31722-262 |
|---|---|
| NDC 10 | 31722-262-21 |
| NDC Item | 31722026221 |
| Packaging | 21 CAPSULE in 1 BOTTLE (31722-262-21) |
| ANDA | ANDA212414 |
| COLORTEXT | white |
| Color | C48325 __ |
| Imprint code | H;L7 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-262 |
NDC Item 43598051501
| NDC 9 | 43598-515 |
|---|---|
| NDC 10 | 43598-515-01 |
| NDC Item | 43598051501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (43598-515-01) |
| ANDA | ANDA209348 |
| COLORTEXT | WHITE(opaque white colored cap and body) |
| Color | C48325 __ |
| Imprint code | RDY;25;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 43598-515 |
NDC Item 43598051521
| NDC 9 | 43598-515 |
|---|---|
| NDC 10 | 43598-515-21 |
| NDC Item | 43598051521 |
| Packaging | 21 CAPSULE in 1 BOTTLE (43598-515-21) |
| ANDA | ANDA209348 |
| COLORTEXT | WHITE(opaque white colored cap and body) |
| Color | C48325 __ |
| Imprint code | RDY;25;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 43598-515 |
NDC Item 47781048801
| NDC 9 | 47781-488 |
|---|---|
| NDC 10 | 47781-488-01 |
| NDC Item | 47781048801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-488-01) |
| ANDA | ANDA210480 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | LP;642 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-488 |
NDC Item 47781048877
| NDC 9 | 47781-488 |
|---|---|
| NDC 10 | 47781-488-77 |
| NDC Item | 47781048877 |
| Packaging | 21 CAPSULE in 1 BOTTLE (47781-488-77) |
| ANDA | ANDA210480 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | LP;642 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-488 |
NDC Item 59651034701
| NDC 9 | 59651-347 |
|---|---|
| NDC 10 | 59651-347-01 |
| NDC Item | 59651034701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (59651-347-01) |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| Imprint code | L;25 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-347 |
NDC Item 59651034707
| NDC 9 | 59651-347 |
|---|---|
| NDC 10 | 59651-347-07 |
| NDC Item | 59651034707 |
| Packaging | 1 BLISTER PACK in 1 CARTON (59651-347-07) / 7 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| Imprint code | L;25 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-347 |
NDC Item 59651034721
| NDC 9 | 59651-347 |
|---|---|
| NDC 10 | 59651-347-21 |
| NDC Item | 59651034721 |
| Packaging | 21 CAPSULE in 1 BOTTLE (59651-347-21) |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| Imprint code | L;25 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-347 |
NDC Item 60219171901
| NDC 9 | 60219-1719 |
|---|---|
| NDC 10 | 60219-1719-1 |
| NDC Item | 60219171901 |
| Packaging | 21 CAPSULE in 1 BOTTLE (60219-1719-1) |
| ANDA | ANDA216213 |
| COLORTEXT | white(white opaque cap),white(white opaque body) |
| Color | C48325;C48325 __ |
| Imprint code | AA22A |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60219-1719 |
NDC Item 60219171902
| NDC 9 | 60219-1719 |
|---|---|
| NDC 10 | 60219-1719-2 |
| NDC Item | 60219171902 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60219-1719-2) |
| ANDA | ANDA216213 |
| COLORTEXT | white(white opaque cap),white(white opaque body) |
| Color | C48325;C48325 __ |
| Imprint code | AA22A |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60219-1719 |
NDC Item 60505453701
| NDC 9 | 60505-4537 |
|---|---|
| NDC 10 | 60505-4537-1 |
| NDC Item | 60505453701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60505-4537-1) |
| ANDA | ANDA211022 |
| COLORTEXT | WHITE(White opaque),WHITE(White opaque) |
| Color | C48325;C48325 __ |
| Imprint code | APO;L25 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60505-4537 |
NDC Item 60505453702
| NDC 9 | 60505-4537 |
|---|---|
| NDC 10 | 60505-4537-2 |
| NDC Item | 60505453702 |
| Packaging | 21 CAPSULE in 1 BOTTLE (60505-4537-2) |
| ANDA | ANDA211022 |
| COLORTEXT | WHITE(White opaque),WHITE(White opaque) |
| Color | C48325;C48325 __ |
| Imprint code | APO;L25 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60505-4537 |
NDC Item 63304004601
| NDC 9 | 63304-046 |
|---|---|
| NDC 10 | 63304-046-01 |
| NDC Item | 63304004601 |
| Packaging | 100 CAPSULE in 1 BOTTLE (63304-046-01) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| Imprint code | RL;;83 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-046 |
NDC Item 63304004622
| NDC 9 | 63304-046 |
|---|---|
| NDC 10 | 63304-046-22 |
| NDC Item | 63304004622 |
| Packaging | 21 CAPSULE in 1 BOTTLE (63304-046-22) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| Imprint code | RL;;83 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-046 |
NDC Item 69097038581
| NDC 9 | 69097-385 |
|---|---|
| NDC 10 | 69097-385-81 |
| NDC Item | 69097038581 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (69097-385-81) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Cipla25mg;385 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 69097-385 |
NDC Item 70377005411
| NDC 9 | 70377-054 |
|---|---|
| NDC 10 | 70377-054-11 |
| NDC Item | 70377005411 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70377-054-11) |
| ANDA | ANDA215759 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Biocon;logo;25;mg |
| Labeler | BIOCON PHARMA INC., |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70377-054 |
NDC Item 70377005412
| NDC 9 | 70377-054 |
|---|---|
| NDC 10 | 70377-054-12 |
| NDC Item | 70377005412 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70377-054-12) |
| ANDA | ANDA215759 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Biocon;logo;25;mg |
| Labeler | BIOCON PHARMA INC., |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70377-054 |
NDC Item 70710103501
| NDC 9 | 70710-1035 |
|---|---|
| NDC 10 | 70710-1035-1 |
| NDC Item | 70710103501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70710-1035-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70710-1035 |
NDC Item 70710103508
| NDC 9 | 70710-1035 |
|---|---|
| NDC 10 | 70710-1035-8 |
| NDC Item | 70710103508 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70710-1035-8) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70710-1035 |
NDC Item 70771168101
| NDC 9 | 70771-1681 |
|---|---|
| NDC 10 | 70771-1681-1 |
| NDC Item | 70771168101 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70771-1681-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(White opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70771-1681 |
NDC Item 70771168108
| NDC 9 | 70771-1681 |
|---|---|
| NDC 10 | 70771-1681-8 |
| NDC Item | 70771168108 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70771-1681-8) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(White opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70771-1681 |
NDC Item 76282070147
| NDC 9 | 76282-701 |
|---|---|
| NDC 10 | 76282-701-47 |
| NDC Item | 76282070147 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (76282-701-47) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Cipla25mg;385 |
| Labeler | EXELAN PHARMACEUTICALS INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 76282-701 |
NDC Item 00378194001
| NDC 9 | 0378-1940 |
|---|---|
| NDC 10 | 0378-1940-01 |
| NDC Item | 00378194001 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1940-01) |
| ANDA | ANDA213912 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| Imprint code | MYLAN;LL;25 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1940 |
NDC Item 00378194021
| NDC 9 | 0378-1940 |
|---|---|
| NDC 10 | 0378-1940-21 |
| NDC Item | 00378194021 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (0378-1940-21) |
| ANDA | ANDA213912 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| Imprint code | MYLAN;LL;25 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1940 |
NDC Item 00480124621
| NDC 9 | 0480-1246 |
|---|---|
| NDC 10 | 0480-1246-21 |
| NDC Item | 00480124621 |
| Packaging | 21 CAPSULE in 1 BOTTLE (0480-1246-21) |
| ANDA | ANDA201452 |
| COLORTEXT | white |
| Color | C48325 __ |
| Imprint code | NAT;25mg |
| Labeler | Teva Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0480-1246 |
NDC Item 31722026201
| NDC 9 | 31722-262 |
|---|---|
| NDC 10 | 31722-262-01 |
| NDC Item | 31722026201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (31722-262-01) |
| ANDA | ANDA212414 |
| COLORTEXT | white |
| Color | C48325 __ |
| Imprint code | H;L7 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-262 |
NDC Item 31722026221
| NDC 9 | 31722-262 |
|---|---|
| NDC 10 | 31722-262-21 |
| NDC Item | 31722026221 |
| Packaging | 21 CAPSULE in 1 BOTTLE (31722-262-21) |
| ANDA | ANDA212414 |
| COLORTEXT | white |
| Color | C48325 __ |
| Imprint code | H;L7 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-262 |
NDC Item 43598051501
| NDC 9 | 43598-515 |
|---|---|
| NDC 10 | 43598-515-01 |
| NDC Item | 43598051501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (43598-515-01) |
| ANDA | ANDA209348 |
| COLORTEXT | WHITE(opaque white colored cap and body) |
| Color | C48325 __ |
| Imprint code | RDY;25;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 43598-515 |
NDC Item 43598051521
| NDC 9 | 43598-515 |
|---|---|
| NDC 10 | 43598-515-21 |
| NDC Item | 43598051521 |
| Packaging | 21 CAPSULE in 1 BOTTLE (43598-515-21) |
| ANDA | ANDA209348 |
| COLORTEXT | WHITE(opaque white colored cap and body) |
| Color | C48325 __ |
| Imprint code | RDY;25;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 43598-515 |
NDC Item 47781048801
| NDC 9 | 47781-488 |
|---|---|
| NDC 10 | 47781-488-01 |
| NDC Item | 47781048801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-488-01) |
| ANDA | ANDA210480 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | LP;642 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-488 |
NDC Item 47781048877
| NDC 9 | 47781-488 |
|---|---|
| NDC 10 | 47781-488-77 |
| NDC Item | 47781048877 |
| Packaging | 21 CAPSULE in 1 BOTTLE (47781-488-77) |
| ANDA | ANDA210480 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | LP;642 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-488 |
NDC Item 59651034701
| NDC 9 | 59651-347 |
|---|---|
| NDC 10 | 59651-347-01 |
| NDC Item | 59651034701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (59651-347-01) |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| Imprint code | L;25 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-347 |
NDC Item 59651034707
| NDC 9 | 59651-347 |
|---|---|
| NDC 10 | 59651-347-07 |
| NDC Item | 59651034707 |
| Packaging | 1 BLISTER PACK in 1 CARTON (59651-347-07) / 7 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| Imprint code | L;25 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-347 |
NDC Item 59651034721
| NDC 9 | 59651-347 |
|---|---|
| NDC 10 | 59651-347-21 |
| NDC Item | 59651034721 |
| Packaging | 21 CAPSULE in 1 BOTTLE (59651-347-21) |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| Imprint code | L;25 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-347 |
NDC Item 60219171901
| NDC 9 | 60219-1719 |
|---|---|
| NDC 10 | 60219-1719-1 |
| NDC Item | 60219171901 |
| Packaging | 21 CAPSULE in 1 BOTTLE (60219-1719-1) |
| ANDA | ANDA216213 |
| COLORTEXT | white(white opaque cap),white(white opaque body) |
| Color | C48325;C48325 __ |
| Imprint code | AA22A |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60219-1719 |
NDC Item 60219171902
| NDC 9 | 60219-1719 |
|---|---|
| NDC 10 | 60219-1719-2 |
| NDC Item | 60219171902 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60219-1719-2) |
| ANDA | ANDA216213 |
| COLORTEXT | white(white opaque cap),white(white opaque body) |
| Color | C48325;C48325 __ |
| Imprint code | AA22A |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60219-1719 |
NDC Item 60505453701
| NDC 9 | 60505-4537 |
|---|---|
| NDC 10 | 60505-4537-1 |
| NDC Item | 60505453701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60505-4537-1) |
| ANDA | ANDA211022 |
| COLORTEXT | WHITE(White opaque),WHITE(White opaque) |
| Color | C48325;C48325 __ |
| Imprint code | APO;L25 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60505-4537 |
NDC Item 60505453702
| NDC 9 | 60505-4537 |
|---|---|
| NDC 10 | 60505-4537-2 |
| NDC Item | 60505453702 |
| Packaging | 21 CAPSULE in 1 BOTTLE (60505-4537-2) |
| ANDA | ANDA211022 |
| COLORTEXT | WHITE(White opaque),WHITE(White opaque) |
| Color | C48325;C48325 __ |
| Imprint code | APO;L25 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60505-4537 |
NDC Item 63304004601
| NDC 9 | 63304-046 |
|---|---|
| NDC 10 | 63304-046-01 |
| NDC Item | 63304004601 |
| Packaging | 100 CAPSULE in 1 BOTTLE (63304-046-01) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| Imprint code | RL;;83 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-046 |
NDC Item 63304004622
| NDC 9 | 63304-046 |
|---|---|
| NDC 10 | 63304-046-22 |
| NDC Item | 63304004622 |
| Packaging | 21 CAPSULE in 1 BOTTLE (63304-046-22) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| Imprint code | RL;;83 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-046 |
NDC Item 69097038581
| NDC 9 | 69097-385 |
|---|---|
| NDC 10 | 69097-385-81 |
| NDC Item | 69097038581 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (69097-385-81) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Cipla25mg;385 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 69097-385 |
NDC Item 70377005411
| NDC 9 | 70377-054 |
|---|---|
| NDC 10 | 70377-054-11 |
| NDC Item | 70377005411 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70377-054-11) |
| ANDA | ANDA215759 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Biocon;logo;25;mg |
| Labeler | BIOCON PHARMA INC., |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70377-054 |
NDC Item 70377005412
| NDC 9 | 70377-054 |
|---|---|
| NDC 10 | 70377-054-12 |
| NDC Item | 70377005412 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70377-054-12) |
| ANDA | ANDA215759 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Biocon;logo;25;mg |
| Labeler | BIOCON PHARMA INC., |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70377-054 |
NDC Item 70710103501
| NDC 9 | 70710-1035 |
|---|---|
| NDC 10 | 70710-1035-1 |
| NDC Item | 70710103501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70710-1035-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70710-1035 |
NDC Item 70710103508
| NDC 9 | 70710-1035 |
|---|---|
| NDC 10 | 70710-1035-8 |
| NDC Item | 70710103508 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70710-1035-8) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70710-1035 |
NDC Item 70771168101
| NDC 9 | 70771-1681 |
|---|---|
| NDC 10 | 70771-1681-1 |
| NDC Item | 70771168101 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70771-1681-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(White opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70771-1681 |
NDC Item 70771168108
| NDC 9 | 70771-1681 |
|---|---|
| NDC 10 | 70771-1681-8 |
| NDC Item | 70771168108 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70771-1681-8) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(White opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70771-1681 |
NDC Item 76282070147
| NDC 9 | 76282-701 |
|---|---|
| NDC 10 | 76282-701-47 |
| NDC Item | 76282070147 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (76282-701-47) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Cipla25mg;385 |
| Labeler | EXELAN PHARMACEUTICALS INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 76282-701 |
NDC Item 00378194001
| NDC 9 | 0378-1940 |
|---|---|
| NDC 10 | 0378-1940-01 |
| NDC Item | 00378194001 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1940-01) |
| ANDA | ANDA213912 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| Imprint code | MYLAN;LL;25 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1940 |
NDC Item 00378194021
| NDC 9 | 0378-1940 |
|---|---|
| NDC 10 | 0378-1940-21 |
| NDC Item | 00378194021 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (0378-1940-21) |
| ANDA | ANDA213912 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| Imprint code | MYLAN;LL;25 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1940 |
NDC Item 00480124621
| NDC 9 | 0480-1246 |
|---|---|
| NDC 10 | 0480-1246-21 |
| NDC Item | 00480124621 |
| Packaging | 21 CAPSULE in 1 BOTTLE (0480-1246-21) |
| ANDA | ANDA201452 |
| COLORTEXT | white |
| Color | C48325 __ |
| Imprint code | NAT;25mg |
| Labeler | Teva Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0480-1246 |
NDC Item 31722026201
| NDC 9 | 31722-262 |
|---|---|
| NDC 10 | 31722-262-01 |
| NDC Item | 31722026201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (31722-262-01) |
| ANDA | ANDA212414 |
| COLORTEXT | white |
| Color | C48325 __ |
| Imprint code | H;L7 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-262 |
NDC Item 31722026221
| NDC 9 | 31722-262 |
|---|---|
| NDC 10 | 31722-262-21 |
| NDC Item | 31722026221 |
| Packaging | 21 CAPSULE in 1 BOTTLE (31722-262-21) |
| ANDA | ANDA212414 |
| COLORTEXT | white |
| Color | C48325 __ |
| Imprint code | H;L7 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-262 |
NDC Item 43598051501
| NDC 9 | 43598-515 |
|---|---|
| NDC 10 | 43598-515-01 |
| NDC Item | 43598051501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (43598-515-01) |
| ANDA | ANDA209348 |
| COLORTEXT | WHITE(opaque white colored cap and body) |
| Color | C48325 __ |
| Imprint code | RDY;25;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 43598-515 |
NDC Item 43598051521
| NDC 9 | 43598-515 |
|---|---|
| NDC 10 | 43598-515-21 |
| NDC Item | 43598051521 |
| Packaging | 21 CAPSULE in 1 BOTTLE (43598-515-21) |
| ANDA | ANDA209348 |
| COLORTEXT | WHITE(opaque white colored cap and body) |
| Color | C48325 __ |
| Imprint code | RDY;25;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 43598-515 |
NDC Item 47781048801
| NDC 9 | 47781-488 |
|---|---|
| NDC 10 | 47781-488-01 |
| NDC Item | 47781048801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-488-01) |
| ANDA | ANDA210480 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | LP;642 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-488 |
NDC Item 47781048877
| NDC 9 | 47781-488 |
|---|---|
| NDC 10 | 47781-488-77 |
| NDC Item | 47781048877 |
| Packaging | 21 CAPSULE in 1 BOTTLE (47781-488-77) |
| ANDA | ANDA210480 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | LP;642 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-488 |
NDC Item 59651034701
| NDC 9 | 59651-347 |
|---|---|
| NDC 10 | 59651-347-01 |
| NDC Item | 59651034701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (59651-347-01) |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| Imprint code | L;25 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-347 |
NDC Item 59651034707
| NDC 9 | 59651-347 |
|---|---|
| NDC 10 | 59651-347-07 |
| NDC Item | 59651034707 |
| Packaging | 1 BLISTER PACK in 1 CARTON (59651-347-07) / 7 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| Imprint code | L;25 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-347 |
NDC Item 59651034721
| NDC 9 | 59651-347 |
|---|---|
| NDC 10 | 59651-347-21 |
| NDC Item | 59651034721 |
| Packaging | 21 CAPSULE in 1 BOTTLE (59651-347-21) |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| Imprint code | L;25 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-347 |
NDC Item 60219171901
| NDC 9 | 60219-1719 |
|---|---|
| NDC 10 | 60219-1719-1 |
| NDC Item | 60219171901 |
| Packaging | 21 CAPSULE in 1 BOTTLE (60219-1719-1) |
| ANDA | ANDA216213 |
| COLORTEXT | white(white opaque cap),white(white opaque body) |
| Color | C48325;C48325 __ |
| Imprint code | AA22A |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60219-1719 |
NDC Item 60219171902
| NDC 9 | 60219-1719 |
|---|---|
| NDC 10 | 60219-1719-2 |
| NDC Item | 60219171902 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60219-1719-2) |
| ANDA | ANDA216213 |
| COLORTEXT | white(white opaque cap),white(white opaque body) |
| Color | C48325;C48325 __ |
| Imprint code | AA22A |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60219-1719 |
NDC Item 60505453701
| NDC 9 | 60505-4537 |
|---|---|
| NDC 10 | 60505-4537-1 |
| NDC Item | 60505453701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60505-4537-1) |
| ANDA | ANDA211022 |
| COLORTEXT | WHITE(White opaque),WHITE(White opaque) |
| Color | C48325;C48325 __ |
| Imprint code | APO;L25 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60505-4537 |
NDC Item 60505453702
| NDC 9 | 60505-4537 |
|---|---|
| NDC 10 | 60505-4537-2 |
| NDC Item | 60505453702 |
| Packaging | 21 CAPSULE in 1 BOTTLE (60505-4537-2) |
| ANDA | ANDA211022 |
| COLORTEXT | WHITE(White opaque),WHITE(White opaque) |
| Color | C48325;C48325 __ |
| Imprint code | APO;L25 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60505-4537 |
NDC Item 63304004601
| NDC 9 | 63304-046 |
|---|---|
| NDC 10 | 63304-046-01 |
| NDC Item | 63304004601 |
| Packaging | 100 CAPSULE in 1 BOTTLE (63304-046-01) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| Imprint code | RL;;83 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-046 |
NDC Item 63304004622
| NDC 9 | 63304-046 |
|---|---|
| NDC 10 | 63304-046-22 |
| NDC Item | 63304004622 |
| Packaging | 21 CAPSULE in 1 BOTTLE (63304-046-22) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| Imprint code | RL;;83 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-046 |
NDC Item 69097038581
| NDC 9 | 69097-385 |
|---|---|
| NDC 10 | 69097-385-81 |
| NDC Item | 69097038581 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (69097-385-81) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Cipla25mg;385 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 69097-385 |
NDC Item 70377005411
| NDC 9 | 70377-054 |
|---|---|
| NDC 10 | 70377-054-11 |
| NDC Item | 70377005411 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70377-054-11) |
| ANDA | ANDA215759 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Biocon;logo;25;mg |
| Labeler | BIOCON PHARMA INC., |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70377-054 |
NDC Item 70377005412
| NDC 9 | 70377-054 |
|---|---|
| NDC 10 | 70377-054-12 |
| NDC Item | 70377005412 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70377-054-12) |
| ANDA | ANDA215759 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Biocon;logo;25;mg |
| Labeler | BIOCON PHARMA INC., |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70377-054 |
NDC Item 70710103501
| NDC 9 | 70710-1035 |
|---|---|
| NDC 10 | 70710-1035-1 |
| NDC Item | 70710103501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70710-1035-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70710-1035 |
NDC Item 70710103508
| NDC 9 | 70710-1035 |
|---|---|
| NDC 10 | 70710-1035-8 |
| NDC Item | 70710103508 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70710-1035-8) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70710-1035 |
NDC Item 70771168101
| NDC 9 | 70771-1681 |
|---|---|
| NDC 10 | 70771-1681-1 |
| NDC Item | 70771168101 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70771-1681-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(White opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70771-1681 |
NDC Item 70771168108
| NDC 9 | 70771-1681 |
|---|---|
| NDC 10 | 70771-1681-8 |
| NDC Item | 70771168108 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70771-1681-8) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(White opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70771-1681 |
NDC Item 76282070147
| NDC 9 | 76282-701 |
|---|---|
| NDC 10 | 76282-701-47 |
| NDC Item | 76282070147 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (76282-701-47) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Cipla25mg;385 |
| Labeler | EXELAN PHARMACEUTICALS INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 76282-701 |
NDC Item 00378194001
| NDC 9 | 0378-1940 |
|---|---|
| NDC 10 | 0378-1940-01 |
| NDC Item | 00378194001 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1940-01) |
| ANDA | ANDA213912 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| Imprint code | MYLAN;LL;25 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1940 |
NDC Item 00378194021
| NDC 9 | 0378-1940 |
|---|---|
| NDC 10 | 0378-1940-21 |
| NDC Item | 00378194021 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (0378-1940-21) |
| ANDA | ANDA213912 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| Imprint code | MYLAN;LL;25 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1940 |
NDC Item 00480124621
| NDC 9 | 0480-1246 |
|---|---|
| NDC 10 | 0480-1246-21 |
| NDC Item | 00480124621 |
| Packaging | 21 CAPSULE in 1 BOTTLE (0480-1246-21) |
| ANDA | ANDA201452 |
| COLORTEXT | white |
| Color | C48325 __ |
| Imprint code | NAT;25mg |
| Labeler | Teva Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0480-1246 |
NDC Item 31722026201
| NDC 9 | 31722-262 |
|---|---|
| NDC 10 | 31722-262-01 |
| NDC Item | 31722026201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (31722-262-01) |
| ANDA | ANDA212414 |
| COLORTEXT | white |
| Color | C48325 __ |
| Imprint code | H;L7 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-262 |
NDC Item 31722026221
| NDC 9 | 31722-262 |
|---|---|
| NDC 10 | 31722-262-21 |
| NDC Item | 31722026221 |
| Packaging | 21 CAPSULE in 1 BOTTLE (31722-262-21) |
| ANDA | ANDA212414 |
| COLORTEXT | white |
| Color | C48325 __ |
| Imprint code | H;L7 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-262 |
NDC Item 43598051501
| NDC 9 | 43598-515 |
|---|---|
| NDC 10 | 43598-515-01 |
| NDC Item | 43598051501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (43598-515-01) |
| ANDA | ANDA209348 |
| COLORTEXT | WHITE(opaque white colored cap and body) |
| Color | C48325 __ |
| Imprint code | RDY;25;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 43598-515 |
NDC Item 43598051521
| NDC 9 | 43598-515 |
|---|---|
| NDC 10 | 43598-515-21 |
| NDC Item | 43598051521 |
| Packaging | 21 CAPSULE in 1 BOTTLE (43598-515-21) |
| ANDA | ANDA209348 |
| COLORTEXT | WHITE(opaque white colored cap and body) |
| Color | C48325 __ |
| Imprint code | RDY;25;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 43598-515 |
NDC Item 47781048801
| NDC 9 | 47781-488 |
|---|---|
| NDC 10 | 47781-488-01 |
| NDC Item | 47781048801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-488-01) |
| ANDA | ANDA210480 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | LP;642 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-488 |
NDC Item 47781048877
| NDC 9 | 47781-488 |
|---|---|
| NDC 10 | 47781-488-77 |
| NDC Item | 47781048877 |
| Packaging | 21 CAPSULE in 1 BOTTLE (47781-488-77) |
| ANDA | ANDA210480 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | LP;642 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-488 |
NDC Item 59651034701
| NDC 9 | 59651-347 |
|---|---|
| NDC 10 | 59651-347-01 |
| NDC Item | 59651034701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (59651-347-01) |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| Imprint code | L;25 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-347 |
NDC Item 59651034707
| NDC 9 | 59651-347 |
|---|---|
| NDC 10 | 59651-347-07 |
| NDC Item | 59651034707 |
| Packaging | 1 BLISTER PACK in 1 CARTON (59651-347-07) / 7 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| Imprint code | L;25 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-347 |
NDC Item 59651034721
| NDC 9 | 59651-347 |
|---|---|
| NDC 10 | 59651-347-21 |
| NDC Item | 59651034721 |
| Packaging | 21 CAPSULE in 1 BOTTLE (59651-347-21) |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| Imprint code | L;25 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-347 |
NDC Item 60219171901
| NDC 9 | 60219-1719 |
|---|---|
| NDC 10 | 60219-1719-1 |
| NDC Item | 60219171901 |
| Packaging | 21 CAPSULE in 1 BOTTLE (60219-1719-1) |
| ANDA | ANDA216213 |
| COLORTEXT | white(white opaque cap),white(white opaque body) |
| Color | C48325;C48325 __ |
| Imprint code | AA22A |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60219-1719 |
NDC Item 60219171902
| NDC 9 | 60219-1719 |
|---|---|
| NDC 10 | 60219-1719-2 |
| NDC Item | 60219171902 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60219-1719-2) |
| ANDA | ANDA216213 |
| COLORTEXT | white(white opaque cap),white(white opaque body) |
| Color | C48325;C48325 __ |
| Imprint code | AA22A |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60219-1719 |
NDC Item 60505453701
| NDC 9 | 60505-4537 |
|---|---|
| NDC 10 | 60505-4537-1 |
| NDC Item | 60505453701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60505-4537-1) |
| ANDA | ANDA211022 |
| COLORTEXT | WHITE(White opaque),WHITE(White opaque) |
| Color | C48325;C48325 __ |
| Imprint code | APO;L25 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60505-4537 |
NDC Item 60505453702
| NDC 9 | 60505-4537 |
|---|---|
| NDC 10 | 60505-4537-2 |
| NDC Item | 60505453702 |
| Packaging | 21 CAPSULE in 1 BOTTLE (60505-4537-2) |
| ANDA | ANDA211022 |
| COLORTEXT | WHITE(White opaque),WHITE(White opaque) |
| Color | C48325;C48325 __ |
| Imprint code | APO;L25 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60505-4537 |
NDC Item 63304004601
| NDC 9 | 63304-046 |
|---|---|
| NDC 10 | 63304-046-01 |
| NDC Item | 63304004601 |
| Packaging | 100 CAPSULE in 1 BOTTLE (63304-046-01) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| Imprint code | RL;;83 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-046 |
NDC Item 63304004622
| NDC 9 | 63304-046 |
|---|---|
| NDC 10 | 63304-046-22 |
| NDC Item | 63304004622 |
| Packaging | 21 CAPSULE in 1 BOTTLE (63304-046-22) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| Imprint code | RL;;83 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-046 |
NDC Item 69097038581
| NDC 9 | 69097-385 |
|---|---|
| NDC 10 | 69097-385-81 |
| NDC Item | 69097038581 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (69097-385-81) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Cipla25mg;385 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 69097-385 |
NDC Item 70377005411
| NDC 9 | 70377-054 |
|---|---|
| NDC 10 | 70377-054-11 |
| NDC Item | 70377005411 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70377-054-11) |
| ANDA | ANDA215759 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Biocon;logo;25;mg |
| Labeler | BIOCON PHARMA INC., |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70377-054 |
NDC Item 70377005412
| NDC 9 | 70377-054 |
|---|---|
| NDC 10 | 70377-054-12 |
| NDC Item | 70377005412 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70377-054-12) |
| ANDA | ANDA215759 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Biocon;logo;25;mg |
| Labeler | BIOCON PHARMA INC., |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70377-054 |
NDC Item 70710103501
| NDC 9 | 70710-1035 |
|---|---|
| NDC 10 | 70710-1035-1 |
| NDC Item | 70710103501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70710-1035-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70710-1035 |
NDC Item 70710103508
| NDC 9 | 70710-1035 |
|---|---|
| NDC 10 | 70710-1035-8 |
| NDC Item | 70710103508 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70710-1035-8) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70710-1035 |
NDC Item 70771168101
| NDC 9 | 70771-1681 |
|---|---|
| NDC 10 | 70771-1681-1 |
| NDC Item | 70771168101 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70771-1681-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(White opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70771-1681 |
NDC Item 70771168108
| NDC 9 | 70771-1681 |
|---|---|
| NDC 10 | 70771-1681-8 |
| NDC Item | 70771168108 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70771-1681-8) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(White opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70771-1681 |
NDC Item 76282070147
| NDC 9 | 76282-701 |
|---|---|
| NDC 10 | 76282-701-47 |
| NDC Item | 76282070147 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (76282-701-47) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Cipla25mg;385 |
| Labeler | EXELAN PHARMACEUTICALS INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 76282-701 |
NDC Item 00378194001
| NDC 9 | 0378-1940 |
|---|---|
| NDC 10 | 0378-1940-01 |
| NDC Item | 00378194001 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1940-01) |
| ANDA | ANDA213912 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| Imprint code | MYLAN;LL;25 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1940 |
NDC Item 00378194021
| NDC 9 | 0378-1940 |
|---|---|
| NDC 10 | 0378-1940-21 |
| NDC Item | 00378194021 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (0378-1940-21) |
| ANDA | ANDA213912 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| Imprint code | MYLAN;LL;25 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1940 |
NDC Item 00480124621
| NDC 9 | 0480-1246 |
|---|---|
| NDC 10 | 0480-1246-21 |
| NDC Item | 00480124621 |
| Packaging | 21 CAPSULE in 1 BOTTLE (0480-1246-21) |
| ANDA | ANDA201452 |
| COLORTEXT | white |
| Color | C48325 __ |
| Imprint code | NAT;25mg |
| Labeler | Teva Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0480-1246 |
NDC Item 31722026201
| NDC 9 | 31722-262 |
|---|---|
| NDC 10 | 31722-262-01 |
| NDC Item | 31722026201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (31722-262-01) |
| ANDA | ANDA212414 |
| COLORTEXT | white |
| Color | C48325 __ |
| Imprint code | H;L7 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-262 |
NDC Item 31722026221
| NDC 9 | 31722-262 |
|---|---|
| NDC 10 | 31722-262-21 |
| NDC Item | 31722026221 |
| Packaging | 21 CAPSULE in 1 BOTTLE (31722-262-21) |
| ANDA | ANDA212414 |
| COLORTEXT | white |
| Color | C48325 __ |
| Imprint code | H;L7 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-262 |
NDC Item 43598051501
| NDC 9 | 43598-515 |
|---|---|
| NDC 10 | 43598-515-01 |
| NDC Item | 43598051501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (43598-515-01) |
| ANDA | ANDA209348 |
| COLORTEXT | WHITE(opaque white colored cap and body) |
| Color | C48325 __ |
| Imprint code | RDY;25;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 43598-515 |
NDC Item 43598051521
| NDC 9 | 43598-515 |
|---|---|
| NDC 10 | 43598-515-21 |
| NDC Item | 43598051521 |
| Packaging | 21 CAPSULE in 1 BOTTLE (43598-515-21) |
| ANDA | ANDA209348 |
| COLORTEXT | WHITE(opaque white colored cap and body) |
| Color | C48325 __ |
| Imprint code | RDY;25;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 43598-515 |
NDC Item 47781048801
| NDC 9 | 47781-488 |
|---|---|
| NDC 10 | 47781-488-01 |
| NDC Item | 47781048801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-488-01) |
| ANDA | ANDA210480 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | LP;642 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-488 |
NDC Item 47781048877
| NDC 9 | 47781-488 |
|---|---|
| NDC 10 | 47781-488-77 |
| NDC Item | 47781048877 |
| Packaging | 21 CAPSULE in 1 BOTTLE (47781-488-77) |
| ANDA | ANDA210480 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | LP;642 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-488 |
NDC Item 59651034701
| NDC 9 | 59651-347 |
|---|---|
| NDC 10 | 59651-347-01 |
| NDC Item | 59651034701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (59651-347-01) |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| Imprint code | L;25 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-347 |
NDC Item 59651034707
| NDC 9 | 59651-347 |
|---|---|
| NDC 10 | 59651-347-07 |
| NDC Item | 59651034707 |
| Packaging | 1 BLISTER PACK in 1 CARTON (59651-347-07) / 7 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| Imprint code | L;25 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-347 |
NDC Item 59651034721
| NDC 9 | 59651-347 |
|---|---|
| NDC 10 | 59651-347-21 |
| NDC Item | 59651034721 |
| Packaging | 21 CAPSULE in 1 BOTTLE (59651-347-21) |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| Imprint code | L;25 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-347 |
NDC Item 60219171901
| NDC 9 | 60219-1719 |
|---|---|
| NDC 10 | 60219-1719-1 |
| NDC Item | 60219171901 |
| Packaging | 21 CAPSULE in 1 BOTTLE (60219-1719-1) |
| ANDA | ANDA216213 |
| COLORTEXT | white(white opaque cap),white(white opaque body) |
| Color | C48325;C48325 __ |
| Imprint code | AA22A |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60219-1719 |
NDC Item 60219171902
| NDC 9 | 60219-1719 |
|---|---|
| NDC 10 | 60219-1719-2 |
| NDC Item | 60219171902 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60219-1719-2) |
| ANDA | ANDA216213 |
| COLORTEXT | white(white opaque cap),white(white opaque body) |
| Color | C48325;C48325 __ |
| Imprint code | AA22A |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60219-1719 |
NDC Item 60505453701
| NDC 9 | 60505-4537 |
|---|---|
| NDC 10 | 60505-4537-1 |
| NDC Item | 60505453701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60505-4537-1) |
| ANDA | ANDA211022 |
| COLORTEXT | WHITE(White opaque),WHITE(White opaque) |
| Color | C48325;C48325 __ |
| Imprint code | APO;L25 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60505-4537 |
NDC Item 60505453702
| NDC 9 | 60505-4537 |
|---|---|
| NDC 10 | 60505-4537-2 |
| NDC Item | 60505453702 |
| Packaging | 21 CAPSULE in 1 BOTTLE (60505-4537-2) |
| ANDA | ANDA211022 |
| COLORTEXT | WHITE(White opaque),WHITE(White opaque) |
| Color | C48325;C48325 __ |
| Imprint code | APO;L25 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60505-4537 |
NDC Item 63304004601
| NDC 9 | 63304-046 |
|---|---|
| NDC 10 | 63304-046-01 |
| NDC Item | 63304004601 |
| Packaging | 100 CAPSULE in 1 BOTTLE (63304-046-01) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| Imprint code | RL;;83 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-046 |
NDC Item 63304004622
| NDC 9 | 63304-046 |
|---|---|
| NDC 10 | 63304-046-22 |
| NDC Item | 63304004622 |
| Packaging | 21 CAPSULE in 1 BOTTLE (63304-046-22) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| Imprint code | RL;;83 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-046 |
NDC Item 69097038581
| NDC 9 | 69097-385 |
|---|---|
| NDC 10 | 69097-385-81 |
| NDC Item | 69097038581 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (69097-385-81) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Cipla25mg;385 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 69097-385 |
NDC Item 70377005411
| NDC 9 | 70377-054 |
|---|---|
| NDC 10 | 70377-054-11 |
| NDC Item | 70377005411 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70377-054-11) |
| ANDA | ANDA215759 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Biocon;logo;25;mg |
| Labeler | BIOCON PHARMA INC., |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70377-054 |
NDC Item 70377005412
| NDC 9 | 70377-054 |
|---|---|
| NDC 10 | 70377-054-12 |
| NDC Item | 70377005412 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70377-054-12) |
| ANDA | ANDA215759 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Biocon;logo;25;mg |
| Labeler | BIOCON PHARMA INC., |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70377-054 |
NDC Item 70710103501
| NDC 9 | 70710-1035 |
|---|---|
| NDC 10 | 70710-1035-1 |
| NDC Item | 70710103501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70710-1035-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70710-1035 |
NDC Item 70710103508
| NDC 9 | 70710-1035 |
|---|---|
| NDC 10 | 70710-1035-8 |
| NDC Item | 70710103508 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70710-1035-8) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70710-1035 |
NDC Item 70771168101
| NDC 9 | 70771-1681 |
|---|---|
| NDC 10 | 70771-1681-1 |
| NDC Item | 70771168101 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70771-1681-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(White opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70771-1681 |
NDC Item 70771168108
| NDC 9 | 70771-1681 |
|---|---|
| NDC 10 | 70771-1681-8 |
| NDC Item | 70771168108 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70771-1681-8) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(White opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70771-1681 |
NDC Item 76282070147
| NDC 9 | 76282-701 |
|---|---|
| NDC 10 | 76282-701-47 |
| NDC Item | 76282070147 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (76282-701-47) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Cipla25mg;385 |
| Labeler | EXELAN PHARMACEUTICALS INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 76282-701 |
NDC Item 00378194001
| NDC 9 | 0378-1940 |
|---|---|
| NDC 10 | 0378-1940-01 |
| NDC Item | 00378194001 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1940-01) |
| ANDA | ANDA213912 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| Imprint code | MYLAN;LL;25 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1940 |
NDC Item 00378194021
| NDC 9 | 0378-1940 |
|---|---|
| NDC 10 | 0378-1940-21 |
| NDC Item | 00378194021 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (0378-1940-21) |
| ANDA | ANDA213912 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| Imprint code | MYLAN;LL;25 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1940 |
NDC Item 00480124621
| NDC 9 | 0480-1246 |
|---|---|
| NDC 10 | 0480-1246-21 |
| NDC Item | 00480124621 |
| Packaging | 21 CAPSULE in 1 BOTTLE (0480-1246-21) |
| ANDA | ANDA201452 |
| COLORTEXT | white |
| Color | C48325 __ |
| Imprint code | NAT;25mg |
| Labeler | Teva Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0480-1246 |
NDC Item 31722026201
| NDC 9 | 31722-262 |
|---|---|
| NDC 10 | 31722-262-01 |
| NDC Item | 31722026201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (31722-262-01) |
| ANDA | ANDA212414 |
| COLORTEXT | white |
| Color | C48325 __ |
| Imprint code | H;L7 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-262 |
NDC Item 31722026221
| NDC 9 | 31722-262 |
|---|---|
| NDC 10 | 31722-262-21 |
| NDC Item | 31722026221 |
| Packaging | 21 CAPSULE in 1 BOTTLE (31722-262-21) |
| ANDA | ANDA212414 |
| COLORTEXT | white |
| Color | C48325 __ |
| Imprint code | H;L7 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-262 |
NDC Item 43598051501
| NDC 9 | 43598-515 |
|---|---|
| NDC 10 | 43598-515-01 |
| NDC Item | 43598051501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (43598-515-01) |
| ANDA | ANDA209348 |
| COLORTEXT | WHITE(opaque white colored cap and body) |
| Color | C48325 __ |
| Imprint code | RDY;25;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 43598-515 |
NDC Item 43598051521
| NDC 9 | 43598-515 |
|---|---|
| NDC 10 | 43598-515-21 |
| NDC Item | 43598051521 |
| Packaging | 21 CAPSULE in 1 BOTTLE (43598-515-21) |
| ANDA | ANDA209348 |
| COLORTEXT | WHITE(opaque white colored cap and body) |
| Color | C48325 __ |
| Imprint code | RDY;25;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 43598-515 |
NDC Item 47781048801
| NDC 9 | 47781-488 |
|---|---|
| NDC 10 | 47781-488-01 |
| NDC Item | 47781048801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-488-01) |
| ANDA | ANDA210480 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | LP;642 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-488 |
NDC Item 47781048877
| NDC 9 | 47781-488 |
|---|---|
| NDC 10 | 47781-488-77 |
| NDC Item | 47781048877 |
| Packaging | 21 CAPSULE in 1 BOTTLE (47781-488-77) |
| ANDA | ANDA210480 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | LP;642 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-488 |
NDC Item 59651034701
| NDC 9 | 59651-347 |
|---|---|
| NDC 10 | 59651-347-01 |
| NDC Item | 59651034701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (59651-347-01) |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| Imprint code | L;25 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-347 |
NDC Item 59651034707
| NDC 9 | 59651-347 |
|---|---|
| NDC 10 | 59651-347-07 |
| NDC Item | 59651034707 |
| Packaging | 1 BLISTER PACK in 1 CARTON (59651-347-07) / 7 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| Imprint code | L;25 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-347 |
NDC Item 59651034721
| NDC 9 | 59651-347 |
|---|---|
| NDC 10 | 59651-347-21 |
| NDC Item | 59651034721 |
| Packaging | 21 CAPSULE in 1 BOTTLE (59651-347-21) |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| Imprint code | L;25 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-347 |
NDC Item 60219171901
| NDC 9 | 60219-1719 |
|---|---|
| NDC 10 | 60219-1719-1 |
| NDC Item | 60219171901 |
| Packaging | 21 CAPSULE in 1 BOTTLE (60219-1719-1) |
| ANDA | ANDA216213 |
| COLORTEXT | white(white opaque cap),white(white opaque body) |
| Color | C48325;C48325 __ |
| Imprint code | AA22A |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60219-1719 |
NDC Item 60219171902
| NDC 9 | 60219-1719 |
|---|---|
| NDC 10 | 60219-1719-2 |
| NDC Item | 60219171902 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60219-1719-2) |
| ANDA | ANDA216213 |
| COLORTEXT | white(white opaque cap),white(white opaque body) |
| Color | C48325;C48325 __ |
| Imprint code | AA22A |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60219-1719 |
NDC Item 60505453701
| NDC 9 | 60505-4537 |
|---|---|
| NDC 10 | 60505-4537-1 |
| NDC Item | 60505453701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60505-4537-1) |
| ANDA | ANDA211022 |
| COLORTEXT | WHITE(White opaque),WHITE(White opaque) |
| Color | C48325;C48325 __ |
| Imprint code | APO;L25 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60505-4537 |
NDC Item 60505453702
| NDC 9 | 60505-4537 |
|---|---|
| NDC 10 | 60505-4537-2 |
| NDC Item | 60505453702 |
| Packaging | 21 CAPSULE in 1 BOTTLE (60505-4537-2) |
| ANDA | ANDA211022 |
| COLORTEXT | WHITE(White opaque),WHITE(White opaque) |
| Color | C48325;C48325 __ |
| Imprint code | APO;L25 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60505-4537 |
NDC Item 63304004601
| NDC 9 | 63304-046 |
|---|---|
| NDC 10 | 63304-046-01 |
| NDC Item | 63304004601 |
| Packaging | 100 CAPSULE in 1 BOTTLE (63304-046-01) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| Imprint code | RL;;83 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-046 |
NDC Item 63304004622
| NDC 9 | 63304-046 |
|---|---|
| NDC 10 | 63304-046-22 |
| NDC Item | 63304004622 |
| Packaging | 21 CAPSULE in 1 BOTTLE (63304-046-22) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| Imprint code | RL;;83 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-046 |
NDC Item 69097038581
| NDC 9 | 69097-385 |
|---|---|
| NDC 10 | 69097-385-81 |
| NDC Item | 69097038581 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (69097-385-81) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Cipla25mg;385 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 69097-385 |
NDC Item 70377005411
| NDC 9 | 70377-054 |
|---|---|
| NDC 10 | 70377-054-11 |
| NDC Item | 70377005411 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70377-054-11) |
| ANDA | ANDA215759 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Biocon;logo;25;mg |
| Labeler | BIOCON PHARMA INC., |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70377-054 |
NDC Item 70377005412
| NDC 9 | 70377-054 |
|---|---|
| NDC 10 | 70377-054-12 |
| NDC Item | 70377005412 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70377-054-12) |
| ANDA | ANDA215759 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Biocon;logo;25;mg |
| Labeler | BIOCON PHARMA INC., |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70377-054 |
NDC Item 70710103501
| NDC 9 | 70710-1035 |
|---|---|
| NDC 10 | 70710-1035-1 |
| NDC Item | 70710103501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70710-1035-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70710-1035 |
NDC Item 70710103508
| NDC 9 | 70710-1035 |
|---|---|
| NDC 10 | 70710-1035-8 |
| NDC Item | 70710103508 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70710-1035-8) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70710-1035 |
NDC Item 70771168101
| NDC 9 | 70771-1681 |
|---|---|
| NDC 10 | 70771-1681-1 |
| NDC Item | 70771168101 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70771-1681-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(White opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70771-1681 |
NDC Item 70771168108
| NDC 9 | 70771-1681 |
|---|---|
| NDC 10 | 70771-1681-8 |
| NDC Item | 70771168108 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70771-1681-8) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(White opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70771-1681 |
NDC Item 76282070147
| NDC 9 | 76282-701 |
|---|---|
| NDC 10 | 76282-701-47 |
| NDC Item | 76282070147 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (76282-701-47) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Cipla25mg;385 |
| Labeler | EXELAN PHARMACEUTICALS INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 76282-701 |
NDC Item 00378194001
| NDC 9 | 0378-1940 |
|---|---|
| NDC 10 | 0378-1940-01 |
| NDC Item | 00378194001 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1940-01) |
| ANDA | ANDA213912 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| Imprint code | MYLAN;LL;25 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1940 |
NDC Item 00378194021
| NDC 9 | 0378-1940 |
|---|---|
| NDC 10 | 0378-1940-21 |
| NDC Item | 00378194021 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (0378-1940-21) |
| ANDA | ANDA213912 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| Imprint code | MYLAN;LL;25 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1940 |
NDC Item 00480124621
| NDC 9 | 0480-1246 |
|---|---|
| NDC 10 | 0480-1246-21 |
| NDC Item | 00480124621 |
| Packaging | 21 CAPSULE in 1 BOTTLE (0480-1246-21) |
| ANDA | ANDA201452 |
| COLORTEXT | white |
| Color | C48325 __ |
| Imprint code | NAT;25mg |
| Labeler | Teva Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0480-1246 |
NDC Item 31722026201
| NDC 9 | 31722-262 |
|---|---|
| NDC 10 | 31722-262-01 |
| NDC Item | 31722026201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (31722-262-01) |
| ANDA | ANDA212414 |
| COLORTEXT | white |
| Color | C48325 __ |
| Imprint code | H;L7 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-262 |
NDC Item 31722026221
| NDC 9 | 31722-262 |
|---|---|
| NDC 10 | 31722-262-21 |
| NDC Item | 31722026221 |
| Packaging | 21 CAPSULE in 1 BOTTLE (31722-262-21) |
| ANDA | ANDA212414 |
| COLORTEXT | white |
| Color | C48325 __ |
| Imprint code | H;L7 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-262 |
NDC Item 43598051501
| NDC 9 | 43598-515 |
|---|---|
| NDC 10 | 43598-515-01 |
| NDC Item | 43598051501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (43598-515-01) |
| ANDA | ANDA209348 |
| COLORTEXT | WHITE(opaque white colored cap and body) |
| Color | C48325 __ |
| Imprint code | RDY;25;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 43598-515 |
NDC Item 43598051521
| NDC 9 | 43598-515 |
|---|---|
| NDC 10 | 43598-515-21 |
| NDC Item | 43598051521 |
| Packaging | 21 CAPSULE in 1 BOTTLE (43598-515-21) |
| ANDA | ANDA209348 |
| COLORTEXT | WHITE(opaque white colored cap and body) |
| Color | C48325 __ |
| Imprint code | RDY;25;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 43598-515 |
NDC Item 47781048801
| NDC 9 | 47781-488 |
|---|---|
| NDC 10 | 47781-488-01 |
| NDC Item | 47781048801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-488-01) |
| ANDA | ANDA210480 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | LP;642 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-488 |
NDC Item 47781048877
| NDC 9 | 47781-488 |
|---|---|
| NDC 10 | 47781-488-77 |
| NDC Item | 47781048877 |
| Packaging | 21 CAPSULE in 1 BOTTLE (47781-488-77) |
| ANDA | ANDA210480 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | LP;642 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-488 |
NDC Item 59651034701
| NDC 9 | 59651-347 |
|---|---|
| NDC 10 | 59651-347-01 |
| NDC Item | 59651034701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (59651-347-01) |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| Imprint code | L;25 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-347 |
NDC Item 59651034707
| NDC 9 | 59651-347 |
|---|---|
| NDC 10 | 59651-347-07 |
| NDC Item | 59651034707 |
| Packaging | 1 BLISTER PACK in 1 CARTON (59651-347-07) / 7 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| Imprint code | L;25 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-347 |
NDC Item 59651034721
| NDC 9 | 59651-347 |
|---|---|
| NDC 10 | 59651-347-21 |
| NDC Item | 59651034721 |
| Packaging | 21 CAPSULE in 1 BOTTLE (59651-347-21) |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| Imprint code | L;25 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-347 |
NDC Item 60219171901
| NDC 9 | 60219-1719 |
|---|---|
| NDC 10 | 60219-1719-1 |
| NDC Item | 60219171901 |
| Packaging | 21 CAPSULE in 1 BOTTLE (60219-1719-1) |
| ANDA | ANDA216213 |
| COLORTEXT | white(white opaque cap),white(white opaque body) |
| Color | C48325;C48325 __ |
| Imprint code | AA22A |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60219-1719 |
NDC Item 60219171902
| NDC 9 | 60219-1719 |
|---|---|
| NDC 10 | 60219-1719-2 |
| NDC Item | 60219171902 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60219-1719-2) |
| ANDA | ANDA216213 |
| COLORTEXT | white(white opaque cap),white(white opaque body) |
| Color | C48325;C48325 __ |
| Imprint code | AA22A |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60219-1719 |
NDC Item 60505453701
| NDC 9 | 60505-4537 |
|---|---|
| NDC 10 | 60505-4537-1 |
| NDC Item | 60505453701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60505-4537-1) |
| ANDA | ANDA211022 |
| COLORTEXT | WHITE(White opaque),WHITE(White opaque) |
| Color | C48325;C48325 __ |
| Imprint code | APO;L25 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60505-4537 |
NDC Item 60505453702
| NDC 9 | 60505-4537 |
|---|---|
| NDC 10 | 60505-4537-2 |
| NDC Item | 60505453702 |
| Packaging | 21 CAPSULE in 1 BOTTLE (60505-4537-2) |
| ANDA | ANDA211022 |
| COLORTEXT | WHITE(White opaque),WHITE(White opaque) |
| Color | C48325;C48325 __ |
| Imprint code | APO;L25 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60505-4537 |
NDC Item 63304004601
| NDC 9 | 63304-046 |
|---|---|
| NDC 10 | 63304-046-01 |
| NDC Item | 63304004601 |
| Packaging | 100 CAPSULE in 1 BOTTLE (63304-046-01) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| Imprint code | RL;;83 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-046 |
NDC Item 63304004622
| NDC 9 | 63304-046 |
|---|---|
| NDC 10 | 63304-046-22 |
| NDC Item | 63304004622 |
| Packaging | 21 CAPSULE in 1 BOTTLE (63304-046-22) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| Imprint code | RL;;83 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-046 |
NDC Item 69097038581
| NDC 9 | 69097-385 |
|---|---|
| NDC 10 | 69097-385-81 |
| NDC Item | 69097038581 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (69097-385-81) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Cipla25mg;385 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 69097-385 |
NDC Item 70377005411
| NDC 9 | 70377-054 |
|---|---|
| NDC 10 | 70377-054-11 |
| NDC Item | 70377005411 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70377-054-11) |
| ANDA | ANDA215759 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Biocon;logo;25;mg |
| Labeler | BIOCON PHARMA INC., |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70377-054 |
NDC Item 70377005412
| NDC 9 | 70377-054 |
|---|---|
| NDC 10 | 70377-054-12 |
| NDC Item | 70377005412 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70377-054-12) |
| ANDA | ANDA215759 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Biocon;logo;25;mg |
| Labeler | BIOCON PHARMA INC., |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70377-054 |
NDC Item 70710103501
| NDC 9 | 70710-1035 |
|---|---|
| NDC 10 | 70710-1035-1 |
| NDC Item | 70710103501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70710-1035-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70710-1035 |
NDC Item 70710103508
| NDC 9 | 70710-1035 |
|---|---|
| NDC 10 | 70710-1035-8 |
| NDC Item | 70710103508 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70710-1035-8) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70710-1035 |
NDC Item 70771168101
| NDC 9 | 70771-1681 |
|---|---|
| NDC 10 | 70771-1681-1 |
| NDC Item | 70771168101 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70771-1681-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(White opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70771-1681 |
NDC Item 70771168108
| NDC 9 | 70771-1681 |
|---|---|
| NDC 10 | 70771-1681-8 |
| NDC Item | 70771168108 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70771-1681-8) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(White opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70771-1681 |
NDC Item 76282070147
| NDC 9 | 76282-701 |
|---|---|
| NDC 10 | 76282-701-47 |
| NDC Item | 76282070147 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (76282-701-47) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Cipla25mg;385 |
| Labeler | EXELAN PHARMACEUTICALS INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 76282-701 |
NDC Item 00378194001
| NDC 9 | 0378-1940 |
|---|---|
| NDC 10 | 0378-1940-01 |
| NDC Item | 00378194001 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1940-01) |
| ANDA | ANDA213912 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| Imprint code | MYLAN;LL;25 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1940 |
NDC Item 00378194021
| NDC 9 | 0378-1940 |
|---|---|
| NDC 10 | 0378-1940-21 |
| NDC Item | 00378194021 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (0378-1940-21) |
| ANDA | ANDA213912 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| Imprint code | MYLAN;LL;25 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1940 |
NDC Item 00480124621
| NDC 9 | 0480-1246 |
|---|---|
| NDC 10 | 0480-1246-21 |
| NDC Item | 00480124621 |
| Packaging | 21 CAPSULE in 1 BOTTLE (0480-1246-21) |
| ANDA | ANDA201452 |
| COLORTEXT | white |
| Color | C48325 __ |
| Imprint code | NAT;25mg |
| Labeler | Teva Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0480-1246 |
NDC Item 31722026201
| NDC 9 | 31722-262 |
|---|---|
| NDC 10 | 31722-262-01 |
| NDC Item | 31722026201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (31722-262-01) |
| ANDA | ANDA212414 |
| COLORTEXT | white |
| Color | C48325 __ |
| Imprint code | H;L7 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-262 |
NDC Item 31722026221
| NDC 9 | 31722-262 |
|---|---|
| NDC 10 | 31722-262-21 |
| NDC Item | 31722026221 |
| Packaging | 21 CAPSULE in 1 BOTTLE (31722-262-21) |
| ANDA | ANDA212414 |
| COLORTEXT | white |
| Color | C48325 __ |
| Imprint code | H;L7 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-262 |
NDC Item 43598051501
| NDC 9 | 43598-515 |
|---|---|
| NDC 10 | 43598-515-01 |
| NDC Item | 43598051501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (43598-515-01) |
| ANDA | ANDA209348 |
| COLORTEXT | WHITE(opaque white colored cap and body) |
| Color | C48325 __ |
| Imprint code | RDY;25;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 43598-515 |
NDC Item 43598051521
| NDC 9 | 43598-515 |
|---|---|
| NDC 10 | 43598-515-21 |
| NDC Item | 43598051521 |
| Packaging | 21 CAPSULE in 1 BOTTLE (43598-515-21) |
| ANDA | ANDA209348 |
| COLORTEXT | WHITE(opaque white colored cap and body) |
| Color | C48325 __ |
| Imprint code | RDY;25;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 43598-515 |
NDC Item 47781048801
| NDC 9 | 47781-488 |
|---|---|
| NDC 10 | 47781-488-01 |
| NDC Item | 47781048801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-488-01) |
| ANDA | ANDA210480 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | LP;642 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-488 |
NDC Item 47781048877
| NDC 9 | 47781-488 |
|---|---|
| NDC 10 | 47781-488-77 |
| NDC Item | 47781048877 |
| Packaging | 21 CAPSULE in 1 BOTTLE (47781-488-77) |
| ANDA | ANDA210480 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | LP;642 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-488 |
NDC Item 59651034701
| NDC 9 | 59651-347 |
|---|---|
| NDC 10 | 59651-347-01 |
| NDC Item | 59651034701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (59651-347-01) |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| Imprint code | L;25 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-347 |
NDC Item 59651034707
| NDC 9 | 59651-347 |
|---|---|
| NDC 10 | 59651-347-07 |
| NDC Item | 59651034707 |
| Packaging | 1 BLISTER PACK in 1 CARTON (59651-347-07) / 7 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| Imprint code | L;25 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-347 |
NDC Item 59651034721
| NDC 9 | 59651-347 |
|---|---|
| NDC 10 | 59651-347-21 |
| NDC Item | 59651034721 |
| Packaging | 21 CAPSULE in 1 BOTTLE (59651-347-21) |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| Imprint code | L;25 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-347 |
NDC Item 60219171901
| NDC 9 | 60219-1719 |
|---|---|
| NDC 10 | 60219-1719-1 |
| NDC Item | 60219171901 |
| Packaging | 21 CAPSULE in 1 BOTTLE (60219-1719-1) |
| ANDA | ANDA216213 |
| COLORTEXT | white(white opaque cap),white(white opaque body) |
| Color | C48325;C48325 __ |
| Imprint code | AA22A |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60219-1719 |
NDC Item 60219171902
| NDC 9 | 60219-1719 |
|---|---|
| NDC 10 | 60219-1719-2 |
| NDC Item | 60219171902 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60219-1719-2) |
| ANDA | ANDA216213 |
| COLORTEXT | white(white opaque cap),white(white opaque body) |
| Color | C48325;C48325 __ |
| Imprint code | AA22A |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60219-1719 |
NDC Item 60505453701
| NDC 9 | 60505-4537 |
|---|---|
| NDC 10 | 60505-4537-1 |
| NDC Item | 60505453701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60505-4537-1) |
| ANDA | ANDA211022 |
| COLORTEXT | WHITE(White opaque),WHITE(White opaque) |
| Color | C48325;C48325 __ |
| Imprint code | APO;L25 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60505-4537 |
NDC Item 60505453702
| NDC 9 | 60505-4537 |
|---|---|
| NDC 10 | 60505-4537-2 |
| NDC Item | 60505453702 |
| Packaging | 21 CAPSULE in 1 BOTTLE (60505-4537-2) |
| ANDA | ANDA211022 |
| COLORTEXT | WHITE(White opaque),WHITE(White opaque) |
| Color | C48325;C48325 __ |
| Imprint code | APO;L25 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60505-4537 |
NDC Item 63304004601
| NDC 9 | 63304-046 |
|---|---|
| NDC 10 | 63304-046-01 |
| NDC Item | 63304004601 |
| Packaging | 100 CAPSULE in 1 BOTTLE (63304-046-01) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| Imprint code | RL;;83 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-046 |
NDC Item 63304004622
| NDC 9 | 63304-046 |
|---|---|
| NDC 10 | 63304-046-22 |
| NDC Item | 63304004622 |
| Packaging | 21 CAPSULE in 1 BOTTLE (63304-046-22) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| Imprint code | RL;;83 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-046 |
NDC Item 69097038581
| NDC 9 | 69097-385 |
|---|---|
| NDC 10 | 69097-385-81 |
| NDC Item | 69097038581 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (69097-385-81) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Cipla25mg;385 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 69097-385 |
NDC Item 70377005411
| NDC 9 | 70377-054 |
|---|---|
| NDC 10 | 70377-054-11 |
| NDC Item | 70377005411 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70377-054-11) |
| ANDA | ANDA215759 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Biocon;logo;25;mg |
| Labeler | BIOCON PHARMA INC., |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70377-054 |
NDC Item 70377005412
| NDC 9 | 70377-054 |
|---|---|
| NDC 10 | 70377-054-12 |
| NDC Item | 70377005412 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70377-054-12) |
| ANDA | ANDA215759 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Biocon;logo;25;mg |
| Labeler | BIOCON PHARMA INC., |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70377-054 |
NDC Item 70710103501
| NDC 9 | 70710-1035 |
|---|---|
| NDC 10 | 70710-1035-1 |
| NDC Item | 70710103501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70710-1035-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70710-1035 |
NDC Item 70710103508
| NDC 9 | 70710-1035 |
|---|---|
| NDC 10 | 70710-1035-8 |
| NDC Item | 70710103508 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70710-1035-8) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70710-1035 |
NDC Item 70771168101
| NDC 9 | 70771-1681 |
|---|---|
| NDC 10 | 70771-1681-1 |
| NDC Item | 70771168101 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70771-1681-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(White opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70771-1681 |
NDC Item 70771168108
| NDC 9 | 70771-1681 |
|---|---|
| NDC 10 | 70771-1681-8 |
| NDC Item | 70771168108 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70771-1681-8) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(White opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70771-1681 |
NDC Item 76282070147
| NDC 9 | 76282-701 |
|---|---|
| NDC 10 | 76282-701-47 |
| NDC Item | 76282070147 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (76282-701-47) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Cipla25mg;385 |
| Labeler | EXELAN PHARMACEUTICALS INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 76282-701 |
NDC Item 00378194001
| NDC 9 | 0378-1940 |
|---|---|
| NDC 10 | 0378-1940-01 |
| NDC Item | 00378194001 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1940-01) |
| ANDA | ANDA213912 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| Imprint code | MYLAN;LL;25 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1940 |
NDC Item 00378194021
| NDC 9 | 0378-1940 |
|---|---|
| NDC 10 | 0378-1940-21 |
| NDC Item | 00378194021 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (0378-1940-21) |
| ANDA | ANDA213912 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| Imprint code | MYLAN;LL;25 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1940 |
NDC Item 00480124621
| NDC 9 | 0480-1246 |
|---|---|
| NDC 10 | 0480-1246-21 |
| NDC Item | 00480124621 |
| Packaging | 21 CAPSULE in 1 BOTTLE (0480-1246-21) |
| ANDA | ANDA201452 |
| COLORTEXT | white |
| Color | C48325 __ |
| Imprint code | NAT;25mg |
| Labeler | Teva Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0480-1246 |
NDC Item 31722026201
| NDC 9 | 31722-262 |
|---|---|
| NDC 10 | 31722-262-01 |
| NDC Item | 31722026201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (31722-262-01) |
| ANDA | ANDA212414 |
| COLORTEXT | white |
| Color | C48325 __ |
| Imprint code | H;L7 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-262 |
NDC Item 31722026221
| NDC 9 | 31722-262 |
|---|---|
| NDC 10 | 31722-262-21 |
| NDC Item | 31722026221 |
| Packaging | 21 CAPSULE in 1 BOTTLE (31722-262-21) |
| ANDA | ANDA212414 |
| COLORTEXT | white |
| Color | C48325 __ |
| Imprint code | H;L7 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-262 |
NDC Item 43598051501
| NDC 9 | 43598-515 |
|---|---|
| NDC 10 | 43598-515-01 |
| NDC Item | 43598051501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (43598-515-01) |
| ANDA | ANDA209348 |
| COLORTEXT | WHITE(opaque white colored cap and body) |
| Color | C48325 __ |
| Imprint code | RDY;25;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 43598-515 |
NDC Item 43598051521
| NDC 9 | 43598-515 |
|---|---|
| NDC 10 | 43598-515-21 |
| NDC Item | 43598051521 |
| Packaging | 21 CAPSULE in 1 BOTTLE (43598-515-21) |
| ANDA | ANDA209348 |
| COLORTEXT | WHITE(opaque white colored cap and body) |
| Color | C48325 __ |
| Imprint code | RDY;25;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 43598-515 |
NDC Item 47781048801
| NDC 9 | 47781-488 |
|---|---|
| NDC 10 | 47781-488-01 |
| NDC Item | 47781048801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-488-01) |
| ANDA | ANDA210480 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | LP;642 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-488 |
NDC Item 47781048877
| NDC 9 | 47781-488 |
|---|---|
| NDC 10 | 47781-488-77 |
| NDC Item | 47781048877 |
| Packaging | 21 CAPSULE in 1 BOTTLE (47781-488-77) |
| ANDA | ANDA210480 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | LP;642 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-488 |
NDC Item 59651034701
| NDC 9 | 59651-347 |
|---|---|
| NDC 10 | 59651-347-01 |
| NDC Item | 59651034701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (59651-347-01) |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| Imprint code | L;25 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-347 |
NDC Item 59651034707
| NDC 9 | 59651-347 |
|---|---|
| NDC 10 | 59651-347-07 |
| NDC Item | 59651034707 |
| Packaging | 1 BLISTER PACK in 1 CARTON (59651-347-07) / 7 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| Imprint code | L;25 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-347 |
NDC Item 59651034721
| NDC 9 | 59651-347 |
|---|---|
| NDC 10 | 59651-347-21 |
| NDC Item | 59651034721 |
| Packaging | 21 CAPSULE in 1 BOTTLE (59651-347-21) |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| Imprint code | L;25 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-347 |
NDC Item 60219171901
| NDC 9 | 60219-1719 |
|---|---|
| NDC 10 | 60219-1719-1 |
| NDC Item | 60219171901 |
| Packaging | 21 CAPSULE in 1 BOTTLE (60219-1719-1) |
| ANDA | ANDA216213 |
| COLORTEXT | white(white opaque cap),white(white opaque body) |
| Color | C48325;C48325 __ |
| Imprint code | AA22A |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60219-1719 |
NDC Item 60219171902
| NDC 9 | 60219-1719 |
|---|---|
| NDC 10 | 60219-1719-2 |
| NDC Item | 60219171902 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60219-1719-2) |
| ANDA | ANDA216213 |
| COLORTEXT | white(white opaque cap),white(white opaque body) |
| Color | C48325;C48325 __ |
| Imprint code | AA22A |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60219-1719 |
NDC Item 60505453701
| NDC 9 | 60505-4537 |
|---|---|
| NDC 10 | 60505-4537-1 |
| NDC Item | 60505453701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60505-4537-1) |
| ANDA | ANDA211022 |
| COLORTEXT | WHITE(White opaque),WHITE(White opaque) |
| Color | C48325;C48325 __ |
| Imprint code | APO;L25 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60505-4537 |
NDC Item 60505453702
| NDC 9 | 60505-4537 |
|---|---|
| NDC 10 | 60505-4537-2 |
| NDC Item | 60505453702 |
| Packaging | 21 CAPSULE in 1 BOTTLE (60505-4537-2) |
| ANDA | ANDA211022 |
| COLORTEXT | WHITE(White opaque),WHITE(White opaque) |
| Color | C48325;C48325 __ |
| Imprint code | APO;L25 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60505-4537 |
NDC Item 63304004601
| NDC 9 | 63304-046 |
|---|---|
| NDC 10 | 63304-046-01 |
| NDC Item | 63304004601 |
| Packaging | 100 CAPSULE in 1 BOTTLE (63304-046-01) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| Imprint code | RL;;83 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-046 |
NDC Item 63304004622
| NDC 9 | 63304-046 |
|---|---|
| NDC 10 | 63304-046-22 |
| NDC Item | 63304004622 |
| Packaging | 21 CAPSULE in 1 BOTTLE (63304-046-22) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| Imprint code | RL;;83 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-046 |
NDC Item 69097038581
| NDC 9 | 69097-385 |
|---|---|
| NDC 10 | 69097-385-81 |
| NDC Item | 69097038581 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (69097-385-81) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Cipla25mg;385 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 69097-385 |
NDC Item 70377005411
| NDC 9 | 70377-054 |
|---|---|
| NDC 10 | 70377-054-11 |
| NDC Item | 70377005411 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70377-054-11) |
| ANDA | ANDA215759 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Biocon;logo;25;mg |
| Labeler | BIOCON PHARMA INC., |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70377-054 |
NDC Item 70377005412
| NDC 9 | 70377-054 |
|---|---|
| NDC 10 | 70377-054-12 |
| NDC Item | 70377005412 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70377-054-12) |
| ANDA | ANDA215759 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Biocon;logo;25;mg |
| Labeler | BIOCON PHARMA INC., |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70377-054 |
NDC Item 70710103501
| NDC 9 | 70710-1035 |
|---|---|
| NDC 10 | 70710-1035-1 |
| NDC Item | 70710103501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70710-1035-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70710-1035 |
NDC Item 70710103508
| NDC 9 | 70710-1035 |
|---|---|
| NDC 10 | 70710-1035-8 |
| NDC Item | 70710103508 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70710-1035-8) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70710-1035 |
NDC Item 70771168101
| NDC 9 | 70771-1681 |
|---|---|
| NDC 10 | 70771-1681-1 |
| NDC Item | 70771168101 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70771-1681-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(White opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70771-1681 |
NDC Item 70771168108
| NDC 9 | 70771-1681 |
|---|---|
| NDC 10 | 70771-1681-8 |
| NDC Item | 70771168108 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70771-1681-8) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(White opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70771-1681 |
NDC Item 76282070147
| NDC 9 | 76282-701 |
|---|---|
| NDC 10 | 76282-701-47 |
| NDC Item | 76282070147 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (76282-701-47) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Cipla25mg;385 |
| Labeler | EXELAN PHARMACEUTICALS INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 76282-701 |
NDC Item 00378194001
| NDC 9 | 0378-1940 |
|---|---|
| NDC 10 | 0378-1940-01 |
| NDC Item | 00378194001 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1940-01) |
| ANDA | ANDA213912 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| Imprint code | MYLAN;LL;25 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1940 |
NDC Item 00378194021
| NDC 9 | 0378-1940 |
|---|---|
| NDC 10 | 0378-1940-21 |
| NDC Item | 00378194021 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (0378-1940-21) |
| ANDA | ANDA213912 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| Imprint code | MYLAN;LL;25 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1940 |
NDC Item 00480124621
| NDC 9 | 0480-1246 |
|---|---|
| NDC 10 | 0480-1246-21 |
| NDC Item | 00480124621 |
| Packaging | 21 CAPSULE in 1 BOTTLE (0480-1246-21) |
| ANDA | ANDA201452 |
| COLORTEXT | white |
| Color | C48325 __ |
| Imprint code | NAT;25mg |
| Labeler | Teva Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0480-1246 |
NDC Item 31722026201
| NDC 9 | 31722-262 |
|---|---|
| NDC 10 | 31722-262-01 |
| NDC Item | 31722026201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (31722-262-01) |
| ANDA | ANDA212414 |
| COLORTEXT | white |
| Color | C48325 __ |
| Imprint code | H;L7 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-262 |
NDC Item 31722026221
| NDC 9 | 31722-262 |
|---|---|
| NDC 10 | 31722-262-21 |
| NDC Item | 31722026221 |
| Packaging | 21 CAPSULE in 1 BOTTLE (31722-262-21) |
| ANDA | ANDA212414 |
| COLORTEXT | white |
| Color | C48325 __ |
| Imprint code | H;L7 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-262 |
NDC Item 43598051501
| NDC 9 | 43598-515 |
|---|---|
| NDC 10 | 43598-515-01 |
| NDC Item | 43598051501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (43598-515-01) |
| ANDA | ANDA209348 |
| COLORTEXT | WHITE(opaque white colored cap and body) |
| Color | C48325 __ |
| Imprint code | RDY;25;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 43598-515 |
NDC Item 43598051521
| NDC 9 | 43598-515 |
|---|---|
| NDC 10 | 43598-515-21 |
| NDC Item | 43598051521 |
| Packaging | 21 CAPSULE in 1 BOTTLE (43598-515-21) |
| ANDA | ANDA209348 |
| COLORTEXT | WHITE(opaque white colored cap and body) |
| Color | C48325 __ |
| Imprint code | RDY;25;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 43598-515 |
NDC Item 47781048801
| NDC 9 | 47781-488 |
|---|---|
| NDC 10 | 47781-488-01 |
| NDC Item | 47781048801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-488-01) |
| ANDA | ANDA210480 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | LP;642 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-488 |
NDC Item 47781048877
| NDC 9 | 47781-488 |
|---|---|
| NDC 10 | 47781-488-77 |
| NDC Item | 47781048877 |
| Packaging | 21 CAPSULE in 1 BOTTLE (47781-488-77) |
| ANDA | ANDA210480 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | LP;642 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-488 |
NDC Item 59651034701
| NDC 9 | 59651-347 |
|---|---|
| NDC 10 | 59651-347-01 |
| NDC Item | 59651034701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (59651-347-01) |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| Imprint code | L;25 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-347 |
NDC Item 59651034707
| NDC 9 | 59651-347 |
|---|---|
| NDC 10 | 59651-347-07 |
| NDC Item | 59651034707 |
| Packaging | 1 BLISTER PACK in 1 CARTON (59651-347-07) / 7 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| Imprint code | L;25 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-347 |
NDC Item 59651034721
| NDC 9 | 59651-347 |
|---|---|
| NDC 10 | 59651-347-21 |
| NDC Item | 59651034721 |
| Packaging | 21 CAPSULE in 1 BOTTLE (59651-347-21) |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| Imprint code | L;25 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-347 |
NDC Item 60219171901
| NDC 9 | 60219-1719 |
|---|---|
| NDC 10 | 60219-1719-1 |
| NDC Item | 60219171901 |
| Packaging | 21 CAPSULE in 1 BOTTLE (60219-1719-1) |
| ANDA | ANDA216213 |
| COLORTEXT | white(white opaque cap),white(white opaque body) |
| Color | C48325;C48325 __ |
| Imprint code | AA22A |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60219-1719 |
NDC Item 60219171902
| NDC 9 | 60219-1719 |
|---|---|
| NDC 10 | 60219-1719-2 |
| NDC Item | 60219171902 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60219-1719-2) |
| ANDA | ANDA216213 |
| COLORTEXT | white(white opaque cap),white(white opaque body) |
| Color | C48325;C48325 __ |
| Imprint code | AA22A |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60219-1719 |
NDC Item 60505453701
| NDC 9 | 60505-4537 |
|---|---|
| NDC 10 | 60505-4537-1 |
| NDC Item | 60505453701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60505-4537-1) |
| ANDA | ANDA211022 |
| COLORTEXT | WHITE(White opaque),WHITE(White opaque) |
| Color | C48325;C48325 __ |
| Imprint code | APO;L25 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60505-4537 |
NDC Item 60505453702
| NDC 9 | 60505-4537 |
|---|---|
| NDC 10 | 60505-4537-2 |
| NDC Item | 60505453702 |
| Packaging | 21 CAPSULE in 1 BOTTLE (60505-4537-2) |
| ANDA | ANDA211022 |
| COLORTEXT | WHITE(White opaque),WHITE(White opaque) |
| Color | C48325;C48325 __ |
| Imprint code | APO;L25 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60505-4537 |
NDC Item 63304004601
| NDC 9 | 63304-046 |
|---|---|
| NDC 10 | 63304-046-01 |
| NDC Item | 63304004601 |
| Packaging | 100 CAPSULE in 1 BOTTLE (63304-046-01) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| Imprint code | RL;;83 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-046 |
NDC Item 63304004622
| NDC 9 | 63304-046 |
|---|---|
| NDC 10 | 63304-046-22 |
| NDC Item | 63304004622 |
| Packaging | 21 CAPSULE in 1 BOTTLE (63304-046-22) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| Imprint code | RL;;83 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-046 |
NDC Item 69097038581
| NDC 9 | 69097-385 |
|---|---|
| NDC 10 | 69097-385-81 |
| NDC Item | 69097038581 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (69097-385-81) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Cipla25mg;385 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 69097-385 |
NDC Item 70377005411
| NDC 9 | 70377-054 |
|---|---|
| NDC 10 | 70377-054-11 |
| NDC Item | 70377005411 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70377-054-11) |
| ANDA | ANDA215759 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Biocon;logo;25;mg |
| Labeler | BIOCON PHARMA INC., |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70377-054 |
NDC Item 70377005412
| NDC 9 | 70377-054 |
|---|---|
| NDC 10 | 70377-054-12 |
| NDC Item | 70377005412 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70377-054-12) |
| ANDA | ANDA215759 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Biocon;logo;25;mg |
| Labeler | BIOCON PHARMA INC., |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70377-054 |
NDC Item 70710103501
| NDC 9 | 70710-1035 |
|---|---|
| NDC 10 | 70710-1035-1 |
| NDC Item | 70710103501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70710-1035-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70710-1035 |
NDC Item 70710103508
| NDC 9 | 70710-1035 |
|---|---|
| NDC 10 | 70710-1035-8 |
| NDC Item | 70710103508 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70710-1035-8) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70710-1035 |
NDC Item 70771168101
| NDC 9 | 70771-1681 |
|---|---|
| NDC 10 | 70771-1681-1 |
| NDC Item | 70771168101 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70771-1681-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(White opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70771-1681 |
NDC Item 70771168108
| NDC 9 | 70771-1681 |
|---|---|
| NDC 10 | 70771-1681-8 |
| NDC Item | 70771168108 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70771-1681-8) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(White opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70771-1681 |
NDC Item 76282070147
| NDC 9 | 76282-701 |
|---|---|
| NDC 10 | 76282-701-47 |
| NDC Item | 76282070147 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (76282-701-47) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Cipla25mg;385 |
| Labeler | EXELAN PHARMACEUTICALS INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 76282-701 |
NDC Item 00378194001
| NDC 9 | 0378-1940 |
|---|---|
| NDC 10 | 0378-1940-01 |
| NDC Item | 00378194001 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1940-01) |
| ANDA | ANDA213912 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| Imprint code | MYLAN;LL;25 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1940 |
NDC Item 00378194021
| NDC 9 | 0378-1940 |
|---|---|
| NDC 10 | 0378-1940-21 |
| NDC Item | 00378194021 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (0378-1940-21) |
| ANDA | ANDA213912 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| Imprint code | MYLAN;LL;25 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1940 |
NDC Item 00480124621
| NDC 9 | 0480-1246 |
|---|---|
| NDC 10 | 0480-1246-21 |
| NDC Item | 00480124621 |
| Packaging | 21 CAPSULE in 1 BOTTLE (0480-1246-21) |
| ANDA | ANDA201452 |
| COLORTEXT | white |
| Color | C48325 __ |
| Imprint code | NAT;25mg |
| Labeler | Teva Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0480-1246 |
NDC Item 31722026201
| NDC 9 | 31722-262 |
|---|---|
| NDC 10 | 31722-262-01 |
| NDC Item | 31722026201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (31722-262-01) |
| ANDA | ANDA212414 |
| COLORTEXT | white |
| Color | C48325 __ |
| Imprint code | H;L7 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-262 |
NDC Item 31722026221
| NDC 9 | 31722-262 |
|---|---|
| NDC 10 | 31722-262-21 |
| NDC Item | 31722026221 |
| Packaging | 21 CAPSULE in 1 BOTTLE (31722-262-21) |
| ANDA | ANDA212414 |
| COLORTEXT | white |
| Color | C48325 __ |
| Imprint code | H;L7 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-262 |
NDC Item 43598051501
| NDC 9 | 43598-515 |
|---|---|
| NDC 10 | 43598-515-01 |
| NDC Item | 43598051501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (43598-515-01) |
| ANDA | ANDA209348 |
| COLORTEXT | WHITE(opaque white colored cap and body) |
| Color | C48325 __ |
| Imprint code | RDY;25;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 43598-515 |
NDC Item 43598051521
| NDC 9 | 43598-515 |
|---|---|
| NDC 10 | 43598-515-21 |
| NDC Item | 43598051521 |
| Packaging | 21 CAPSULE in 1 BOTTLE (43598-515-21) |
| ANDA | ANDA209348 |
| COLORTEXT | WHITE(opaque white colored cap and body) |
| Color | C48325 __ |
| Imprint code | RDY;25;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 43598-515 |
NDC Item 47781048801
| NDC 9 | 47781-488 |
|---|---|
| NDC 10 | 47781-488-01 |
| NDC Item | 47781048801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-488-01) |
| ANDA | ANDA210480 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | LP;642 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-488 |
NDC Item 47781048877
| NDC 9 | 47781-488 |
|---|---|
| NDC 10 | 47781-488-77 |
| NDC Item | 47781048877 |
| Packaging | 21 CAPSULE in 1 BOTTLE (47781-488-77) |
| ANDA | ANDA210480 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | LP;642 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-488 |
NDC Item 59651034701
| NDC 9 | 59651-347 |
|---|---|
| NDC 10 | 59651-347-01 |
| NDC Item | 59651034701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (59651-347-01) |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| Imprint code | L;25 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-347 |
NDC Item 59651034707
| NDC 9 | 59651-347 |
|---|---|
| NDC 10 | 59651-347-07 |
| NDC Item | 59651034707 |
| Packaging | 1 BLISTER PACK in 1 CARTON (59651-347-07) / 7 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| Imprint code | L;25 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-347 |
NDC Item 59651034721
| NDC 9 | 59651-347 |
|---|---|
| NDC 10 | 59651-347-21 |
| NDC Item | 59651034721 |
| Packaging | 21 CAPSULE in 1 BOTTLE (59651-347-21) |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| Imprint code | L;25 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-347 |
NDC Item 60219171901
| NDC 9 | 60219-1719 |
|---|---|
| NDC 10 | 60219-1719-1 |
| NDC Item | 60219171901 |
| Packaging | 21 CAPSULE in 1 BOTTLE (60219-1719-1) |
| ANDA | ANDA216213 |
| COLORTEXT | white(white opaque cap),white(white opaque body) |
| Color | C48325;C48325 __ |
| Imprint code | AA22A |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60219-1719 |
NDC Item 60219171902
| NDC 9 | 60219-1719 |
|---|---|
| NDC 10 | 60219-1719-2 |
| NDC Item | 60219171902 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60219-1719-2) |
| ANDA | ANDA216213 |
| COLORTEXT | white(white opaque cap),white(white opaque body) |
| Color | C48325;C48325 __ |
| Imprint code | AA22A |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60219-1719 |
NDC Item 60505453701
| NDC 9 | 60505-4537 |
|---|---|
| NDC 10 | 60505-4537-1 |
| NDC Item | 60505453701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60505-4537-1) |
| ANDA | ANDA211022 |
| COLORTEXT | WHITE(White opaque),WHITE(White opaque) |
| Color | C48325;C48325 __ |
| Imprint code | APO;L25 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60505-4537 |
NDC Item 60505453702
| NDC 9 | 60505-4537 |
|---|---|
| NDC 10 | 60505-4537-2 |
| NDC Item | 60505453702 |
| Packaging | 21 CAPSULE in 1 BOTTLE (60505-4537-2) |
| ANDA | ANDA211022 |
| COLORTEXT | WHITE(White opaque),WHITE(White opaque) |
| Color | C48325;C48325 __ |
| Imprint code | APO;L25 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60505-4537 |
NDC Item 63304004601
| NDC 9 | 63304-046 |
|---|---|
| NDC 10 | 63304-046-01 |
| NDC Item | 63304004601 |
| Packaging | 100 CAPSULE in 1 BOTTLE (63304-046-01) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| Imprint code | RL;;83 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-046 |
NDC Item 63304004622
| NDC 9 | 63304-046 |
|---|---|
| NDC 10 | 63304-046-22 |
| NDC Item | 63304004622 |
| Packaging | 21 CAPSULE in 1 BOTTLE (63304-046-22) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| Imprint code | RL;;83 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-046 |
NDC Item 69097038581
| NDC 9 | 69097-385 |
|---|---|
| NDC 10 | 69097-385-81 |
| NDC Item | 69097038581 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (69097-385-81) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Cipla25mg;385 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 69097-385 |
NDC Item 70377005411
| NDC 9 | 70377-054 |
|---|---|
| NDC 10 | 70377-054-11 |
| NDC Item | 70377005411 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70377-054-11) |
| ANDA | ANDA215759 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Biocon;logo;25;mg |
| Labeler | BIOCON PHARMA INC., |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70377-054 |
NDC Item 70377005412
| NDC 9 | 70377-054 |
|---|---|
| NDC 10 | 70377-054-12 |
| NDC Item | 70377005412 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70377-054-12) |
| ANDA | ANDA215759 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Biocon;logo;25;mg |
| Labeler | BIOCON PHARMA INC., |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70377-054 |
NDC Item 70710103501
| NDC 9 | 70710-1035 |
|---|---|
| NDC 10 | 70710-1035-1 |
| NDC Item | 70710103501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70710-1035-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70710-1035 |
NDC Item 70710103508
| NDC 9 | 70710-1035 |
|---|---|
| NDC 10 | 70710-1035-8 |
| NDC Item | 70710103508 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70710-1035-8) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70710-1035 |
NDC Item 70771168101
| NDC 9 | 70771-1681 |
|---|---|
| NDC 10 | 70771-1681-1 |
| NDC Item | 70771168101 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70771-1681-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(White opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70771-1681 |
NDC Item 70771168108
| NDC 9 | 70771-1681 |
|---|---|
| NDC 10 | 70771-1681-8 |
| NDC Item | 70771168108 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70771-1681-8) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(White opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70771-1681 |
NDC Item 76282070147
| NDC 9 | 76282-701 |
|---|---|
| NDC 10 | 76282-701-47 |
| NDC Item | 76282070147 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (76282-701-47) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Cipla25mg;385 |
| Labeler | EXELAN PHARMACEUTICALS INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 76282-701 |
NDC Item 00378194001
| NDC 9 | 0378-1940 |
|---|---|
| NDC 10 | 0378-1940-01 |
| NDC Item | 00378194001 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1940-01) |
| ANDA | ANDA213912 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| Imprint code | MYLAN;LL;25 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1940 |
NDC Item 00378194021
| NDC 9 | 0378-1940 |
|---|---|
| NDC 10 | 0378-1940-21 |
| NDC Item | 00378194021 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (0378-1940-21) |
| ANDA | ANDA213912 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| Imprint code | MYLAN;LL;25 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1940 |
NDC Item 00480124621
| NDC 9 | 0480-1246 |
|---|---|
| NDC 10 | 0480-1246-21 |
| NDC Item | 00480124621 |
| Packaging | 21 CAPSULE in 1 BOTTLE (0480-1246-21) |
| ANDA | ANDA201452 |
| COLORTEXT | white |
| Color | C48325 __ |
| Imprint code | NAT;25mg |
| Labeler | Teva Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0480-1246 |
NDC Item 31722026201
| NDC 9 | 31722-262 |
|---|---|
| NDC 10 | 31722-262-01 |
| NDC Item | 31722026201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (31722-262-01) |
| ANDA | ANDA212414 |
| COLORTEXT | white |
| Color | C48325 __ |
| Imprint code | H;L7 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-262 |
NDC Item 31722026221
| NDC 9 | 31722-262 |
|---|---|
| NDC 10 | 31722-262-21 |
| NDC Item | 31722026221 |
| Packaging | 21 CAPSULE in 1 BOTTLE (31722-262-21) |
| ANDA | ANDA212414 |
| COLORTEXT | white |
| Color | C48325 __ |
| Imprint code | H;L7 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-262 |
NDC Item 43598051501
| NDC 9 | 43598-515 |
|---|---|
| NDC 10 | 43598-515-01 |
| NDC Item | 43598051501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (43598-515-01) |
| ANDA | ANDA209348 |
| COLORTEXT | WHITE(opaque white colored cap and body) |
| Color | C48325 __ |
| Imprint code | RDY;25;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 43598-515 |
NDC Item 43598051521
| NDC 9 | 43598-515 |
|---|---|
| NDC 10 | 43598-515-21 |
| NDC Item | 43598051521 |
| Packaging | 21 CAPSULE in 1 BOTTLE (43598-515-21) |
| ANDA | ANDA209348 |
| COLORTEXT | WHITE(opaque white colored cap and body) |
| Color | C48325 __ |
| Imprint code | RDY;25;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 43598-515 |
NDC Item 47781048801
| NDC 9 | 47781-488 |
|---|---|
| NDC 10 | 47781-488-01 |
| NDC Item | 47781048801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-488-01) |
| ANDA | ANDA210480 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | LP;642 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-488 |
NDC Item 47781048877
| NDC 9 | 47781-488 |
|---|---|
| NDC 10 | 47781-488-77 |
| NDC Item | 47781048877 |
| Packaging | 21 CAPSULE in 1 BOTTLE (47781-488-77) |
| ANDA | ANDA210480 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | LP;642 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-488 |
NDC Item 59651034701
| NDC 9 | 59651-347 |
|---|---|
| NDC 10 | 59651-347-01 |
| NDC Item | 59651034701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (59651-347-01) |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| Imprint code | L;25 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-347 |
NDC Item 59651034707
| NDC 9 | 59651-347 |
|---|---|
| NDC 10 | 59651-347-07 |
| NDC Item | 59651034707 |
| Packaging | 1 BLISTER PACK in 1 CARTON (59651-347-07) / 7 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| Imprint code | L;25 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-347 |
NDC Item 59651034721
| NDC 9 | 59651-347 |
|---|---|
| NDC 10 | 59651-347-21 |
| NDC Item | 59651034721 |
| Packaging | 21 CAPSULE in 1 BOTTLE (59651-347-21) |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| Imprint code | L;25 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-347 |
NDC Item 60219171901
| NDC 9 | 60219-1719 |
|---|---|
| NDC 10 | 60219-1719-1 |
| NDC Item | 60219171901 |
| Packaging | 21 CAPSULE in 1 BOTTLE (60219-1719-1) |
| ANDA | ANDA216213 |
| COLORTEXT | white(white opaque cap),white(white opaque body) |
| Color | C48325;C48325 __ |
| Imprint code | AA22A |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60219-1719 |
NDC Item 60219171902
| NDC 9 | 60219-1719 |
|---|---|
| NDC 10 | 60219-1719-2 |
| NDC Item | 60219171902 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60219-1719-2) |
| ANDA | ANDA216213 |
| COLORTEXT | white(white opaque cap),white(white opaque body) |
| Color | C48325;C48325 __ |
| Imprint code | AA22A |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60219-1719 |
NDC Item 60505453701
| NDC 9 | 60505-4537 |
|---|---|
| NDC 10 | 60505-4537-1 |
| NDC Item | 60505453701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60505-4537-1) |
| ANDA | ANDA211022 |
| COLORTEXT | WHITE(White opaque),WHITE(White opaque) |
| Color | C48325;C48325 __ |
| Imprint code | APO;L25 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60505-4537 |
NDC Item 60505453702
| NDC 9 | 60505-4537 |
|---|---|
| NDC 10 | 60505-4537-2 |
| NDC Item | 60505453702 |
| Packaging | 21 CAPSULE in 1 BOTTLE (60505-4537-2) |
| ANDA | ANDA211022 |
| COLORTEXT | WHITE(White opaque),WHITE(White opaque) |
| Color | C48325;C48325 __ |
| Imprint code | APO;L25 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60505-4537 |
NDC Item 63304004601
| NDC 9 | 63304-046 |
|---|---|
| NDC 10 | 63304-046-01 |
| NDC Item | 63304004601 |
| Packaging | 100 CAPSULE in 1 BOTTLE (63304-046-01) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| Imprint code | RL;;83 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-046 |
NDC Item 63304004622
| NDC 9 | 63304-046 |
|---|---|
| NDC 10 | 63304-046-22 |
| NDC Item | 63304004622 |
| Packaging | 21 CAPSULE in 1 BOTTLE (63304-046-22) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| Imprint code | RL;;83 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-046 |
NDC Item 69097038581
| NDC 9 | 69097-385 |
|---|---|
| NDC 10 | 69097-385-81 |
| NDC Item | 69097038581 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (69097-385-81) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Cipla25mg;385 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 69097-385 |
NDC Item 70377005411
| NDC 9 | 70377-054 |
|---|---|
| NDC 10 | 70377-054-11 |
| NDC Item | 70377005411 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70377-054-11) |
| ANDA | ANDA215759 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Biocon;logo;25;mg |
| Labeler | BIOCON PHARMA INC., |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70377-054 |
NDC Item 70377005412
| NDC 9 | 70377-054 |
|---|---|
| NDC 10 | 70377-054-12 |
| NDC Item | 70377005412 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70377-054-12) |
| ANDA | ANDA215759 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Biocon;logo;25;mg |
| Labeler | BIOCON PHARMA INC., |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70377-054 |
NDC Item 70710103501
| NDC 9 | 70710-1035 |
|---|---|
| NDC 10 | 70710-1035-1 |
| NDC Item | 70710103501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70710-1035-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70710-1035 |
NDC Item 70710103508
| NDC 9 | 70710-1035 |
|---|---|
| NDC 10 | 70710-1035-8 |
| NDC Item | 70710103508 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70710-1035-8) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70710-1035 |
NDC Item 70771168101
| NDC 9 | 70771-1681 |
|---|---|
| NDC 10 | 70771-1681-1 |
| NDC Item | 70771168101 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70771-1681-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(White opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70771-1681 |
NDC Item 70771168108
| NDC 9 | 70771-1681 |
|---|---|
| NDC 10 | 70771-1681-8 |
| NDC Item | 70771168108 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70771-1681-8) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(White opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70771-1681 |
NDC Item 76282070147
| NDC 9 | 76282-701 |
|---|---|
| NDC 10 | 76282-701-47 |
| NDC Item | 76282070147 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (76282-701-47) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Cipla25mg;385 |
| Labeler | EXELAN PHARMACEUTICALS INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 76282-701 |
NDC Item 00378194001
| NDC 9 | 0378-1940 |
|---|---|
| NDC 10 | 0378-1940-01 |
| NDC Item | 00378194001 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1940-01) |
| ANDA | ANDA213912 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| Imprint code | MYLAN;LL;25 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1940 |
NDC Item 00378194021
| NDC 9 | 0378-1940 |
|---|---|
| NDC 10 | 0378-1940-21 |
| NDC Item | 00378194021 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (0378-1940-21) |
| ANDA | ANDA213912 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| Imprint code | MYLAN;LL;25 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1940 |
NDC Item 00480124621
| NDC 9 | 0480-1246 |
|---|---|
| NDC 10 | 0480-1246-21 |
| NDC Item | 00480124621 |
| Packaging | 21 CAPSULE in 1 BOTTLE (0480-1246-21) |
| ANDA | ANDA201452 |
| COLORTEXT | white |
| Color | C48325 __ |
| Imprint code | NAT;25mg |
| Labeler | Teva Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0480-1246 |
NDC Item 31722026201
| NDC 9 | 31722-262 |
|---|---|
| NDC 10 | 31722-262-01 |
| NDC Item | 31722026201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (31722-262-01) |
| ANDA | ANDA212414 |
| COLORTEXT | white |
| Color | C48325 __ |
| Imprint code | H;L7 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-262 |
NDC Item 31722026221
| NDC 9 | 31722-262 |
|---|---|
| NDC 10 | 31722-262-21 |
| NDC Item | 31722026221 |
| Packaging | 21 CAPSULE in 1 BOTTLE (31722-262-21) |
| ANDA | ANDA212414 |
| COLORTEXT | white |
| Color | C48325 __ |
| Imprint code | H;L7 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-262 |
NDC Item 43598051501
| NDC 9 | 43598-515 |
|---|---|
| NDC 10 | 43598-515-01 |
| NDC Item | 43598051501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (43598-515-01) |
| ANDA | ANDA209348 |
| COLORTEXT | WHITE(opaque white colored cap and body) |
| Color | C48325 __ |
| Imprint code | RDY;25;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 43598-515 |
NDC Item 43598051521
| NDC 9 | 43598-515 |
|---|---|
| NDC 10 | 43598-515-21 |
| NDC Item | 43598051521 |
| Packaging | 21 CAPSULE in 1 BOTTLE (43598-515-21) |
| ANDA | ANDA209348 |
| COLORTEXT | WHITE(opaque white colored cap and body) |
| Color | C48325 __ |
| Imprint code | RDY;25;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 43598-515 |
NDC Item 47781048801
| NDC 9 | 47781-488 |
|---|---|
| NDC 10 | 47781-488-01 |
| NDC Item | 47781048801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-488-01) |
| ANDA | ANDA210480 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | LP;642 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-488 |
NDC Item 47781048877
| NDC 9 | 47781-488 |
|---|---|
| NDC 10 | 47781-488-77 |
| NDC Item | 47781048877 |
| Packaging | 21 CAPSULE in 1 BOTTLE (47781-488-77) |
| ANDA | ANDA210480 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | LP;642 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-488 |
NDC Item 59651034701
| NDC 9 | 59651-347 |
|---|---|
| NDC 10 | 59651-347-01 |
| NDC Item | 59651034701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (59651-347-01) |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| Imprint code | L;25 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-347 |
NDC Item 59651034707
| NDC 9 | 59651-347 |
|---|---|
| NDC 10 | 59651-347-07 |
| NDC Item | 59651034707 |
| Packaging | 1 BLISTER PACK in 1 CARTON (59651-347-07) / 7 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| Imprint code | L;25 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-347 |
NDC Item 59651034721
| NDC 9 | 59651-347 |
|---|---|
| NDC 10 | 59651-347-21 |
| NDC Item | 59651034721 |
| Packaging | 21 CAPSULE in 1 BOTTLE (59651-347-21) |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| Imprint code | L;25 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-347 |
NDC Item 60219171901
| NDC 9 | 60219-1719 |
|---|---|
| NDC 10 | 60219-1719-1 |
| NDC Item | 60219171901 |
| Packaging | 21 CAPSULE in 1 BOTTLE (60219-1719-1) |
| ANDA | ANDA216213 |
| COLORTEXT | white(white opaque cap),white(white opaque body) |
| Color | C48325;C48325 __ |
| Imprint code | AA22A |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60219-1719 |
NDC Item 60219171902
| NDC 9 | 60219-1719 |
|---|---|
| NDC 10 | 60219-1719-2 |
| NDC Item | 60219171902 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60219-1719-2) |
| ANDA | ANDA216213 |
| COLORTEXT | white(white opaque cap),white(white opaque body) |
| Color | C48325;C48325 __ |
| Imprint code | AA22A |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60219-1719 |
NDC Item 60505453701
| NDC 9 | 60505-4537 |
|---|---|
| NDC 10 | 60505-4537-1 |
| NDC Item | 60505453701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60505-4537-1) |
| ANDA | ANDA211022 |
| COLORTEXT | WHITE(White opaque),WHITE(White opaque) |
| Color | C48325;C48325 __ |
| Imprint code | APO;L25 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60505-4537 |
NDC Item 60505453702
| NDC 9 | 60505-4537 |
|---|---|
| NDC 10 | 60505-4537-2 |
| NDC Item | 60505453702 |
| Packaging | 21 CAPSULE in 1 BOTTLE (60505-4537-2) |
| ANDA | ANDA211022 |
| COLORTEXT | WHITE(White opaque),WHITE(White opaque) |
| Color | C48325;C48325 __ |
| Imprint code | APO;L25 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60505-4537 |
NDC Item 63304004601
| NDC 9 | 63304-046 |
|---|---|
| NDC 10 | 63304-046-01 |
| NDC Item | 63304004601 |
| Packaging | 100 CAPSULE in 1 BOTTLE (63304-046-01) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| Imprint code | RL;;83 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-046 |
NDC Item 63304004622
| NDC 9 | 63304-046 |
|---|---|
| NDC 10 | 63304-046-22 |
| NDC Item | 63304004622 |
| Packaging | 21 CAPSULE in 1 BOTTLE (63304-046-22) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| Imprint code | RL;;83 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-046 |
NDC Item 69097038581
| NDC 9 | 69097-385 |
|---|---|
| NDC 10 | 69097-385-81 |
| NDC Item | 69097038581 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (69097-385-81) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Cipla25mg;385 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 69097-385 |
NDC Item 70377005411
| NDC 9 | 70377-054 |
|---|---|
| NDC 10 | 70377-054-11 |
| NDC Item | 70377005411 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70377-054-11) |
| ANDA | ANDA215759 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Biocon;logo;25;mg |
| Labeler | BIOCON PHARMA INC., |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70377-054 |
NDC Item 70377005412
| NDC 9 | 70377-054 |
|---|---|
| NDC 10 | 70377-054-12 |
| NDC Item | 70377005412 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70377-054-12) |
| ANDA | ANDA215759 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Biocon;logo;25;mg |
| Labeler | BIOCON PHARMA INC., |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70377-054 |
NDC Item 70710103501
| NDC 9 | 70710-1035 |
|---|---|
| NDC 10 | 70710-1035-1 |
| NDC Item | 70710103501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70710-1035-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70710-1035 |
NDC Item 70710103508
| NDC 9 | 70710-1035 |
|---|---|
| NDC 10 | 70710-1035-8 |
| NDC Item | 70710103508 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70710-1035-8) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70710-1035 |
NDC Item 70771168101
| NDC 9 | 70771-1681 |
|---|---|
| NDC 10 | 70771-1681-1 |
| NDC Item | 70771168101 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70771-1681-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(White opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70771-1681 |
NDC Item 70771168108
| NDC 9 | 70771-1681 |
|---|---|
| NDC 10 | 70771-1681-8 |
| NDC Item | 70771168108 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70771-1681-8) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(White opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70771-1681 |
NDC Item 76282070147
| NDC 9 | 76282-701 |
|---|---|
| NDC 10 | 76282-701-47 |
| NDC Item | 76282070147 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (76282-701-47) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Cipla25mg;385 |
| Labeler | EXELAN PHARMACEUTICALS INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 76282-701 |
NDC Item 00378194001
| NDC 9 | 0378-1940 |
|---|---|
| NDC 10 | 0378-1940-01 |
| NDC Item | 00378194001 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1940-01) |
| ANDA | ANDA213912 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| Imprint code | MYLAN;LL;25 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1940 |
NDC Item 00378194021
| NDC 9 | 0378-1940 |
|---|---|
| NDC 10 | 0378-1940-21 |
| NDC Item | 00378194021 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (0378-1940-21) |
| ANDA | ANDA213912 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| Imprint code | MYLAN;LL;25 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1940 |
NDC Item 00480124621
| NDC 9 | 0480-1246 |
|---|---|
| NDC 10 | 0480-1246-21 |
| NDC Item | 00480124621 |
| Packaging | 21 CAPSULE in 1 BOTTLE (0480-1246-21) |
| ANDA | ANDA201452 |
| COLORTEXT | white |
| Color | C48325 __ |
| Imprint code | NAT;25mg |
| Labeler | Teva Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0480-1246 |
NDC Item 31722026201
| NDC 9 | 31722-262 |
|---|---|
| NDC 10 | 31722-262-01 |
| NDC Item | 31722026201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (31722-262-01) |
| ANDA | ANDA212414 |
| COLORTEXT | white |
| Color | C48325 __ |
| Imprint code | H;L7 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-262 |
NDC Item 31722026221
| NDC 9 | 31722-262 |
|---|---|
| NDC 10 | 31722-262-21 |
| NDC Item | 31722026221 |
| Packaging | 21 CAPSULE in 1 BOTTLE (31722-262-21) |
| ANDA | ANDA212414 |
| COLORTEXT | white |
| Color | C48325 __ |
| Imprint code | H;L7 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-262 |
NDC Item 43598051501
| NDC 9 | 43598-515 |
|---|---|
| NDC 10 | 43598-515-01 |
| NDC Item | 43598051501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (43598-515-01) |
| ANDA | ANDA209348 |
| COLORTEXT | WHITE(opaque white colored cap and body) |
| Color | C48325 __ |
| Imprint code | RDY;25;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 43598-515 |
NDC Item 43598051521
| NDC 9 | 43598-515 |
|---|---|
| NDC 10 | 43598-515-21 |
| NDC Item | 43598051521 |
| Packaging | 21 CAPSULE in 1 BOTTLE (43598-515-21) |
| ANDA | ANDA209348 |
| COLORTEXT | WHITE(opaque white colored cap and body) |
| Color | C48325 __ |
| Imprint code | RDY;25;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 43598-515 |
NDC Item 47781048801
| NDC 9 | 47781-488 |
|---|---|
| NDC 10 | 47781-488-01 |
| NDC Item | 47781048801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-488-01) |
| ANDA | ANDA210480 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | LP;642 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-488 |
NDC Item 47781048877
| NDC 9 | 47781-488 |
|---|---|
| NDC 10 | 47781-488-77 |
| NDC Item | 47781048877 |
| Packaging | 21 CAPSULE in 1 BOTTLE (47781-488-77) |
| ANDA | ANDA210480 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | LP;642 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-488 |
NDC Item 59651034701
| NDC 9 | 59651-347 |
|---|---|
| NDC 10 | 59651-347-01 |
| NDC Item | 59651034701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (59651-347-01) |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| Imprint code | L;25 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-347 |
NDC Item 59651034707
| NDC 9 | 59651-347 |
|---|---|
| NDC 10 | 59651-347-07 |
| NDC Item | 59651034707 |
| Packaging | 1 BLISTER PACK in 1 CARTON (59651-347-07) / 7 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| Imprint code | L;25 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-347 |
NDC Item 59651034721
| NDC 9 | 59651-347 |
|---|---|
| NDC 10 | 59651-347-21 |
| NDC Item | 59651034721 |
| Packaging | 21 CAPSULE in 1 BOTTLE (59651-347-21) |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| Imprint code | L;25 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-347 |
NDC Item 60219171901
| NDC 9 | 60219-1719 |
|---|---|
| NDC 10 | 60219-1719-1 |
| NDC Item | 60219171901 |
| Packaging | 21 CAPSULE in 1 BOTTLE (60219-1719-1) |
| ANDA | ANDA216213 |
| COLORTEXT | white(white opaque cap),white(white opaque body) |
| Color | C48325;C48325 __ |
| Imprint code | AA22A |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60219-1719 |
NDC Item 60219171902
| NDC 9 | 60219-1719 |
|---|---|
| NDC 10 | 60219-1719-2 |
| NDC Item | 60219171902 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60219-1719-2) |
| ANDA | ANDA216213 |
| COLORTEXT | white(white opaque cap),white(white opaque body) |
| Color | C48325;C48325 __ |
| Imprint code | AA22A |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60219-1719 |
NDC Item 60505453701
| NDC 9 | 60505-4537 |
|---|---|
| NDC 10 | 60505-4537-1 |
| NDC Item | 60505453701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60505-4537-1) |
| ANDA | ANDA211022 |
| COLORTEXT | WHITE(White opaque),WHITE(White opaque) |
| Color | C48325;C48325 __ |
| Imprint code | APO;L25 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60505-4537 |
NDC Item 60505453702
| NDC 9 | 60505-4537 |
|---|---|
| NDC 10 | 60505-4537-2 |
| NDC Item | 60505453702 |
| Packaging | 21 CAPSULE in 1 BOTTLE (60505-4537-2) |
| ANDA | ANDA211022 |
| COLORTEXT | WHITE(White opaque),WHITE(White opaque) |
| Color | C48325;C48325 __ |
| Imprint code | APO;L25 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60505-4537 |
NDC Item 63304004601
| NDC 9 | 63304-046 |
|---|---|
| NDC 10 | 63304-046-01 |
| NDC Item | 63304004601 |
| Packaging | 100 CAPSULE in 1 BOTTLE (63304-046-01) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| Imprint code | RL;;83 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-046 |
NDC Item 63304004622
| NDC 9 | 63304-046 |
|---|---|
| NDC 10 | 63304-046-22 |
| NDC Item | 63304004622 |
| Packaging | 21 CAPSULE in 1 BOTTLE (63304-046-22) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| Imprint code | RL;;83 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-046 |
NDC Item 69097038581
| NDC 9 | 69097-385 |
|---|---|
| NDC 10 | 69097-385-81 |
| NDC Item | 69097038581 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (69097-385-81) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Cipla25mg;385 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 69097-385 |
NDC Item 70377005411
| NDC 9 | 70377-054 |
|---|---|
| NDC 10 | 70377-054-11 |
| NDC Item | 70377005411 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70377-054-11) |
| ANDA | ANDA215759 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Biocon;logo;25;mg |
| Labeler | BIOCON PHARMA INC., |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70377-054 |
NDC Item 70377005412
| NDC 9 | 70377-054 |
|---|---|
| NDC 10 | 70377-054-12 |
| NDC Item | 70377005412 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70377-054-12) |
| ANDA | ANDA215759 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Biocon;logo;25;mg |
| Labeler | BIOCON PHARMA INC., |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70377-054 |
NDC Item 70710103501
| NDC 9 | 70710-1035 |
|---|---|
| NDC 10 | 70710-1035-1 |
| NDC Item | 70710103501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70710-1035-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70710-1035 |
NDC Item 70710103508
| NDC 9 | 70710-1035 |
|---|---|
| NDC 10 | 70710-1035-8 |
| NDC Item | 70710103508 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70710-1035-8) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70710-1035 |
NDC Item 70771168101
| NDC 9 | 70771-1681 |
|---|---|
| NDC 10 | 70771-1681-1 |
| NDC Item | 70771168101 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70771-1681-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(White opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70771-1681 |
NDC Item 70771168108
| NDC 9 | 70771-1681 |
|---|---|
| NDC 10 | 70771-1681-8 |
| NDC Item | 70771168108 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70771-1681-8) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(White opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70771-1681 |
NDC Item 76282070147
| NDC 9 | 76282-701 |
|---|---|
| NDC 10 | 76282-701-47 |
| NDC Item | 76282070147 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (76282-701-47) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Cipla25mg;385 |
| Labeler | EXELAN PHARMACEUTICALS INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 76282-701 |
NDC Item 00378194001
| NDC 9 | 0378-1940 |
|---|---|
| NDC 10 | 0378-1940-01 |
| NDC Item | 00378194001 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1940-01) |
| ANDA | ANDA213912 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| Imprint code | MYLAN;LL;25 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1940 |
NDC Item 00378194021
| NDC 9 | 0378-1940 |
|---|---|
| NDC 10 | 0378-1940-21 |
| NDC Item | 00378194021 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (0378-1940-21) |
| ANDA | ANDA213912 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| Imprint code | MYLAN;LL;25 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1940 |
NDC Item 00480124621
| NDC 9 | 0480-1246 |
|---|---|
| NDC 10 | 0480-1246-21 |
| NDC Item | 00480124621 |
| Packaging | 21 CAPSULE in 1 BOTTLE (0480-1246-21) |
| ANDA | ANDA201452 |
| COLORTEXT | white |
| Color | C48325 __ |
| Imprint code | NAT;25mg |
| Labeler | Teva Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0480-1246 |
NDC Item 31722026201
| NDC 9 | 31722-262 |
|---|---|
| NDC 10 | 31722-262-01 |
| NDC Item | 31722026201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (31722-262-01) |
| ANDA | ANDA212414 |
| COLORTEXT | white |
| Color | C48325 __ |
| Imprint code | H;L7 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-262 |
NDC Item 31722026221
| NDC 9 | 31722-262 |
|---|---|
| NDC 10 | 31722-262-21 |
| NDC Item | 31722026221 |
| Packaging | 21 CAPSULE in 1 BOTTLE (31722-262-21) |
| ANDA | ANDA212414 |
| COLORTEXT | white |
| Color | C48325 __ |
| Imprint code | H;L7 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-262 |
NDC Item 43598051501
| NDC 9 | 43598-515 |
|---|---|
| NDC 10 | 43598-515-01 |
| NDC Item | 43598051501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (43598-515-01) |
| ANDA | ANDA209348 |
| COLORTEXT | WHITE(opaque white colored cap and body) |
| Color | C48325 __ |
| Imprint code | RDY;25;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 43598-515 |
NDC Item 43598051521
| NDC 9 | 43598-515 |
|---|---|
| NDC 10 | 43598-515-21 |
| NDC Item | 43598051521 |
| Packaging | 21 CAPSULE in 1 BOTTLE (43598-515-21) |
| ANDA | ANDA209348 |
| COLORTEXT | WHITE(opaque white colored cap and body) |
| Color | C48325 __ |
| Imprint code | RDY;25;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 43598-515 |
NDC Item 47781048801
| NDC 9 | 47781-488 |
|---|---|
| NDC 10 | 47781-488-01 |
| NDC Item | 47781048801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-488-01) |
| ANDA | ANDA210480 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | LP;642 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-488 |
NDC Item 47781048877
| NDC 9 | 47781-488 |
|---|---|
| NDC 10 | 47781-488-77 |
| NDC Item | 47781048877 |
| Packaging | 21 CAPSULE in 1 BOTTLE (47781-488-77) |
| ANDA | ANDA210480 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | LP;642 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-488 |
NDC Item 59651034701
| NDC 9 | 59651-347 |
|---|---|
| NDC 10 | 59651-347-01 |
| NDC Item | 59651034701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (59651-347-01) |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| Imprint code | L;25 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-347 |
NDC Item 59651034707
| NDC 9 | 59651-347 |
|---|---|
| NDC 10 | 59651-347-07 |
| NDC Item | 59651034707 |
| Packaging | 1 BLISTER PACK in 1 CARTON (59651-347-07) / 7 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| Imprint code | L;25 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-347 |
NDC Item 59651034721
| NDC 9 | 59651-347 |
|---|---|
| NDC 10 | 59651-347-21 |
| NDC Item | 59651034721 |
| Packaging | 21 CAPSULE in 1 BOTTLE (59651-347-21) |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| Imprint code | L;25 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-347 |
NDC Item 60219171901
| NDC 9 | 60219-1719 |
|---|---|
| NDC 10 | 60219-1719-1 |
| NDC Item | 60219171901 |
| Packaging | 21 CAPSULE in 1 BOTTLE (60219-1719-1) |
| ANDA | ANDA216213 |
| COLORTEXT | white(white opaque cap),white(white opaque body) |
| Color | C48325;C48325 __ |
| Imprint code | AA22A |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60219-1719 |
NDC Item 60219171902
| NDC 9 | 60219-1719 |
|---|---|
| NDC 10 | 60219-1719-2 |
| NDC Item | 60219171902 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60219-1719-2) |
| ANDA | ANDA216213 |
| COLORTEXT | white(white opaque cap),white(white opaque body) |
| Color | C48325;C48325 __ |
| Imprint code | AA22A |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60219-1719 |
NDC Item 60505453701
| NDC 9 | 60505-4537 |
|---|---|
| NDC 10 | 60505-4537-1 |
| NDC Item | 60505453701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60505-4537-1) |
| ANDA | ANDA211022 |
| COLORTEXT | WHITE(White opaque),WHITE(White opaque) |
| Color | C48325;C48325 __ |
| Imprint code | APO;L25 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60505-4537 |
NDC Item 60505453702
| NDC 9 | 60505-4537 |
|---|---|
| NDC 10 | 60505-4537-2 |
| NDC Item | 60505453702 |
| Packaging | 21 CAPSULE in 1 BOTTLE (60505-4537-2) |
| ANDA | ANDA211022 |
| COLORTEXT | WHITE(White opaque),WHITE(White opaque) |
| Color | C48325;C48325 __ |
| Imprint code | APO;L25 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60505-4537 |
NDC Item 63304004601
| NDC 9 | 63304-046 |
|---|---|
| NDC 10 | 63304-046-01 |
| NDC Item | 63304004601 |
| Packaging | 100 CAPSULE in 1 BOTTLE (63304-046-01) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| Imprint code | RL;;83 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-046 |
NDC Item 63304004622
| NDC 9 | 63304-046 |
|---|---|
| NDC 10 | 63304-046-22 |
| NDC Item | 63304004622 |
| Packaging | 21 CAPSULE in 1 BOTTLE (63304-046-22) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| Imprint code | RL;;83 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-046 |
NDC Item 69097038581
| NDC 9 | 69097-385 |
|---|---|
| NDC 10 | 69097-385-81 |
| NDC Item | 69097038581 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (69097-385-81) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Cipla25mg;385 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 69097-385 |
NDC Item 70377005411
| NDC 9 | 70377-054 |
|---|---|
| NDC 10 | 70377-054-11 |
| NDC Item | 70377005411 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70377-054-11) |
| ANDA | ANDA215759 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Biocon;logo;25;mg |
| Labeler | BIOCON PHARMA INC., |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70377-054 |
NDC Item 70377005412
| NDC 9 | 70377-054 |
|---|---|
| NDC 10 | 70377-054-12 |
| NDC Item | 70377005412 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70377-054-12) |
| ANDA | ANDA215759 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Biocon;logo;25;mg |
| Labeler | BIOCON PHARMA INC., |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70377-054 |
NDC Item 70710103501
| NDC 9 | 70710-1035 |
|---|---|
| NDC 10 | 70710-1035-1 |
| NDC Item | 70710103501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70710-1035-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70710-1035 |
NDC Item 70710103508
| NDC 9 | 70710-1035 |
|---|---|
| NDC 10 | 70710-1035-8 |
| NDC Item | 70710103508 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70710-1035-8) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70710-1035 |
NDC Item 70771168101
| NDC 9 | 70771-1681 |
|---|---|
| NDC 10 | 70771-1681-1 |
| NDC Item | 70771168101 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70771-1681-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(White opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70771-1681 |
NDC Item 70771168108
| NDC 9 | 70771-1681 |
|---|---|
| NDC 10 | 70771-1681-8 |
| NDC Item | 70771168108 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70771-1681-8) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(White opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70771-1681 |
NDC Item 76282070147
| NDC 9 | 76282-701 |
|---|---|
| NDC 10 | 76282-701-47 |
| NDC Item | 76282070147 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (76282-701-47) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Cipla25mg;385 |
| Labeler | EXELAN PHARMACEUTICALS INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 76282-701 |
NDC Item 00378194001
| NDC 9 | 0378-1940 |
|---|---|
| NDC 10 | 0378-1940-01 |
| NDC Item | 00378194001 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1940-01) |
| ANDA | ANDA213912 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| Imprint code | MYLAN;LL;25 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1940 |
NDC Item 00378194021
| NDC 9 | 0378-1940 |
|---|---|
| NDC 10 | 0378-1940-21 |
| NDC Item | 00378194021 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (0378-1940-21) |
| ANDA | ANDA213912 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| Imprint code | MYLAN;LL;25 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1940 |
NDC Item 00480124621
| NDC 9 | 0480-1246 |
|---|---|
| NDC 10 | 0480-1246-21 |
| NDC Item | 00480124621 |
| Packaging | 21 CAPSULE in 1 BOTTLE (0480-1246-21) |
| ANDA | ANDA201452 |
| COLORTEXT | white |
| Color | C48325 __ |
| Imprint code | NAT;25mg |
| Labeler | Teva Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0480-1246 |
NDC Item 31722026201
| NDC 9 | 31722-262 |
|---|---|
| NDC 10 | 31722-262-01 |
| NDC Item | 31722026201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (31722-262-01) |
| ANDA | ANDA212414 |
| COLORTEXT | white |
| Color | C48325 __ |
| Imprint code | H;L7 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-262 |
NDC Item 31722026221
| NDC 9 | 31722-262 |
|---|---|
| NDC 10 | 31722-262-21 |
| NDC Item | 31722026221 |
| Packaging | 21 CAPSULE in 1 BOTTLE (31722-262-21) |
| ANDA | ANDA212414 |
| COLORTEXT | white |
| Color | C48325 __ |
| Imprint code | H;L7 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-262 |
NDC Item 43598051501
| NDC 9 | 43598-515 |
|---|---|
| NDC 10 | 43598-515-01 |
| NDC Item | 43598051501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (43598-515-01) |
| ANDA | ANDA209348 |
| COLORTEXT | WHITE(opaque white colored cap and body) |
| Color | C48325 __ |
| Imprint code | RDY;25;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 43598-515 |
NDC Item 43598051521
| NDC 9 | 43598-515 |
|---|---|
| NDC 10 | 43598-515-21 |
| NDC Item | 43598051521 |
| Packaging | 21 CAPSULE in 1 BOTTLE (43598-515-21) |
| ANDA | ANDA209348 |
| COLORTEXT | WHITE(opaque white colored cap and body) |
| Color | C48325 __ |
| Imprint code | RDY;25;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 43598-515 |
NDC Item 47781048801
| NDC 9 | 47781-488 |
|---|---|
| NDC 10 | 47781-488-01 |
| NDC Item | 47781048801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-488-01) |
| ANDA | ANDA210480 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | LP;642 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-488 |
NDC Item 47781048877
| NDC 9 | 47781-488 |
|---|---|
| NDC 10 | 47781-488-77 |
| NDC Item | 47781048877 |
| Packaging | 21 CAPSULE in 1 BOTTLE (47781-488-77) |
| ANDA | ANDA210480 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | LP;642 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-488 |
NDC Item 59651034701
| NDC 9 | 59651-347 |
|---|---|
| NDC 10 | 59651-347-01 |
| NDC Item | 59651034701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (59651-347-01) |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| Imprint code | L;25 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-347 |
NDC Item 59651034707
| NDC 9 | 59651-347 |
|---|---|
| NDC 10 | 59651-347-07 |
| NDC Item | 59651034707 |
| Packaging | 1 BLISTER PACK in 1 CARTON (59651-347-07) / 7 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| Imprint code | L;25 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-347 |
NDC Item 59651034721
| NDC 9 | 59651-347 |
|---|---|
| NDC 10 | 59651-347-21 |
| NDC Item | 59651034721 |
| Packaging | 21 CAPSULE in 1 BOTTLE (59651-347-21) |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| Imprint code | L;25 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-347 |
NDC Item 60219171901
| NDC 9 | 60219-1719 |
|---|---|
| NDC 10 | 60219-1719-1 |
| NDC Item | 60219171901 |
| Packaging | 21 CAPSULE in 1 BOTTLE (60219-1719-1) |
| ANDA | ANDA216213 |
| COLORTEXT | white(white opaque cap),white(white opaque body) |
| Color | C48325;C48325 __ |
| Imprint code | AA22A |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60219-1719 |
NDC Item 60219171902
| NDC 9 | 60219-1719 |
|---|---|
| NDC 10 | 60219-1719-2 |
| NDC Item | 60219171902 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60219-1719-2) |
| ANDA | ANDA216213 |
| COLORTEXT | white(white opaque cap),white(white opaque body) |
| Color | C48325;C48325 __ |
| Imprint code | AA22A |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60219-1719 |
NDC Item 60505453701
| NDC 9 | 60505-4537 |
|---|---|
| NDC 10 | 60505-4537-1 |
| NDC Item | 60505453701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60505-4537-1) |
| ANDA | ANDA211022 |
| COLORTEXT | WHITE(White opaque),WHITE(White opaque) |
| Color | C48325;C48325 __ |
| Imprint code | APO;L25 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60505-4537 |
NDC Item 60505453702
| NDC 9 | 60505-4537 |
|---|---|
| NDC 10 | 60505-4537-2 |
| NDC Item | 60505453702 |
| Packaging | 21 CAPSULE in 1 BOTTLE (60505-4537-2) |
| ANDA | ANDA211022 |
| COLORTEXT | WHITE(White opaque),WHITE(White opaque) |
| Color | C48325;C48325 __ |
| Imprint code | APO;L25 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60505-4537 |
NDC Item 63304004601
| NDC 9 | 63304-046 |
|---|---|
| NDC 10 | 63304-046-01 |
| NDC Item | 63304004601 |
| Packaging | 100 CAPSULE in 1 BOTTLE (63304-046-01) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| Imprint code | RL;;83 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-046 |
NDC Item 63304004622
| NDC 9 | 63304-046 |
|---|---|
| NDC 10 | 63304-046-22 |
| NDC Item | 63304004622 |
| Packaging | 21 CAPSULE in 1 BOTTLE (63304-046-22) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| Imprint code | RL;;83 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-046 |
NDC Item 69097038581
| NDC 9 | 69097-385 |
|---|---|
| NDC 10 | 69097-385-81 |
| NDC Item | 69097038581 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (69097-385-81) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Cipla25mg;385 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 69097-385 |
NDC Item 70377005411
| NDC 9 | 70377-054 |
|---|---|
| NDC 10 | 70377-054-11 |
| NDC Item | 70377005411 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70377-054-11) |
| ANDA | ANDA215759 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Biocon;logo;25;mg |
| Labeler | BIOCON PHARMA INC., |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70377-054 |
NDC Item 70377005412
| NDC 9 | 70377-054 |
|---|---|
| NDC 10 | 70377-054-12 |
| NDC Item | 70377005412 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70377-054-12) |
| ANDA | ANDA215759 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Biocon;logo;25;mg |
| Labeler | BIOCON PHARMA INC., |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70377-054 |
NDC Item 70710103501
| NDC 9 | 70710-1035 |
|---|---|
| NDC 10 | 70710-1035-1 |
| NDC Item | 70710103501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70710-1035-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70710-1035 |
NDC Item 70710103508
| NDC 9 | 70710-1035 |
|---|---|
| NDC 10 | 70710-1035-8 |
| NDC Item | 70710103508 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70710-1035-8) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70710-1035 |
NDC Item 70771168101
| NDC 9 | 70771-1681 |
|---|---|
| NDC 10 | 70771-1681-1 |
| NDC Item | 70771168101 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70771-1681-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(White opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70771-1681 |
NDC Item 70771168108
| NDC 9 | 70771-1681 |
|---|---|
| NDC 10 | 70771-1681-8 |
| NDC Item | 70771168108 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70771-1681-8) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(White opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70771-1681 |
NDC Item 76282070147
| NDC 9 | 76282-701 |
|---|---|
| NDC 10 | 76282-701-47 |
| NDC Item | 76282070147 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (76282-701-47) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Cipla25mg;385 |
| Labeler | EXELAN PHARMACEUTICALS INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 76282-701 |
NDC Item 00378194001
| NDC 9 | 0378-1940 |
|---|---|
| NDC 10 | 0378-1940-01 |
| NDC Item | 00378194001 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1940-01) |
| ANDA | ANDA213912 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| Imprint code | MYLAN;LL;25 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1940 |
NDC Item 00378194021
| NDC 9 | 0378-1940 |
|---|---|
| NDC 10 | 0378-1940-21 |
| NDC Item | 00378194021 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (0378-1940-21) |
| ANDA | ANDA213912 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| Imprint code | MYLAN;LL;25 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1940 |
NDC Item 00480124621
| NDC 9 | 0480-1246 |
|---|---|
| NDC 10 | 0480-1246-21 |
| NDC Item | 00480124621 |
| Packaging | 21 CAPSULE in 1 BOTTLE (0480-1246-21) |
| ANDA | ANDA201452 |
| COLORTEXT | white |
| Color | C48325 __ |
| Imprint code | NAT;25mg |
| Labeler | Teva Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0480-1246 |
NDC Item 31722026201
| NDC 9 | 31722-262 |
|---|---|
| NDC 10 | 31722-262-01 |
| NDC Item | 31722026201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (31722-262-01) |
| ANDA | ANDA212414 |
| COLORTEXT | white |
| Color | C48325 __ |
| Imprint code | H;L7 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-262 |
NDC Item 31722026221
| NDC 9 | 31722-262 |
|---|---|
| NDC 10 | 31722-262-21 |
| NDC Item | 31722026221 |
| Packaging | 21 CAPSULE in 1 BOTTLE (31722-262-21) |
| ANDA | ANDA212414 |
| COLORTEXT | white |
| Color | C48325 __ |
| Imprint code | H;L7 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-262 |
NDC Item 43598051501
| NDC 9 | 43598-515 |
|---|---|
| NDC 10 | 43598-515-01 |
| NDC Item | 43598051501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (43598-515-01) |
| ANDA | ANDA209348 |
| COLORTEXT | WHITE(opaque white colored cap and body) |
| Color | C48325 __ |
| Imprint code | RDY;25;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 43598-515 |
NDC Item 43598051521
| NDC 9 | 43598-515 |
|---|---|
| NDC 10 | 43598-515-21 |
| NDC Item | 43598051521 |
| Packaging | 21 CAPSULE in 1 BOTTLE (43598-515-21) |
| ANDA | ANDA209348 |
| COLORTEXT | WHITE(opaque white colored cap and body) |
| Color | C48325 __ |
| Imprint code | RDY;25;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 43598-515 |
NDC Item 47781048801
| NDC 9 | 47781-488 |
|---|---|
| NDC 10 | 47781-488-01 |
| NDC Item | 47781048801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-488-01) |
| ANDA | ANDA210480 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | LP;642 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-488 |
NDC Item 47781048877
| NDC 9 | 47781-488 |
|---|---|
| NDC 10 | 47781-488-77 |
| NDC Item | 47781048877 |
| Packaging | 21 CAPSULE in 1 BOTTLE (47781-488-77) |
| ANDA | ANDA210480 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | LP;642 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-488 |
NDC Item 59651034701
| NDC 9 | 59651-347 |
|---|---|
| NDC 10 | 59651-347-01 |
| NDC Item | 59651034701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (59651-347-01) |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| Imprint code | L;25 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-347 |
NDC Item 59651034707
| NDC 9 | 59651-347 |
|---|---|
| NDC 10 | 59651-347-07 |
| NDC Item | 59651034707 |
| Packaging | 1 BLISTER PACK in 1 CARTON (59651-347-07) / 7 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| Imprint code | L;25 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-347 |
NDC Item 59651034721
| NDC 9 | 59651-347 |
|---|---|
| NDC 10 | 59651-347-21 |
| NDC Item | 59651034721 |
| Packaging | 21 CAPSULE in 1 BOTTLE (59651-347-21) |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| Imprint code | L;25 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-347 |
NDC Item 60219171901
| NDC 9 | 60219-1719 |
|---|---|
| NDC 10 | 60219-1719-1 |
| NDC Item | 60219171901 |
| Packaging | 21 CAPSULE in 1 BOTTLE (60219-1719-1) |
| ANDA | ANDA216213 |
| COLORTEXT | white(white opaque cap),white(white opaque body) |
| Color | C48325;C48325 __ |
| Imprint code | AA22A |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60219-1719 |
NDC Item 60219171902
| NDC 9 | 60219-1719 |
|---|---|
| NDC 10 | 60219-1719-2 |
| NDC Item | 60219171902 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60219-1719-2) |
| ANDA | ANDA216213 |
| COLORTEXT | white(white opaque cap),white(white opaque body) |
| Color | C48325;C48325 __ |
| Imprint code | AA22A |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60219-1719 |
NDC Item 60505453701
| NDC 9 | 60505-4537 |
|---|---|
| NDC 10 | 60505-4537-1 |
| NDC Item | 60505453701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60505-4537-1) |
| ANDA | ANDA211022 |
| COLORTEXT | WHITE(White opaque),WHITE(White opaque) |
| Color | C48325;C48325 __ |
| Imprint code | APO;L25 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60505-4537 |
NDC Item 60505453702
| NDC 9 | 60505-4537 |
|---|---|
| NDC 10 | 60505-4537-2 |
| NDC Item | 60505453702 |
| Packaging | 21 CAPSULE in 1 BOTTLE (60505-4537-2) |
| ANDA | ANDA211022 |
| COLORTEXT | WHITE(White opaque),WHITE(White opaque) |
| Color | C48325;C48325 __ |
| Imprint code | APO;L25 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60505-4537 |
NDC Item 63304004601
| NDC 9 | 63304-046 |
|---|---|
| NDC 10 | 63304-046-01 |
| NDC Item | 63304004601 |
| Packaging | 100 CAPSULE in 1 BOTTLE (63304-046-01) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| Imprint code | RL;;83 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-046 |
NDC Item 63304004622
| NDC 9 | 63304-046 |
|---|---|
| NDC 10 | 63304-046-22 |
| NDC Item | 63304004622 |
| Packaging | 21 CAPSULE in 1 BOTTLE (63304-046-22) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| Imprint code | RL;;83 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-046 |
NDC Item 69097038581
| NDC 9 | 69097-385 |
|---|---|
| NDC 10 | 69097-385-81 |
| NDC Item | 69097038581 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (69097-385-81) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Cipla25mg;385 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 69097-385 |
NDC Item 70377005411
| NDC 9 | 70377-054 |
|---|---|
| NDC 10 | 70377-054-11 |
| NDC Item | 70377005411 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70377-054-11) |
| ANDA | ANDA215759 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Biocon;logo;25;mg |
| Labeler | BIOCON PHARMA INC., |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70377-054 |
NDC Item 70377005412
| NDC 9 | 70377-054 |
|---|---|
| NDC 10 | 70377-054-12 |
| NDC Item | 70377005412 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70377-054-12) |
| ANDA | ANDA215759 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Biocon;logo;25;mg |
| Labeler | BIOCON PHARMA INC., |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70377-054 |
NDC Item 70710103501
| NDC 9 | 70710-1035 |
|---|---|
| NDC 10 | 70710-1035-1 |
| NDC Item | 70710103501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70710-1035-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70710-1035 |
NDC Item 70710103508
| NDC 9 | 70710-1035 |
|---|---|
| NDC 10 | 70710-1035-8 |
| NDC Item | 70710103508 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70710-1035-8) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70710-1035 |
NDC Item 70771168101
| NDC 9 | 70771-1681 |
|---|---|
| NDC 10 | 70771-1681-1 |
| NDC Item | 70771168101 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70771-1681-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(White opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70771-1681 |
NDC Item 70771168108
| NDC 9 | 70771-1681 |
|---|---|
| NDC 10 | 70771-1681-8 |
| NDC Item | 70771168108 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70771-1681-8) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(White opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70771-1681 |
NDC Item 76282070147
| NDC 9 | 76282-701 |
|---|---|
| NDC 10 | 76282-701-47 |
| NDC Item | 76282070147 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (76282-701-47) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Cipla25mg;385 |
| Labeler | EXELAN PHARMACEUTICALS INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 76282-701 |
NDC Item 00378194001
| NDC 9 | 0378-1940 |
|---|---|
| NDC 10 | 0378-1940-01 |
| NDC Item | 00378194001 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1940-01) |
| ANDA | ANDA213912 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| Imprint code | MYLAN;LL;25 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1940 |
NDC Item 00378194021
| NDC 9 | 0378-1940 |
|---|---|
| NDC 10 | 0378-1940-21 |
| NDC Item | 00378194021 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (0378-1940-21) |
| ANDA | ANDA213912 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| Imprint code | MYLAN;LL;25 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1940 |
NDC Item 00480124621
| NDC 9 | 0480-1246 |
|---|---|
| NDC 10 | 0480-1246-21 |
| NDC Item | 00480124621 |
| Packaging | 21 CAPSULE in 1 BOTTLE (0480-1246-21) |
| ANDA | ANDA201452 |
| COLORTEXT | white |
| Color | C48325 __ |
| Imprint code | NAT;25mg |
| Labeler | Teva Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0480-1246 |
NDC Item 31722026201
| NDC 9 | 31722-262 |
|---|---|
| NDC 10 | 31722-262-01 |
| NDC Item | 31722026201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (31722-262-01) |
| ANDA | ANDA212414 |
| COLORTEXT | white |
| Color | C48325 __ |
| Imprint code | H;L7 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-262 |
NDC Item 31722026221
| NDC 9 | 31722-262 |
|---|---|
| NDC 10 | 31722-262-21 |
| NDC Item | 31722026221 |
| Packaging | 21 CAPSULE in 1 BOTTLE (31722-262-21) |
| ANDA | ANDA212414 |
| COLORTEXT | white |
| Color | C48325 __ |
| Imprint code | H;L7 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-262 |
NDC Item 43598051501
| NDC 9 | 43598-515 |
|---|---|
| NDC 10 | 43598-515-01 |
| NDC Item | 43598051501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (43598-515-01) |
| ANDA | ANDA209348 |
| COLORTEXT | WHITE(opaque white colored cap and body) |
| Color | C48325 __ |
| Imprint code | RDY;25;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 43598-515 |
NDC Item 43598051521
| NDC 9 | 43598-515 |
|---|---|
| NDC 10 | 43598-515-21 |
| NDC Item | 43598051521 |
| Packaging | 21 CAPSULE in 1 BOTTLE (43598-515-21) |
| ANDA | ANDA209348 |
| COLORTEXT | WHITE(opaque white colored cap and body) |
| Color | C48325 __ |
| Imprint code | RDY;25;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 43598-515 |
NDC Item 47781048801
| NDC 9 | 47781-488 |
|---|---|
| NDC 10 | 47781-488-01 |
| NDC Item | 47781048801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-488-01) |
| ANDA | ANDA210480 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | LP;642 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-488 |
NDC Item 47781048877
| NDC 9 | 47781-488 |
|---|---|
| NDC 10 | 47781-488-77 |
| NDC Item | 47781048877 |
| Packaging | 21 CAPSULE in 1 BOTTLE (47781-488-77) |
| ANDA | ANDA210480 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | LP;642 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-488 |
NDC Item 59651034701
| NDC 9 | 59651-347 |
|---|---|
| NDC 10 | 59651-347-01 |
| NDC Item | 59651034701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (59651-347-01) |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| Imprint code | L;25 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-347 |
NDC Item 59651034707
| NDC 9 | 59651-347 |
|---|---|
| NDC 10 | 59651-347-07 |
| NDC Item | 59651034707 |
| Packaging | 1 BLISTER PACK in 1 CARTON (59651-347-07) / 7 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| Imprint code | L;25 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-347 |
NDC Item 59651034721
| NDC 9 | 59651-347 |
|---|---|
| NDC 10 | 59651-347-21 |
| NDC Item | 59651034721 |
| Packaging | 21 CAPSULE in 1 BOTTLE (59651-347-21) |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| Imprint code | L;25 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-347 |
NDC Item 60219171901
| NDC 9 | 60219-1719 |
|---|---|
| NDC 10 | 60219-1719-1 |
| NDC Item | 60219171901 |
| Packaging | 21 CAPSULE in 1 BOTTLE (60219-1719-1) |
| ANDA | ANDA216213 |
| COLORTEXT | white(white opaque cap),white(white opaque body) |
| Color | C48325;C48325 __ |
| Imprint code | AA22A |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60219-1719 |
NDC Item 60219171902
| NDC 9 | 60219-1719 |
|---|---|
| NDC 10 | 60219-1719-2 |
| NDC Item | 60219171902 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60219-1719-2) |
| ANDA | ANDA216213 |
| COLORTEXT | white(white opaque cap),white(white opaque body) |
| Color | C48325;C48325 __ |
| Imprint code | AA22A |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60219-1719 |
NDC Item 60505453701
| NDC 9 | 60505-4537 |
|---|---|
| NDC 10 | 60505-4537-1 |
| NDC Item | 60505453701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60505-4537-1) |
| ANDA | ANDA211022 |
| COLORTEXT | WHITE(White opaque),WHITE(White opaque) |
| Color | C48325;C48325 __ |
| Imprint code | APO;L25 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60505-4537 |
NDC Item 60505453702
| NDC 9 | 60505-4537 |
|---|---|
| NDC 10 | 60505-4537-2 |
| NDC Item | 60505453702 |
| Packaging | 21 CAPSULE in 1 BOTTLE (60505-4537-2) |
| ANDA | ANDA211022 |
| COLORTEXT | WHITE(White opaque),WHITE(White opaque) |
| Color | C48325;C48325 __ |
| Imprint code | APO;L25 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60505-4537 |
NDC Item 63304004601
| NDC 9 | 63304-046 |
|---|---|
| NDC 10 | 63304-046-01 |
| NDC Item | 63304004601 |
| Packaging | 100 CAPSULE in 1 BOTTLE (63304-046-01) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| Imprint code | RL;;83 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-046 |
NDC Item 63304004622
| NDC 9 | 63304-046 |
|---|---|
| NDC 10 | 63304-046-22 |
| NDC Item | 63304004622 |
| Packaging | 21 CAPSULE in 1 BOTTLE (63304-046-22) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| Imprint code | RL;;83 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-046 |
NDC Item 69097038581
| NDC 9 | 69097-385 |
|---|---|
| NDC 10 | 69097-385-81 |
| NDC Item | 69097038581 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (69097-385-81) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Cipla25mg;385 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 69097-385 |
NDC Item 70377005411
| NDC 9 | 70377-054 |
|---|---|
| NDC 10 | 70377-054-11 |
| NDC Item | 70377005411 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70377-054-11) |
| ANDA | ANDA215759 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Biocon;logo;25;mg |
| Labeler | BIOCON PHARMA INC., |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70377-054 |
NDC Item 70377005412
| NDC 9 | 70377-054 |
|---|---|
| NDC 10 | 70377-054-12 |
| NDC Item | 70377005412 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70377-054-12) |
| ANDA | ANDA215759 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Biocon;logo;25;mg |
| Labeler | BIOCON PHARMA INC., |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70377-054 |
NDC Item 70710103501
| NDC 9 | 70710-1035 |
|---|---|
| NDC 10 | 70710-1035-1 |
| NDC Item | 70710103501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70710-1035-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70710-1035 |
NDC Item 70710103508
| NDC 9 | 70710-1035 |
|---|---|
| NDC 10 | 70710-1035-8 |
| NDC Item | 70710103508 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70710-1035-8) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70710-1035 |
NDC Item 70771168101
| NDC 9 | 70771-1681 |
|---|---|
| NDC 10 | 70771-1681-1 |
| NDC Item | 70771168101 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70771-1681-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(White opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70771-1681 |
NDC Item 70771168108
| NDC 9 | 70771-1681 |
|---|---|
| NDC 10 | 70771-1681-8 |
| NDC Item | 70771168108 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70771-1681-8) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(White opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70771-1681 |
NDC Item 76282070147
| NDC 9 | 76282-701 |
|---|---|
| NDC 10 | 76282-701-47 |
| NDC Item | 76282070147 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (76282-701-47) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Cipla25mg;385 |
| Labeler | EXELAN PHARMACEUTICALS INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 76282-701 |
NDC Item 00378194001
| NDC 9 | 0378-1940 |
|---|---|
| NDC 10 | 0378-1940-01 |
| NDC Item | 00378194001 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1940-01) |
| ANDA | ANDA213912 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| Imprint code | MYLAN;LL;25 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1940 |
NDC Item 00378194021
| NDC 9 | 0378-1940 |
|---|---|
| NDC 10 | 0378-1940-21 |
| NDC Item | 00378194021 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (0378-1940-21) |
| ANDA | ANDA213912 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| Imprint code | MYLAN;LL;25 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1940 |
NDC Item 00480124621
| NDC 9 | 0480-1246 |
|---|---|
| NDC 10 | 0480-1246-21 |
| NDC Item | 00480124621 |
| Packaging | 21 CAPSULE in 1 BOTTLE (0480-1246-21) |
| ANDA | ANDA201452 |
| COLORTEXT | white |
| Color | C48325 __ |
| Imprint code | NAT;25mg |
| Labeler | Teva Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0480-1246 |
NDC Item 31722026201
| NDC 9 | 31722-262 |
|---|---|
| NDC 10 | 31722-262-01 |
| NDC Item | 31722026201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (31722-262-01) |
| ANDA | ANDA212414 |
| COLORTEXT | white |
| Color | C48325 __ |
| Imprint code | H;L7 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-262 |
NDC Item 31722026221
| NDC 9 | 31722-262 |
|---|---|
| NDC 10 | 31722-262-21 |
| NDC Item | 31722026221 |
| Packaging | 21 CAPSULE in 1 BOTTLE (31722-262-21) |
| ANDA | ANDA212414 |
| COLORTEXT | white |
| Color | C48325 __ |
| Imprint code | H;L7 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-262 |
NDC Item 43598051501
| NDC 9 | 43598-515 |
|---|---|
| NDC 10 | 43598-515-01 |
| NDC Item | 43598051501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (43598-515-01) |
| ANDA | ANDA209348 |
| COLORTEXT | WHITE(opaque white colored cap and body) |
| Color | C48325 __ |
| Imprint code | RDY;25;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 43598-515 |
NDC Item 43598051521
| NDC 9 | 43598-515 |
|---|---|
| NDC 10 | 43598-515-21 |
| NDC Item | 43598051521 |
| Packaging | 21 CAPSULE in 1 BOTTLE (43598-515-21) |
| ANDA | ANDA209348 |
| COLORTEXT | WHITE(opaque white colored cap and body) |
| Color | C48325 __ |
| Imprint code | RDY;25;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 43598-515 |
NDC Item 47781048801
| NDC 9 | 47781-488 |
|---|---|
| NDC 10 | 47781-488-01 |
| NDC Item | 47781048801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-488-01) |
| ANDA | ANDA210480 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | LP;642 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-488 |
NDC Item 47781048877
| NDC 9 | 47781-488 |
|---|---|
| NDC 10 | 47781-488-77 |
| NDC Item | 47781048877 |
| Packaging | 21 CAPSULE in 1 BOTTLE (47781-488-77) |
| ANDA | ANDA210480 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | LP;642 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-488 |
NDC Item 59651034701
| NDC 9 | 59651-347 |
|---|---|
| NDC 10 | 59651-347-01 |
| NDC Item | 59651034701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (59651-347-01) |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| Imprint code | L;25 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-347 |
NDC Item 59651034707
| NDC 9 | 59651-347 |
|---|---|
| NDC 10 | 59651-347-07 |
| NDC Item | 59651034707 |
| Packaging | 1 BLISTER PACK in 1 CARTON (59651-347-07) / 7 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| Imprint code | L;25 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-347 |
NDC Item 59651034721
| NDC 9 | 59651-347 |
|---|---|
| NDC 10 | 59651-347-21 |
| NDC Item | 59651034721 |
| Packaging | 21 CAPSULE in 1 BOTTLE (59651-347-21) |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| Imprint code | L;25 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-347 |
NDC Item 60219171901
| NDC 9 | 60219-1719 |
|---|---|
| NDC 10 | 60219-1719-1 |
| NDC Item | 60219171901 |
| Packaging | 21 CAPSULE in 1 BOTTLE (60219-1719-1) |
| ANDA | ANDA216213 |
| COLORTEXT | white(white opaque cap),white(white opaque body) |
| Color | C48325;C48325 __ |
| Imprint code | AA22A |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60219-1719 |
NDC Item 60219171902
| NDC 9 | 60219-1719 |
|---|---|
| NDC 10 | 60219-1719-2 |
| NDC Item | 60219171902 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60219-1719-2) |
| ANDA | ANDA216213 |
| COLORTEXT | white(white opaque cap),white(white opaque body) |
| Color | C48325;C48325 __ |
| Imprint code | AA22A |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60219-1719 |
NDC Item 60505453701
| NDC 9 | 60505-4537 |
|---|---|
| NDC 10 | 60505-4537-1 |
| NDC Item | 60505453701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60505-4537-1) |
| ANDA | ANDA211022 |
| COLORTEXT | WHITE(White opaque),WHITE(White opaque) |
| Color | C48325;C48325 __ |
| Imprint code | APO;L25 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60505-4537 |
NDC Item 60505453702
| NDC 9 | 60505-4537 |
|---|---|
| NDC 10 | 60505-4537-2 |
| NDC Item | 60505453702 |
| Packaging | 21 CAPSULE in 1 BOTTLE (60505-4537-2) |
| ANDA | ANDA211022 |
| COLORTEXT | WHITE(White opaque),WHITE(White opaque) |
| Color | C48325;C48325 __ |
| Imprint code | APO;L25 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60505-4537 |
NDC Item 63304004601
| NDC 9 | 63304-046 |
|---|---|
| NDC 10 | 63304-046-01 |
| NDC Item | 63304004601 |
| Packaging | 100 CAPSULE in 1 BOTTLE (63304-046-01) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| Imprint code | RL;;83 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-046 |
NDC Item 63304004622
| NDC 9 | 63304-046 |
|---|---|
| NDC 10 | 63304-046-22 |
| NDC Item | 63304004622 |
| Packaging | 21 CAPSULE in 1 BOTTLE (63304-046-22) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| Imprint code | RL;;83 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-046 |
NDC Item 69097038581
| NDC 9 | 69097-385 |
|---|---|
| NDC 10 | 69097-385-81 |
| NDC Item | 69097038581 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (69097-385-81) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Cipla25mg;385 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 69097-385 |
NDC Item 70377005411
| NDC 9 | 70377-054 |
|---|---|
| NDC 10 | 70377-054-11 |
| NDC Item | 70377005411 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70377-054-11) |
| ANDA | ANDA215759 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Biocon;logo;25;mg |
| Labeler | BIOCON PHARMA INC., |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70377-054 |
NDC Item 70377005412
| NDC 9 | 70377-054 |
|---|---|
| NDC 10 | 70377-054-12 |
| NDC Item | 70377005412 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70377-054-12) |
| ANDA | ANDA215759 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Biocon;logo;25;mg |
| Labeler | BIOCON PHARMA INC., |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70377-054 |
NDC Item 70710103501
| NDC 9 | 70710-1035 |
|---|---|
| NDC 10 | 70710-1035-1 |
| NDC Item | 70710103501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70710-1035-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70710-1035 |
NDC Item 70710103508
| NDC 9 | 70710-1035 |
|---|---|
| NDC 10 | 70710-1035-8 |
| NDC Item | 70710103508 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70710-1035-8) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70710-1035 |
NDC Item 70771168101
| NDC 9 | 70771-1681 |
|---|---|
| NDC 10 | 70771-1681-1 |
| NDC Item | 70771168101 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70771-1681-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(White opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70771-1681 |
NDC Item 70771168108
| NDC 9 | 70771-1681 |
|---|---|
| NDC 10 | 70771-1681-8 |
| NDC Item | 70771168108 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70771-1681-8) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(White opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70771-1681 |
NDC Item 76282070147
| NDC 9 | 76282-701 |
|---|---|
| NDC 10 | 76282-701-47 |
| NDC Item | 76282070147 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (76282-701-47) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Cipla25mg;385 |
| Labeler | EXELAN PHARMACEUTICALS INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 76282-701 |
NDC Item 00378194001
| NDC 9 | 0378-1940 |
|---|---|
| NDC 10 | 0378-1940-01 |
| NDC Item | 00378194001 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1940-01) |
| ANDA | ANDA213912 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| Imprint code | MYLAN;LL;25 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1940 |
NDC Item 00378194021
| NDC 9 | 0378-1940 |
|---|---|
| NDC 10 | 0378-1940-21 |
| NDC Item | 00378194021 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (0378-1940-21) |
| ANDA | ANDA213912 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| Imprint code | MYLAN;LL;25 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1940 |
NDC Item 00480124621
| NDC 9 | 0480-1246 |
|---|---|
| NDC 10 | 0480-1246-21 |
| NDC Item | 00480124621 |
| Packaging | 21 CAPSULE in 1 BOTTLE (0480-1246-21) |
| ANDA | ANDA201452 |
| COLORTEXT | white |
| Color | C48325 __ |
| Imprint code | NAT;25mg |
| Labeler | Teva Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0480-1246 |
NDC Item 31722026201
| NDC 9 | 31722-262 |
|---|---|
| NDC 10 | 31722-262-01 |
| NDC Item | 31722026201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (31722-262-01) |
| ANDA | ANDA212414 |
| COLORTEXT | white |
| Color | C48325 __ |
| Imprint code | H;L7 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-262 |
NDC Item 31722026221
| NDC 9 | 31722-262 |
|---|---|
| NDC 10 | 31722-262-21 |
| NDC Item | 31722026221 |
| Packaging | 21 CAPSULE in 1 BOTTLE (31722-262-21) |
| ANDA | ANDA212414 |
| COLORTEXT | white |
| Color | C48325 __ |
| Imprint code | H;L7 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-262 |
NDC Item 43598051501
| NDC 9 | 43598-515 |
|---|---|
| NDC 10 | 43598-515-01 |
| NDC Item | 43598051501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (43598-515-01) |
| ANDA | ANDA209348 |
| COLORTEXT | WHITE(opaque white colored cap and body) |
| Color | C48325 __ |
| Imprint code | RDY;25;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 43598-515 |
NDC Item 43598051521
| NDC 9 | 43598-515 |
|---|---|
| NDC 10 | 43598-515-21 |
| NDC Item | 43598051521 |
| Packaging | 21 CAPSULE in 1 BOTTLE (43598-515-21) |
| ANDA | ANDA209348 |
| COLORTEXT | WHITE(opaque white colored cap and body) |
| Color | C48325 __ |
| Imprint code | RDY;25;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 43598-515 |
NDC Item 47781048801
| NDC 9 | 47781-488 |
|---|---|
| NDC 10 | 47781-488-01 |
| NDC Item | 47781048801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-488-01) |
| ANDA | ANDA210480 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | LP;642 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-488 |
NDC Item 47781048877
| NDC 9 | 47781-488 |
|---|---|
| NDC 10 | 47781-488-77 |
| NDC Item | 47781048877 |
| Packaging | 21 CAPSULE in 1 BOTTLE (47781-488-77) |
| ANDA | ANDA210480 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | LP;642 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-488 |
NDC Item 59651034701
| NDC 9 | 59651-347 |
|---|---|
| NDC 10 | 59651-347-01 |
| NDC Item | 59651034701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (59651-347-01) |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| Imprint code | L;25 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-347 |
NDC Item 59651034707
| NDC 9 | 59651-347 |
|---|---|
| NDC 10 | 59651-347-07 |
| NDC Item | 59651034707 |
| Packaging | 1 BLISTER PACK in 1 CARTON (59651-347-07) / 7 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| Imprint code | L;25 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-347 |
NDC Item 59651034721
| NDC 9 | 59651-347 |
|---|---|
| NDC 10 | 59651-347-21 |
| NDC Item | 59651034721 |
| Packaging | 21 CAPSULE in 1 BOTTLE (59651-347-21) |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| Imprint code | L;25 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-347 |
NDC Item 60219171901
| NDC 9 | 60219-1719 |
|---|---|
| NDC 10 | 60219-1719-1 |
| NDC Item | 60219171901 |
| Packaging | 21 CAPSULE in 1 BOTTLE (60219-1719-1) |
| ANDA | ANDA216213 |
| COLORTEXT | white(white opaque cap),white(white opaque body) |
| Color | C48325;C48325 __ |
| Imprint code | AA22A |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60219-1719 |
NDC Item 60219171902
| NDC 9 | 60219-1719 |
|---|---|
| NDC 10 | 60219-1719-2 |
| NDC Item | 60219171902 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60219-1719-2) |
| ANDA | ANDA216213 |
| COLORTEXT | white(white opaque cap),white(white opaque body) |
| Color | C48325;C48325 __ |
| Imprint code | AA22A |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60219-1719 |
NDC Item 60505453701
| NDC 9 | 60505-4537 |
|---|---|
| NDC 10 | 60505-4537-1 |
| NDC Item | 60505453701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60505-4537-1) |
| ANDA | ANDA211022 |
| COLORTEXT | WHITE(White opaque),WHITE(White opaque) |
| Color | C48325;C48325 __ |
| Imprint code | APO;L25 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60505-4537 |
NDC Item 60505453702
| NDC 9 | 60505-4537 |
|---|---|
| NDC 10 | 60505-4537-2 |
| NDC Item | 60505453702 |
| Packaging | 21 CAPSULE in 1 BOTTLE (60505-4537-2) |
| ANDA | ANDA211022 |
| COLORTEXT | WHITE(White opaque),WHITE(White opaque) |
| Color | C48325;C48325 __ |
| Imprint code | APO;L25 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60505-4537 |
NDC Item 63304004601
| NDC 9 | 63304-046 |
|---|---|
| NDC 10 | 63304-046-01 |
| NDC Item | 63304004601 |
| Packaging | 100 CAPSULE in 1 BOTTLE (63304-046-01) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| Imprint code | RL;;83 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-046 |
NDC Item 63304004622
| NDC 9 | 63304-046 |
|---|---|
| NDC 10 | 63304-046-22 |
| NDC Item | 63304004622 |
| Packaging | 21 CAPSULE in 1 BOTTLE (63304-046-22) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| Imprint code | RL;;83 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-046 |
NDC Item 69097038581
| NDC 9 | 69097-385 |
|---|---|
| NDC 10 | 69097-385-81 |
| NDC Item | 69097038581 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (69097-385-81) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Cipla25mg;385 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 69097-385 |
NDC Item 70377005411
| NDC 9 | 70377-054 |
|---|---|
| NDC 10 | 70377-054-11 |
| NDC Item | 70377005411 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70377-054-11) |
| ANDA | ANDA215759 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Biocon;logo;25;mg |
| Labeler | BIOCON PHARMA INC., |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70377-054 |
NDC Item 70377005412
| NDC 9 | 70377-054 |
|---|---|
| NDC 10 | 70377-054-12 |
| NDC Item | 70377005412 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70377-054-12) |
| ANDA | ANDA215759 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Biocon;logo;25;mg |
| Labeler | BIOCON PHARMA INC., |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70377-054 |
NDC Item 70710103501
| NDC 9 | 70710-1035 |
|---|---|
| NDC 10 | 70710-1035-1 |
| NDC Item | 70710103501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70710-1035-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70710-1035 |
NDC Item 70710103508
| NDC 9 | 70710-1035 |
|---|---|
| NDC 10 | 70710-1035-8 |
| NDC Item | 70710103508 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70710-1035-8) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70710-1035 |
NDC Item 70771168101
| NDC 9 | 70771-1681 |
|---|---|
| NDC 10 | 70771-1681-1 |
| NDC Item | 70771168101 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70771-1681-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(White opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70771-1681 |
NDC Item 70771168108
| NDC 9 | 70771-1681 |
|---|---|
| NDC 10 | 70771-1681-8 |
| NDC Item | 70771168108 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70771-1681-8) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(White opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70771-1681 |
NDC Item 76282070147
| NDC 9 | 76282-701 |
|---|---|
| NDC 10 | 76282-701-47 |
| NDC Item | 76282070147 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (76282-701-47) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Cipla25mg;385 |
| Labeler | EXELAN PHARMACEUTICALS INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 76282-701 |
NDC Item 00378194001
| NDC 9 | 0378-1940 |
|---|---|
| NDC 10 | 0378-1940-01 |
| NDC Item | 00378194001 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1940-01) |
| ANDA | ANDA213912 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| Imprint code | MYLAN;LL;25 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1940 |
NDC Item 00378194021
| NDC 9 | 0378-1940 |
|---|---|
| NDC 10 | 0378-1940-21 |
| NDC Item | 00378194021 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (0378-1940-21) |
| ANDA | ANDA213912 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| Imprint code | MYLAN;LL;25 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1940 |
NDC Item 00480124621
| NDC 9 | 0480-1246 |
|---|---|
| NDC 10 | 0480-1246-21 |
| NDC Item | 00480124621 |
| Packaging | 21 CAPSULE in 1 BOTTLE (0480-1246-21) |
| ANDA | ANDA201452 |
| COLORTEXT | white |
| Color | C48325 __ |
| Imprint code | NAT;25mg |
| Labeler | Teva Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0480-1246 |
NDC Item 31722026201
| NDC 9 | 31722-262 |
|---|---|
| NDC 10 | 31722-262-01 |
| NDC Item | 31722026201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (31722-262-01) |
| ANDA | ANDA212414 |
| COLORTEXT | white |
| Color | C48325 __ |
| Imprint code | H;L7 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-262 |
NDC Item 31722026221
| NDC 9 | 31722-262 |
|---|---|
| NDC 10 | 31722-262-21 |
| NDC Item | 31722026221 |
| Packaging | 21 CAPSULE in 1 BOTTLE (31722-262-21) |
| ANDA | ANDA212414 |
| COLORTEXT | white |
| Color | C48325 __ |
| Imprint code | H;L7 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-262 |
NDC Item 43598051501
| NDC 9 | 43598-515 |
|---|---|
| NDC 10 | 43598-515-01 |
| NDC Item | 43598051501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (43598-515-01) |
| ANDA | ANDA209348 |
| COLORTEXT | WHITE(opaque white colored cap and body) |
| Color | C48325 __ |
| Imprint code | RDY;25;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 43598-515 |
NDC Item 43598051521
| NDC 9 | 43598-515 |
|---|---|
| NDC 10 | 43598-515-21 |
| NDC Item | 43598051521 |
| Packaging | 21 CAPSULE in 1 BOTTLE (43598-515-21) |
| ANDA | ANDA209348 |
| COLORTEXT | WHITE(opaque white colored cap and body) |
| Color | C48325 __ |
| Imprint code | RDY;25;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 43598-515 |
NDC Item 47781048801
| NDC 9 | 47781-488 |
|---|---|
| NDC 10 | 47781-488-01 |
| NDC Item | 47781048801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-488-01) |
| ANDA | ANDA210480 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | LP;642 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-488 |
NDC Item 47781048877
| NDC 9 | 47781-488 |
|---|---|
| NDC 10 | 47781-488-77 |
| NDC Item | 47781048877 |
| Packaging | 21 CAPSULE in 1 BOTTLE (47781-488-77) |
| ANDA | ANDA210480 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | LP;642 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-488 |
NDC Item 59651034701
| NDC 9 | 59651-347 |
|---|---|
| NDC 10 | 59651-347-01 |
| NDC Item | 59651034701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (59651-347-01) |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| Imprint code | L;25 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-347 |
NDC Item 59651034707
| NDC 9 | 59651-347 |
|---|---|
| NDC 10 | 59651-347-07 |
| NDC Item | 59651034707 |
| Packaging | 1 BLISTER PACK in 1 CARTON (59651-347-07) / 7 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| Imprint code | L;25 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-347 |
NDC Item 59651034721
| NDC 9 | 59651-347 |
|---|---|
| NDC 10 | 59651-347-21 |
| NDC Item | 59651034721 |
| Packaging | 21 CAPSULE in 1 BOTTLE (59651-347-21) |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| Imprint code | L;25 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-347 |
NDC Item 60219171901
| NDC 9 | 60219-1719 |
|---|---|
| NDC 10 | 60219-1719-1 |
| NDC Item | 60219171901 |
| Packaging | 21 CAPSULE in 1 BOTTLE (60219-1719-1) |
| ANDA | ANDA216213 |
| COLORTEXT | white(white opaque cap),white(white opaque body) |
| Color | C48325;C48325 __ |
| Imprint code | AA22A |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60219-1719 |
NDC Item 60219171902
| NDC 9 | 60219-1719 |
|---|---|
| NDC 10 | 60219-1719-2 |
| NDC Item | 60219171902 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60219-1719-2) |
| ANDA | ANDA216213 |
| COLORTEXT | white(white opaque cap),white(white opaque body) |
| Color | C48325;C48325 __ |
| Imprint code | AA22A |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60219-1719 |
NDC Item 60505453701
| NDC 9 | 60505-4537 |
|---|---|
| NDC 10 | 60505-4537-1 |
| NDC Item | 60505453701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60505-4537-1) |
| ANDA | ANDA211022 |
| COLORTEXT | WHITE(White opaque),WHITE(White opaque) |
| Color | C48325;C48325 __ |
| Imprint code | APO;L25 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60505-4537 |
NDC Item 60505453702
| NDC 9 | 60505-4537 |
|---|---|
| NDC 10 | 60505-4537-2 |
| NDC Item | 60505453702 |
| Packaging | 21 CAPSULE in 1 BOTTLE (60505-4537-2) |
| ANDA | ANDA211022 |
| COLORTEXT | WHITE(White opaque),WHITE(White opaque) |
| Color | C48325;C48325 __ |
| Imprint code | APO;L25 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60505-4537 |
NDC Item 63304004601
| NDC 9 | 63304-046 |
|---|---|
| NDC 10 | 63304-046-01 |
| NDC Item | 63304004601 |
| Packaging | 100 CAPSULE in 1 BOTTLE (63304-046-01) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| Imprint code | RL;;83 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-046 |
NDC Item 63304004622
| NDC 9 | 63304-046 |
|---|---|
| NDC 10 | 63304-046-22 |
| NDC Item | 63304004622 |
| Packaging | 21 CAPSULE in 1 BOTTLE (63304-046-22) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| Imprint code | RL;;83 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-046 |
NDC Item 69097038581
| NDC 9 | 69097-385 |
|---|---|
| NDC 10 | 69097-385-81 |
| NDC Item | 69097038581 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (69097-385-81) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Cipla25mg;385 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 69097-385 |
NDC Item 70377005411
| NDC 9 | 70377-054 |
|---|---|
| NDC 10 | 70377-054-11 |
| NDC Item | 70377005411 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70377-054-11) |
| ANDA | ANDA215759 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Biocon;logo;25;mg |
| Labeler | BIOCON PHARMA INC., |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70377-054 |
NDC Item 70377005412
| NDC 9 | 70377-054 |
|---|---|
| NDC 10 | 70377-054-12 |
| NDC Item | 70377005412 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70377-054-12) |
| ANDA | ANDA215759 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Biocon;logo;25;mg |
| Labeler | BIOCON PHARMA INC., |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70377-054 |
NDC Item 70710103501
| NDC 9 | 70710-1035 |
|---|---|
| NDC 10 | 70710-1035-1 |
| NDC Item | 70710103501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70710-1035-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70710-1035 |
NDC Item 70710103508
| NDC 9 | 70710-1035 |
|---|---|
| NDC 10 | 70710-1035-8 |
| NDC Item | 70710103508 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70710-1035-8) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70710-1035 |
NDC Item 70771168101
| NDC 9 | 70771-1681 |
|---|---|
| NDC 10 | 70771-1681-1 |
| NDC Item | 70771168101 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70771-1681-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(White opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70771-1681 |
NDC Item 70771168108
| NDC 9 | 70771-1681 |
|---|---|
| NDC 10 | 70771-1681-8 |
| NDC Item | 70771168108 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70771-1681-8) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(White opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70771-1681 |
NDC Item 76282070147
| NDC 9 | 76282-701 |
|---|---|
| NDC 10 | 76282-701-47 |
| NDC Item | 76282070147 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (76282-701-47) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Cipla25mg;385 |
| Labeler | EXELAN PHARMACEUTICALS INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 76282-701 |
NDC Item 00378194001
| NDC 9 | 0378-1940 |
|---|---|
| NDC 10 | 0378-1940-01 |
| NDC Item | 00378194001 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1940-01) |
| ANDA | ANDA213912 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| Imprint code | MYLAN;LL;25 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1940 |
NDC Item 00378194021
| NDC 9 | 0378-1940 |
|---|---|
| NDC 10 | 0378-1940-21 |
| NDC Item | 00378194021 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (0378-1940-21) |
| ANDA | ANDA213912 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| Imprint code | MYLAN;LL;25 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1940 |
NDC Item 00480124621
| NDC 9 | 0480-1246 |
|---|---|
| NDC 10 | 0480-1246-21 |
| NDC Item | 00480124621 |
| Packaging | 21 CAPSULE in 1 BOTTLE (0480-1246-21) |
| ANDA | ANDA201452 |
| COLORTEXT | white |
| Color | C48325 __ |
| Imprint code | NAT;25mg |
| Labeler | Teva Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0480-1246 |
NDC Item 31722026201
| NDC 9 | 31722-262 |
|---|---|
| NDC 10 | 31722-262-01 |
| NDC Item | 31722026201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (31722-262-01) |
| ANDA | ANDA212414 |
| COLORTEXT | white |
| Color | C48325 __ |
| Imprint code | H;L7 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-262 |
NDC Item 31722026221
| NDC 9 | 31722-262 |
|---|---|
| NDC 10 | 31722-262-21 |
| NDC Item | 31722026221 |
| Packaging | 21 CAPSULE in 1 BOTTLE (31722-262-21) |
| ANDA | ANDA212414 |
| COLORTEXT | white |
| Color | C48325 __ |
| Imprint code | H;L7 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-262 |
NDC Item 43598051501
| NDC 9 | 43598-515 |
|---|---|
| NDC 10 | 43598-515-01 |
| NDC Item | 43598051501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (43598-515-01) |
| ANDA | ANDA209348 |
| COLORTEXT | WHITE(opaque white colored cap and body) |
| Color | C48325 __ |
| Imprint code | RDY;25;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 43598-515 |
NDC Item 43598051521
| NDC 9 | 43598-515 |
|---|---|
| NDC 10 | 43598-515-21 |
| NDC Item | 43598051521 |
| Packaging | 21 CAPSULE in 1 BOTTLE (43598-515-21) |
| ANDA | ANDA209348 |
| COLORTEXT | WHITE(opaque white colored cap and body) |
| Color | C48325 __ |
| Imprint code | RDY;25;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 43598-515 |
NDC Item 47781048801
| NDC 9 | 47781-488 |
|---|---|
| NDC 10 | 47781-488-01 |
| NDC Item | 47781048801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-488-01) |
| ANDA | ANDA210480 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | LP;642 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-488 |
NDC Item 47781048877
| NDC 9 | 47781-488 |
|---|---|
| NDC 10 | 47781-488-77 |
| NDC Item | 47781048877 |
| Packaging | 21 CAPSULE in 1 BOTTLE (47781-488-77) |
| ANDA | ANDA210480 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | LP;642 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-488 |
NDC Item 59651034701
| NDC 9 | 59651-347 |
|---|---|
| NDC 10 | 59651-347-01 |
| NDC Item | 59651034701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (59651-347-01) |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| Imprint code | L;25 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-347 |
NDC Item 59651034707
| NDC 9 | 59651-347 |
|---|---|
| NDC 10 | 59651-347-07 |
| NDC Item | 59651034707 |
| Packaging | 1 BLISTER PACK in 1 CARTON (59651-347-07) / 7 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| Imprint code | L;25 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-347 |
NDC Item 59651034721
| NDC 9 | 59651-347 |
|---|---|
| NDC 10 | 59651-347-21 |
| NDC Item | 59651034721 |
| Packaging | 21 CAPSULE in 1 BOTTLE (59651-347-21) |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| Imprint code | L;25 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-347 |
NDC Item 60219171901
| NDC 9 | 60219-1719 |
|---|---|
| NDC 10 | 60219-1719-1 |
| NDC Item | 60219171901 |
| Packaging | 21 CAPSULE in 1 BOTTLE (60219-1719-1) |
| ANDA | ANDA216213 |
| COLORTEXT | white(white opaque cap),white(white opaque body) |
| Color | C48325;C48325 __ |
| Imprint code | AA22A |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60219-1719 |
NDC Item 60219171902
| NDC 9 | 60219-1719 |
|---|---|
| NDC 10 | 60219-1719-2 |
| NDC Item | 60219171902 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60219-1719-2) |
| ANDA | ANDA216213 |
| COLORTEXT | white(white opaque cap),white(white opaque body) |
| Color | C48325;C48325 __ |
| Imprint code | AA22A |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60219-1719 |
NDC Item 60505453701
| NDC 9 | 60505-4537 |
|---|---|
| NDC 10 | 60505-4537-1 |
| NDC Item | 60505453701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60505-4537-1) |
| ANDA | ANDA211022 |
| COLORTEXT | WHITE(White opaque),WHITE(White opaque) |
| Color | C48325;C48325 __ |
| Imprint code | APO;L25 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60505-4537 |
NDC Item 60505453702
| NDC 9 | 60505-4537 |
|---|---|
| NDC 10 | 60505-4537-2 |
| NDC Item | 60505453702 |
| Packaging | 21 CAPSULE in 1 BOTTLE (60505-4537-2) |
| ANDA | ANDA211022 |
| COLORTEXT | WHITE(White opaque),WHITE(White opaque) |
| Color | C48325;C48325 __ |
| Imprint code | APO;L25 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60505-4537 |
NDC Item 63304004601
| NDC 9 | 63304-046 |
|---|---|
| NDC 10 | 63304-046-01 |
| NDC Item | 63304004601 |
| Packaging | 100 CAPSULE in 1 BOTTLE (63304-046-01) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| Imprint code | RL;;83 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-046 |
NDC Item 63304004622
| NDC 9 | 63304-046 |
|---|---|
| NDC 10 | 63304-046-22 |
| NDC Item | 63304004622 |
| Packaging | 21 CAPSULE in 1 BOTTLE (63304-046-22) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| Imprint code | RL;;83 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-046 |
NDC Item 69097038581
| NDC 9 | 69097-385 |
|---|---|
| NDC 10 | 69097-385-81 |
| NDC Item | 69097038581 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (69097-385-81) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Cipla25mg;385 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 69097-385 |
NDC Item 70377005411
| NDC 9 | 70377-054 |
|---|---|
| NDC 10 | 70377-054-11 |
| NDC Item | 70377005411 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70377-054-11) |
| ANDA | ANDA215759 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Biocon;logo;25;mg |
| Labeler | BIOCON PHARMA INC., |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70377-054 |
NDC Item 70377005412
| NDC 9 | 70377-054 |
|---|---|
| NDC 10 | 70377-054-12 |
| NDC Item | 70377005412 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70377-054-12) |
| ANDA | ANDA215759 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Biocon;logo;25;mg |
| Labeler | BIOCON PHARMA INC., |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70377-054 |
NDC Item 70710103501
| NDC 9 | 70710-1035 |
|---|---|
| NDC 10 | 70710-1035-1 |
| NDC Item | 70710103501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70710-1035-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70710-1035 |
NDC Item 70710103508
| NDC 9 | 70710-1035 |
|---|---|
| NDC 10 | 70710-1035-8 |
| NDC Item | 70710103508 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70710-1035-8) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70710-1035 |
NDC Item 70771168101
| NDC 9 | 70771-1681 |
|---|---|
| NDC 10 | 70771-1681-1 |
| NDC Item | 70771168101 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70771-1681-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(White opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70771-1681 |
NDC Item 70771168108
| NDC 9 | 70771-1681 |
|---|---|
| NDC 10 | 70771-1681-8 |
| NDC Item | 70771168108 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70771-1681-8) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(White opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70771-1681 |
NDC Item 76282070147
| NDC 9 | 76282-701 |
|---|---|
| NDC 10 | 76282-701-47 |
| NDC Item | 76282070147 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (76282-701-47) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Cipla25mg;385 |
| Labeler | EXELAN PHARMACEUTICALS INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 76282-701 |
NDC Item 00378194001
| NDC 9 | 0378-1940 |
|---|---|
| NDC 10 | 0378-1940-01 |
| NDC Item | 00378194001 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1940-01) |
| ANDA | ANDA213912 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| Imprint code | MYLAN;LL;25 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1940 |
NDC Item 00378194021
| NDC 9 | 0378-1940 |
|---|---|
| NDC 10 | 0378-1940-21 |
| NDC Item | 00378194021 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (0378-1940-21) |
| ANDA | ANDA213912 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| Imprint code | MYLAN;LL;25 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1940 |
NDC Item 00480124621
| NDC 9 | 0480-1246 |
|---|---|
| NDC 10 | 0480-1246-21 |
| NDC Item | 00480124621 |
| Packaging | 21 CAPSULE in 1 BOTTLE (0480-1246-21) |
| ANDA | ANDA201452 |
| COLORTEXT | white |
| Color | C48325 __ |
| Imprint code | NAT;25mg |
| Labeler | Teva Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0480-1246 |
NDC Item 31722026201
| NDC 9 | 31722-262 |
|---|---|
| NDC 10 | 31722-262-01 |
| NDC Item | 31722026201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (31722-262-01) |
| ANDA | ANDA212414 |
| COLORTEXT | white |
| Color | C48325 __ |
| Imprint code | H;L7 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-262 |
NDC Item 31722026221
| NDC 9 | 31722-262 |
|---|---|
| NDC 10 | 31722-262-21 |
| NDC Item | 31722026221 |
| Packaging | 21 CAPSULE in 1 BOTTLE (31722-262-21) |
| ANDA | ANDA212414 |
| COLORTEXT | white |
| Color | C48325 __ |
| Imprint code | H;L7 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-262 |
NDC Item 43598051501
| NDC 9 | 43598-515 |
|---|---|
| NDC 10 | 43598-515-01 |
| NDC Item | 43598051501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (43598-515-01) |
| ANDA | ANDA209348 |
| COLORTEXT | WHITE(opaque white colored cap and body) |
| Color | C48325 __ |
| Imprint code | RDY;25;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 43598-515 |
NDC Item 43598051521
| NDC 9 | 43598-515 |
|---|---|
| NDC 10 | 43598-515-21 |
| NDC Item | 43598051521 |
| Packaging | 21 CAPSULE in 1 BOTTLE (43598-515-21) |
| ANDA | ANDA209348 |
| COLORTEXT | WHITE(opaque white colored cap and body) |
| Color | C48325 __ |
| Imprint code | RDY;25;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 43598-515 |
NDC Item 47781048801
| NDC 9 | 47781-488 |
|---|---|
| NDC 10 | 47781-488-01 |
| NDC Item | 47781048801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-488-01) |
| ANDA | ANDA210480 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | LP;642 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-488 |
NDC Item 47781048877
| NDC 9 | 47781-488 |
|---|---|
| NDC 10 | 47781-488-77 |
| NDC Item | 47781048877 |
| Packaging | 21 CAPSULE in 1 BOTTLE (47781-488-77) |
| ANDA | ANDA210480 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | LP;642 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-488 |
NDC Item 59651034701
| NDC 9 | 59651-347 |
|---|---|
| NDC 10 | 59651-347-01 |
| NDC Item | 59651034701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (59651-347-01) |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| Imprint code | L;25 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-347 |
NDC Item 59651034707
| NDC 9 | 59651-347 |
|---|---|
| NDC 10 | 59651-347-07 |
| NDC Item | 59651034707 |
| Packaging | 1 BLISTER PACK in 1 CARTON (59651-347-07) / 7 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| Imprint code | L;25 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-347 |
NDC Item 59651034721
| NDC 9 | 59651-347 |
|---|---|
| NDC 10 | 59651-347-21 |
| NDC Item | 59651034721 |
| Packaging | 21 CAPSULE in 1 BOTTLE (59651-347-21) |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| Imprint code | L;25 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-347 |
NDC Item 60219171901
| NDC 9 | 60219-1719 |
|---|---|
| NDC 10 | 60219-1719-1 |
| NDC Item | 60219171901 |
| Packaging | 21 CAPSULE in 1 BOTTLE (60219-1719-1) |
| ANDA | ANDA216213 |
| COLORTEXT | white(white opaque cap),white(white opaque body) |
| Color | C48325;C48325 __ |
| Imprint code | AA22A |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60219-1719 |
NDC Item 60219171902
| NDC 9 | 60219-1719 |
|---|---|
| NDC 10 | 60219-1719-2 |
| NDC Item | 60219171902 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60219-1719-2) |
| ANDA | ANDA216213 |
| COLORTEXT | white(white opaque cap),white(white opaque body) |
| Color | C48325;C48325 __ |
| Imprint code | AA22A |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60219-1719 |
NDC Item 60505453701
| NDC 9 | 60505-4537 |
|---|---|
| NDC 10 | 60505-4537-1 |
| NDC Item | 60505453701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60505-4537-1) |
| ANDA | ANDA211022 |
| COLORTEXT | WHITE(White opaque),WHITE(White opaque) |
| Color | C48325;C48325 __ |
| Imprint code | APO;L25 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60505-4537 |
NDC Item 60505453702
| NDC 9 | 60505-4537 |
|---|---|
| NDC 10 | 60505-4537-2 |
| NDC Item | 60505453702 |
| Packaging | 21 CAPSULE in 1 BOTTLE (60505-4537-2) |
| ANDA | ANDA211022 |
| COLORTEXT | WHITE(White opaque),WHITE(White opaque) |
| Color | C48325;C48325 __ |
| Imprint code | APO;L25 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60505-4537 |
NDC Item 63304004601
| NDC 9 | 63304-046 |
|---|---|
| NDC 10 | 63304-046-01 |
| NDC Item | 63304004601 |
| Packaging | 100 CAPSULE in 1 BOTTLE (63304-046-01) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| Imprint code | RL;;83 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-046 |
NDC Item 63304004622
| NDC 9 | 63304-046 |
|---|---|
| NDC 10 | 63304-046-22 |
| NDC Item | 63304004622 |
| Packaging | 21 CAPSULE in 1 BOTTLE (63304-046-22) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| Imprint code | RL;;83 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-046 |
NDC Item 69097038581
| NDC 9 | 69097-385 |
|---|---|
| NDC 10 | 69097-385-81 |
| NDC Item | 69097038581 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (69097-385-81) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Cipla25mg;385 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 69097-385 |
NDC Item 70377005411
| NDC 9 | 70377-054 |
|---|---|
| NDC 10 | 70377-054-11 |
| NDC Item | 70377005411 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70377-054-11) |
| ANDA | ANDA215759 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Biocon;logo;25;mg |
| Labeler | BIOCON PHARMA INC., |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70377-054 |
NDC Item 70377005412
| NDC 9 | 70377-054 |
|---|---|
| NDC 10 | 70377-054-12 |
| NDC Item | 70377005412 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70377-054-12) |
| ANDA | ANDA215759 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Biocon;logo;25;mg |
| Labeler | BIOCON PHARMA INC., |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70377-054 |
NDC Item 70710103501
| NDC 9 | 70710-1035 |
|---|---|
| NDC 10 | 70710-1035-1 |
| NDC Item | 70710103501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70710-1035-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70710-1035 |
NDC Item 70710103508
| NDC 9 | 70710-1035 |
|---|---|
| NDC 10 | 70710-1035-8 |
| NDC Item | 70710103508 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70710-1035-8) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70710-1035 |
NDC Item 70771168101
| NDC 9 | 70771-1681 |
|---|---|
| NDC 10 | 70771-1681-1 |
| NDC Item | 70771168101 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70771-1681-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(White opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70771-1681 |
NDC Item 70771168108
| NDC 9 | 70771-1681 |
|---|---|
| NDC 10 | 70771-1681-8 |
| NDC Item | 70771168108 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70771-1681-8) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(White opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70771-1681 |
NDC Item 76282070147
| NDC 9 | 76282-701 |
|---|---|
| NDC 10 | 76282-701-47 |
| NDC Item | 76282070147 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (76282-701-47) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Cipla25mg;385 |
| Labeler | EXELAN PHARMACEUTICALS INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 76282-701 |
NDC Item 00378194001
| NDC 9 | 0378-1940 |
|---|---|
| NDC 10 | 0378-1940-01 |
| NDC Item | 00378194001 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1940-01) |
| ANDA | ANDA213912 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| Imprint code | MYLAN;LL;25 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1940 |
NDC Item 00378194021
| NDC 9 | 0378-1940 |
|---|---|
| NDC 10 | 0378-1940-21 |
| NDC Item | 00378194021 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (0378-1940-21) |
| ANDA | ANDA213912 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| Imprint code | MYLAN;LL;25 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1940 |
NDC Item 00480124621
| NDC 9 | 0480-1246 |
|---|---|
| NDC 10 | 0480-1246-21 |
| NDC Item | 00480124621 |
| Packaging | 21 CAPSULE in 1 BOTTLE (0480-1246-21) |
| ANDA | ANDA201452 |
| COLORTEXT | white |
| Color | C48325 __ |
| Imprint code | NAT;25mg |
| Labeler | Teva Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0480-1246 |
NDC Item 31722026201
| NDC 9 | 31722-262 |
|---|---|
| NDC 10 | 31722-262-01 |
| NDC Item | 31722026201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (31722-262-01) |
| ANDA | ANDA212414 |
| COLORTEXT | white |
| Color | C48325 __ |
| Imprint code | H;L7 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-262 |
NDC Item 31722026221
| NDC 9 | 31722-262 |
|---|---|
| NDC 10 | 31722-262-21 |
| NDC Item | 31722026221 |
| Packaging | 21 CAPSULE in 1 BOTTLE (31722-262-21) |
| ANDA | ANDA212414 |
| COLORTEXT | white |
| Color | C48325 __ |
| Imprint code | H;L7 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-262 |
NDC Item 43598051501
| NDC 9 | 43598-515 |
|---|---|
| NDC 10 | 43598-515-01 |
| NDC Item | 43598051501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (43598-515-01) |
| ANDA | ANDA209348 |
| COLORTEXT | WHITE(opaque white colored cap and body) |
| Color | C48325 __ |
| Imprint code | RDY;25;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 43598-515 |
NDC Item 43598051521
| NDC 9 | 43598-515 |
|---|---|
| NDC 10 | 43598-515-21 |
| NDC Item | 43598051521 |
| Packaging | 21 CAPSULE in 1 BOTTLE (43598-515-21) |
| ANDA | ANDA209348 |
| COLORTEXT | WHITE(opaque white colored cap and body) |
| Color | C48325 __ |
| Imprint code | RDY;25;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 43598-515 |
NDC Item 47781048801
| NDC 9 | 47781-488 |
|---|---|
| NDC 10 | 47781-488-01 |
| NDC Item | 47781048801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-488-01) |
| ANDA | ANDA210480 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | LP;642 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-488 |
NDC Item 47781048877
| NDC 9 | 47781-488 |
|---|---|
| NDC 10 | 47781-488-77 |
| NDC Item | 47781048877 |
| Packaging | 21 CAPSULE in 1 BOTTLE (47781-488-77) |
| ANDA | ANDA210480 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | LP;642 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-488 |
NDC Item 59651034701
| NDC 9 | 59651-347 |
|---|---|
| NDC 10 | 59651-347-01 |
| NDC Item | 59651034701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (59651-347-01) |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| Imprint code | L;25 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-347 |
NDC Item 59651034707
| NDC 9 | 59651-347 |
|---|---|
| NDC 10 | 59651-347-07 |
| NDC Item | 59651034707 |
| Packaging | 1 BLISTER PACK in 1 CARTON (59651-347-07) / 7 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| Imprint code | L;25 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-347 |
NDC Item 59651034721
| NDC 9 | 59651-347 |
|---|---|
| NDC 10 | 59651-347-21 |
| NDC Item | 59651034721 |
| Packaging | 21 CAPSULE in 1 BOTTLE (59651-347-21) |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| Imprint code | L;25 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-347 |
NDC Item 60219171901
| NDC 9 | 60219-1719 |
|---|---|
| NDC 10 | 60219-1719-1 |
| NDC Item | 60219171901 |
| Packaging | 21 CAPSULE in 1 BOTTLE (60219-1719-1) |
| ANDA | ANDA216213 |
| COLORTEXT | white(white opaque cap),white(white opaque body) |
| Color | C48325;C48325 __ |
| Imprint code | AA22A |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60219-1719 |
NDC Item 60219171902
| NDC 9 | 60219-1719 |
|---|---|
| NDC 10 | 60219-1719-2 |
| NDC Item | 60219171902 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60219-1719-2) |
| ANDA | ANDA216213 |
| COLORTEXT | white(white opaque cap),white(white opaque body) |
| Color | C48325;C48325 __ |
| Imprint code | AA22A |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60219-1719 |
NDC Item 60505453701
| NDC 9 | 60505-4537 |
|---|---|
| NDC 10 | 60505-4537-1 |
| NDC Item | 60505453701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60505-4537-1) |
| ANDA | ANDA211022 |
| COLORTEXT | WHITE(White opaque),WHITE(White opaque) |
| Color | C48325;C48325 __ |
| Imprint code | APO;L25 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60505-4537 |
NDC Item 60505453702
| NDC 9 | 60505-4537 |
|---|---|
| NDC 10 | 60505-4537-2 |
| NDC Item | 60505453702 |
| Packaging | 21 CAPSULE in 1 BOTTLE (60505-4537-2) |
| ANDA | ANDA211022 |
| COLORTEXT | WHITE(White opaque),WHITE(White opaque) |
| Color | C48325;C48325 __ |
| Imprint code | APO;L25 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60505-4537 |
NDC Item 63304004601
| NDC 9 | 63304-046 |
|---|---|
| NDC 10 | 63304-046-01 |
| NDC Item | 63304004601 |
| Packaging | 100 CAPSULE in 1 BOTTLE (63304-046-01) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| Imprint code | RL;;83 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-046 |
NDC Item 63304004622
| NDC 9 | 63304-046 |
|---|---|
| NDC 10 | 63304-046-22 |
| NDC Item | 63304004622 |
| Packaging | 21 CAPSULE in 1 BOTTLE (63304-046-22) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| Imprint code | RL;;83 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-046 |
NDC Item 69097038581
| NDC 9 | 69097-385 |
|---|---|
| NDC 10 | 69097-385-81 |
| NDC Item | 69097038581 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (69097-385-81) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Cipla25mg;385 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 69097-385 |
NDC Item 70377005411
| NDC 9 | 70377-054 |
|---|---|
| NDC 10 | 70377-054-11 |
| NDC Item | 70377005411 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70377-054-11) |
| ANDA | ANDA215759 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Biocon;logo;25;mg |
| Labeler | BIOCON PHARMA INC., |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70377-054 |
NDC Item 70377005412
| NDC 9 | 70377-054 |
|---|---|
| NDC 10 | 70377-054-12 |
| NDC Item | 70377005412 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70377-054-12) |
| ANDA | ANDA215759 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Biocon;logo;25;mg |
| Labeler | BIOCON PHARMA INC., |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70377-054 |
NDC Item 70710103501
| NDC 9 | 70710-1035 |
|---|---|
| NDC 10 | 70710-1035-1 |
| NDC Item | 70710103501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70710-1035-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70710-1035 |
NDC Item 70710103508
| NDC 9 | 70710-1035 |
|---|---|
| NDC 10 | 70710-1035-8 |
| NDC Item | 70710103508 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70710-1035-8) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70710-1035 |
NDC Item 70771168101
| NDC 9 | 70771-1681 |
|---|---|
| NDC 10 | 70771-1681-1 |
| NDC Item | 70771168101 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70771-1681-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(White opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70771-1681 |
NDC Item 70771168108
| NDC 9 | 70771-1681 |
|---|---|
| NDC 10 | 70771-1681-8 |
| NDC Item | 70771168108 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70771-1681-8) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(White opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70771-1681 |
NDC Item 76282070147
| NDC 9 | 76282-701 |
|---|---|
| NDC 10 | 76282-701-47 |
| NDC Item | 76282070147 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (76282-701-47) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Cipla25mg;385 |
| Labeler | EXELAN PHARMACEUTICALS INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 76282-701 |
NDC Item 00378194001
| NDC 9 | 0378-1940 |
|---|---|
| NDC 10 | 0378-1940-01 |
| NDC Item | 00378194001 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0378-1940-01) |
| ANDA | ANDA213912 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| Imprint code | MYLAN;LL;25 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1940 |
NDC Item 00378194021
| NDC 9 | 0378-1940 |
|---|---|
| NDC 10 | 0378-1940-21 |
| NDC Item | 00378194021 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (0378-1940-21) |
| ANDA | ANDA213912 |
| COLORTEXT | WHITE(white opaque) |
| Color | C48325 __ |
| Imprint code | MYLAN;LL;25 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0378-1940 |
NDC Item 00480124621
| NDC 9 | 0480-1246 |
|---|---|
| NDC 10 | 0480-1246-21 |
| NDC Item | 00480124621 |
| Packaging | 21 CAPSULE in 1 BOTTLE (0480-1246-21) |
| ANDA | ANDA201452 |
| COLORTEXT | white |
| Color | C48325 __ |
| Imprint code | NAT;25mg |
| Labeler | Teva Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0480-1246 |
NDC Item 31722026201
| NDC 9 | 31722-262 |
|---|---|
| NDC 10 | 31722-262-01 |
| NDC Item | 31722026201 |
| Packaging | 100 CAPSULE in 1 BOTTLE (31722-262-01) |
| ANDA | ANDA212414 |
| COLORTEXT | white |
| Color | C48325 __ |
| Imprint code | H;L7 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-262 |
NDC Item 31722026221
| NDC 9 | 31722-262 |
|---|---|
| NDC 10 | 31722-262-21 |
| NDC Item | 31722026221 |
| Packaging | 21 CAPSULE in 1 BOTTLE (31722-262-21) |
| ANDA | ANDA212414 |
| COLORTEXT | white |
| Color | C48325 __ |
| Imprint code | H;L7 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-05-11 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 31722-262 |
NDC Item 43598051501
| NDC 9 | 43598-515 |
|---|---|
| NDC 10 | 43598-515-01 |
| NDC Item | 43598051501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (43598-515-01) |
| ANDA | ANDA209348 |
| COLORTEXT | WHITE(opaque white colored cap and body) |
| Color | C48325 __ |
| Imprint code | RDY;25;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 43598-515 |
NDC Item 43598051521
| NDC 9 | 43598-515 |
|---|---|
| NDC 10 | 43598-515-21 |
| NDC Item | 43598051521 |
| Packaging | 21 CAPSULE in 1 BOTTLE (43598-515-21) |
| ANDA | ANDA209348 |
| COLORTEXT | WHITE(opaque white colored cap and body) |
| Color | C48325 __ |
| Imprint code | RDY;25;mg |
| Labeler | Dr. Reddy's Laboratories Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-07 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 43598-515 |
NDC Item 47781048801
| NDC 9 | 47781-488 |
|---|---|
| NDC 10 | 47781-488-01 |
| NDC Item | 47781048801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-488-01) |
| ANDA | ANDA210480 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | LP;642 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-488 |
NDC Item 47781048877
| NDC 9 | 47781-488 |
|---|---|
| NDC 10 | 47781-488-77 |
| NDC Item | 47781048877 |
| Packaging | 21 CAPSULE in 1 BOTTLE (47781-488-77) |
| ANDA | ANDA210480 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | LP;642 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-488 |
NDC Item 59651034701
| NDC 9 | 59651-347 |
|---|---|
| NDC 10 | 59651-347-01 |
| NDC Item | 59651034701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (59651-347-01) |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| Imprint code | L;25 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-347 |
NDC Item 59651034707
| NDC 9 | 59651-347 |
|---|---|
| NDC 10 | 59651-347-07 |
| NDC Item | 59651034707 |
| Packaging | 1 BLISTER PACK in 1 CARTON (59651-347-07) / 7 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| Imprint code | L;25 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-347 |
NDC Item 59651034721
| NDC 9 | 59651-347 |
|---|---|
| NDC 10 | 59651-347-21 |
| NDC Item | 59651034721 |
| Packaging | 21 CAPSULE in 1 BOTTLE (59651-347-21) |
| ANDA | ANDA213885 |
| COLORTEXT | WHITE(White Opaque Cap, White Opaque Body) |
| Color | C48325 __ |
| Imprint code | L;25 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 59651-347 |
NDC Item 60219171901
| NDC 9 | 60219-1719 |
|---|---|
| NDC 10 | 60219-1719-1 |
| NDC Item | 60219171901 |
| Packaging | 21 CAPSULE in 1 BOTTLE (60219-1719-1) |
| ANDA | ANDA216213 |
| COLORTEXT | white(white opaque cap),white(white opaque body) |
| Color | C48325;C48325 __ |
| Imprint code | AA22A |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60219-1719 |
NDC Item 60219171902
| NDC 9 | 60219-1719 |
|---|---|
| NDC 10 | 60219-1719-2 |
| NDC Item | 60219171902 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60219-1719-2) |
| ANDA | ANDA216213 |
| COLORTEXT | white(white opaque cap),white(white opaque body) |
| Color | C48325;C48325 __ |
| Imprint code | AA22A |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-02-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60219-1719 |
NDC Item 60505453701
| NDC 9 | 60505-4537 |
|---|---|
| NDC 10 | 60505-4537-1 |
| NDC Item | 60505453701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60505-4537-1) |
| ANDA | ANDA211022 |
| COLORTEXT | WHITE(White opaque),WHITE(White opaque) |
| Color | C48325;C48325 __ |
| Imprint code | APO;L25 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60505-4537 |
NDC Item 60505453702
| NDC 9 | 60505-4537 |
|---|---|
| NDC 10 | 60505-4537-2 |
| NDC Item | 60505453702 |
| Packaging | 21 CAPSULE in 1 BOTTLE (60505-4537-2) |
| ANDA | ANDA211022 |
| COLORTEXT | WHITE(White opaque),WHITE(White opaque) |
| Color | C48325;C48325 __ |
| Imprint code | APO;L25 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60505-4537 |
NDC Item 63304004601
| NDC 9 | 63304-046 |
|---|---|
| NDC 10 | 63304-046-01 |
| NDC Item | 63304004601 |
| Packaging | 100 CAPSULE in 1 BOTTLE (63304-046-01) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| Imprint code | RL;;83 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-046 |
NDC Item 63304004622
| NDC 9 | 63304-046 |
|---|---|
| NDC 10 | 63304-046-22 |
| NDC Item | 63304004622 |
| Packaging | 21 CAPSULE in 1 BOTTLE (63304-046-22) |
| ANDA | ANDA211846 |
| COLORTEXT | white,white |
| Color | C48325;C48325 __ |
| Imprint code | RL;;83 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-03-04 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 63304-046 |
NDC Item 69097038581
| NDC 9 | 69097-385 |
|---|---|
| NDC 10 | 69097-385-81 |
| NDC Item | 69097038581 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (69097-385-81) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Cipla25mg;385 |
| Labeler | Cipla USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 69097-385 |
NDC Item 70377005411
| NDC 9 | 70377-054 |
|---|---|
| NDC 10 | 70377-054-11 |
| NDC Item | 70377005411 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70377-054-11) |
| ANDA | ANDA215759 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Biocon;logo;25;mg |
| Labeler | BIOCON PHARMA INC., |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70377-054 |
NDC Item 70377005412
| NDC 9 | 70377-054 |
|---|---|
| NDC 10 | 70377-054-12 |
| NDC Item | 70377005412 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70377-054-12) |
| ANDA | ANDA215759 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Biocon;logo;25;mg |
| Labeler | BIOCON PHARMA INC., |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2025-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70377-054 |
NDC Item 70710103501
| NDC 9 | 70710-1035 |
|---|---|
| NDC 10 | 70710-1035-1 |
| NDC Item | 70710103501 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70710-1035-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70710-1035 |
NDC Item 70710103508
| NDC 9 | 70710-1035 |
|---|---|
| NDC 10 | 70710-1035-8 |
| NDC Item | 70710103508 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70710-1035-8) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(white opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70710-1035 |
NDC Item 70771168101
| NDC 9 | 70771-1681 |
|---|---|
| NDC 10 | 70771-1681-1 |
| NDC Item | 70771168101 |
| Packaging | 100 CAPSULE in 1 BOTTLE (70771-1681-1) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(White opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70771-1681 |
NDC Item 70771168108
| NDC 9 | 70771-1681 |
|---|---|
| NDC 10 | 70771-1681-8 |
| NDC Item | 70771168108 |
| Packaging | 21 CAPSULE in 1 BOTTLE (70771-1681-8) |
| ANDA | ANDA210154 |
| COLORTEXT | WHITE(White opaque cap),BLUE(Light Blue opaque body) |
| Color | C48325;C48333 __ |
| Imprint code | 1035 |
| Labeler | Zydus Lifesciences Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | capsule |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 70771-1681 |
NDC Item 76282070147
| NDC 9 | 76282-701 |
|---|---|
| NDC 10 | 76282-701-47 |
| NDC Item | 76282070147 |
| Packaging | 21 CAPSULE in 1 BOTTLE, PLASTIC (76282-701-47) |
| ANDA | ANDA210435 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| Imprint code | Cipla25mg;385 |
| Labeler | EXELAN PHARMACEUTICALS INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-06 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 76282-701 |